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SUMMARY
Paracetamol (Acetaminophen, V-acetyl-p-aminophenol, AAP) is a popular domestic 
analgesic and antipyretic for adults and children. It has a high margin o f  safety when 
used in therapeutic doses. However, acute paracetamol overdose results in hepatic (and 
renal) damage. It is believed that such liver damage occurs in two phases. The first 
phase is due to formation o f the highly reactive oxidation product, V-acetyl-p- 
benzoquinone-imine (NAPQI). After consuming the hepatic reservoir o f  glutathione, 
NAPQI oxidises thiol (SH-) groups o f key enzymes, which causes cell death, liver 
failure, and occasionally death. The pathophysiology o f  the second phase o f liver 
damage is poorly characterised and probably results from the continuing damage 
inflicted by persistently high levels o f  serum paracetamol.
Although it is generally accepted that centrilobular hepatocyte necrosis is characteristic 
o f paracetamol hapatotoxicity, several sporadic reports have previously presented 
evidence for the occurrence o f some morphological and biochemical (such as DNA 
fragmentation) changes that are suggestive o f apoptosis. Therefore, in this in vivo study, 
a more in-depth investigation o f the role o f apoptosis in paracetamol-induced hepatic 
injury was carried out using different modulators o f the induction o f  parenchymal cell 
apoptosis by paracetamol.
Six hours after paracetamol administration to BALB/c mice, a significant loss o f  hepatic 
mitochondrial cytochrome c was observed that was similar in extent to the loss observed 
after in vivo activation o f  the apoptosis inducing death receptor CD95. Paracetamol-
induced loss o f  mitochondrial cytochrome c coincided with the appearance in the cytosol 
o f a fragment corresponding to truncated Bid (t-Bid). At the same time, t-Bid became 
detectable in the mitochondrial fraction, and concomitantly, Bax was found translocated 
to mitochondria. However, paracetamol failed to activate the execution caspases-3 and - 
7 as evidenced by a lack o f  procaspase processing and the absence o f  an increase in 
caspase-3-like activity.
On the other hand, pretreating BALB/c mice with the broad-spectrum caspase inhibitor 
benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-fmk) or the caspase- 
3 family specific inhibitor Z-Asp-Glu-Val-Asp-chloromethylketone (Z-DEVD-cmk) 
nearly completely abrogated paracetamol-induced damage as reflected by the degree o f  
histopathological lesions (centrilobular necrosis, haemorrhagic damage and congestion), 
the rise in serum transaminases, and DNA damage (as assessed by the TUNEL method 
and DNA agarose gel electrophoresis). At the same time, the analogue 
benzyloxycarbonyl-Phe-Ala-fluoromethylketone (Z-FA-fmk) that does not inhibit 
caspases did not prevent the development o f paracetamol-induced liver injury or the 
appearance o f apoptotic parenchymal cells. This demonstrates that caspase inhibitors 
protected the liver by pharmacologically targeting caspases.
I found that Z-VAD-fmk was protective when administered up to two hours after 
paracetamol dosing. This protective effect against paracetamol-related liver damage by 
Z-VAD-fmk also correlated with the inhibition o f the processing o f  Bid to tBid. 
However, Z-VAD-fmk failed to prevent both the redistribution o f  Bax to the 
mitochondria and the loss o f  cytochrome c.
IV
In contrast, pretreatment o f mice with gadolinium chloride to block Kupffer cell function 
did not prevent liver injury but completely blocked paracetamol-induced parenchymal 
cell DNA fragmentation (as assessed by the TUNEL method).
Our findings also suggest that the development o f liver injury in paracetamol toxicity is 
not necessarily a direct consequence to parenchymal cell apoptosis but instead, damage 
to the sinusoidal endothelial cells may play a major role through haemorrhagic 
congestion and shut down o f hepatic microvascular perfiision.
In conclusion, apoptosis is an important causal event in the initiation o f the hepatic 
injury inflicted by paracetamol and is primarily triggered by Kupffer cell-derived 
factors. As suggested by the lack o f activation o f  the main execution caspases, apoptosis 
is not properly executed and degenerates into necrosis. However, the causal role o f  
apoptosis in paracetamol-induced hepatic damage meant that an opportunity for 
pharmacological intervention to protect the liver from drug-induced injury was 
uncovered.
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Chapter 1
Introduction
1.1 Apoptosis
1.1.1 Historical review
In Greek, apo means “from”, ptosis means “fall”; apoptosis used to describe the 
“dropping o f f ’ or “falling o f f ’ o f petals o f flowers, or leaves from trees (Kerr et ah, 
1972; Majno and Joris, 1995). The word apoptosis was first adopted by Kerr et al in 
1972 to depict the phenomenon o f controlled cell death as an antithesis to mitosis in the 
regulation o f cell populations (Kerr et al., 1972). The same authors had previously 
named this mode o f cell death as “shrinkage necrosis” reflecting that cells undergoing 
apoptosis become condensed and compacted (Kerr, 1971).
Although apoptosis is a fashionable topic now, it was largely neglected for almost a 
century after its discovery. Both Flemming and Nissen first reported the observation o f  
apoptosis in 1885, under the name “chromatolysis” (Majno and Joris, 1995; Wang and 
Wang, 1999).
In a 1914 paper “A new joint o f view regarding the elimination o f cells” (translated from 
German), Graper proposed chromatolysis to be a mechanism counterbalancing mitosis 
and responsible for the elimination o f  unwanted cells, and he was the first to note the 
debris o f dead cells was taken up by neighbouring cells (Graper, 1914; Majno and Joris, 
1995).
In 1950s, Glucksmann extensively described a “form o f  physiological cell death” among 
vertebrate embryos, and his descriptions were generally consistent with what we now 
know to occur during apoptosis (Glucksmann, 1951). Glucksmann realised that what he
had observed was a new type o f  cell death distinct from necrosis (Majno and Joris, 1995). 
However he did not designate a new term to specify it. This was left until 1964 when 
Lockshin and Williams used the term “programmed cell death” (PCD) to refer to the 
death o f  given cell types in predictable sites at predictable times during ontogeny 
(Lockshin and Williams, 1964).
In 1971 the term “shrinkage necrosis” was used to differentiate a newly identified type o f  
cell death from classical necrosis (Kerr, 1971), and in 1972 the term “apoptosis” was 
used to describe cell death with characteristic morphology (Kerr et al., 1972).
Kerr et al defined apoptosis as a form o f  cell death with a pivotal role in embryogenesis, 
metamorphosis, and maturation o f immune systems, as well as natural tissue turnover 
whereby apoptosis maintains the balance between cell loss and cell gain and is therefore 
regarded as nature’s way o f  eliminating unwanted, senescent, and damaged cells from 
multicellular organisms (Kerr et al., 1972).
From 1976 through 1981, three independent groups noted that chromatin breaks into 
pieces the size o f  multiple nucleosomes. This was termed “DNA laddering” which is a 
distinctive double strand cleavage o f nuclear DNA at the linker regions between 
nucleosomes (Skalka et ah, 1976; Yamada et al., 1981; Zhivotovsky et al., 1981). 
However, Wyllie, in 1980 was the first to link DNA laddering and activation o f  
endogenous endonuclease to apoptosis (Wyllie, 1980).
1.1.2 Apoptosis versus Necrosis
It is important to recognise that these terms (apoptosis and necrosis) relate to a 
morphological description o f  cell death only, and it remains possible that the two 
processes might actually be part o f a continuum, with morphological necrosis being the 
ultimate fate for cells that undergo apoptotic changes initially (Dong et aL, 1997).
As outlined in Table 1 and in contrast to necrosis, apoptosis is an active process 
associated with cell shrinkage, loss o f contact with neighbouring cells, release o f  
cytochrome c from mitochondria, caspase activation, plasma membrane blebbing, 
phosphatidylserine externalisation on the plasma membrane, chromatin condensation at 
the nuclear membrane, and nuclear and cytoplasmic fragmentation with formation o f the 
so called “apoptotic bodies” that can be taken up and degraded by neighbouring cells 
(Allen et aL, 1997; Thompson, 1995; Wilson, 1998).
During apoptosis, plasma membrane is kept intact thus preventing cytosolic contents 
from leaking to the exterior. Therefore apoptosis is not associated with an inflammatory 
response (Wyllie, 1997b).
Necrosis, on the other hand, is a passive form o f cell death that tends to affect contiguous 
cells, is associated with inflammation, and is often due to an overwhelming cellular 
insult. As shown in Table 1, necrosis is characterised by swelling o f  the cytoplasm and 
organelles, breakdown o f plasma membrane, release o f  lysosomal enzymes, and cell lysis 
with spillage o f pro-inflammatory intracellular constituents into the extracellular milieu 
which results in an inflammatory response in the surrounding tissue (Fadeel et aL, 1999; 
Trump and Berezesky, 1995).
Table 1, Differentiation between apoptosis and necrosis (adopted, with modification, 
from Leist et al (Leist et al., 1998)).
Changes Apoptosis Necrosis
Distribution Scattered single cells Contiguous group o f  cells
Nucleus Convolution o f  nuclear outline and 
breakdown
Initially condensation 
(pyknosis), later mostly 
disintegration (karyorrhexis) 
and dissolution (karyolysis)
Nuclear
chromatin
Condensation and margination, with 
formation o f  uniformly dense 
masses, often yielding characteristic 
crescent-shaped figures
Clumping, not sharply defined
DNA
breakdown
Characteristic high molecular weight 
(50-300 kbp) DNA fi*agmentation. 
Often oligonucleosomal cleavage 
into « X 180 bp DNA fi-agments
Random DNA degradation
Cytoplasm Condensation o f cytosol. Dense 
packaging o f relatively intact 
organelles. Occasional dilatation o f  
endoplasmic reticulum
Oedematous swelling o f  
organelles and rupture o f  
intracellular membranes
Plasma
membrane
Blebbing with maintenance o f  
membrane integrity
Blebbing with eventual rupture 
o f  plasma membrane and 
spillage o f  intracellular 
contents
Cell Formation o f  apoptotic bodies Swelling and later 
disintegration
Phagocytosis Rapid removal by professional 
phagocytes and by neighbouring 
cells
Clearance by infiltrating 
phagocytes after disintegration 
o f  cells
Exudative
inflammation
Absent Present, with occasional scar 
formation
Studies suggest that apoptosis and necrosis generally occur simultaneously and that both 
intracellular energy levels and the severity o f the insult are important determinants o f the 
mode o f cell death (Ankarcrona et aL, 1995; Bonfoco et aL, 1995; Leist et aL, 1997b; 
Nicotera c? a/., 1998).
While both types o f  cell death are associated with DNA damage, the pattern o f  DNA 
degradation is different between the two. In apoptosis there selective DNA cleavage at 
intemucleosomal sites, whereas in necrosis degradation is random (Dong et aL, 1997; 
Leist a/., 1998).
Apoptosis-associated nuclear condensation and DNA fragmentation is usually 
accompanied by the activation o f endonucleases that first cleave the DNA into HMW 
(50-300 kb) pieces and then further into smaller intemucleosomal fragments o f  180-200- 
base pairs in length, the latter gives the classic DNA-laddering constituting an important 
biochemical criterion found in most apoptotic cells (Duke et aL, 1983; Wyllie, 1980; 
Wyllie et aL, 1984).
A specific endonuclease called CAD (caspase-activated DNase) cleaves the chromosomal 
DNA in a caspase-dependent manner. CAD is normally synthesized with the help o f  
ICAD (inhibitor o f  CAD), which works as a specific chaperone for CAD and is found 
complexed with it in proliferating cells. When cells are induced to undergo apoptosis, 
effector caspases (particularly caspase-3) dissociate and degrade the ICAD, which, in 
turn, liberates CAD resulting in the induction o f  nuclease activity, nuclear condensation, 
and DNA fragmentation (Enari et aL, 1998; Mitamura et aL, 1998; Nagata, 2000; 
Sakahira c /a /., 1998).
However, DNA fragmentation is not pathognomonic to apoptosis as it is also observed in 
some cell deaths with ultrastructural features o f necrosis (Collins et aL, 1992). Also 
reports o f  failure to detect intemucleosomal DNA cleavage in some apoptotic cells raise 
further doubts about the validity o f using DNA electrophoresis in isolation to categorise 
cell death (Cohen et aL, 1992a). Therefore, intemucleosomal DNA cleavage should not 
be the sole criterion for identifying apoptosis (Collins et aL, 1992; Dong et aL, 1997).
1.1.3 Pathways of apoptosis
Since the proposal o f the term “apoptosis” and its implications within the context o f  
human cell biology and diseases in the early 1970s (Kerr and Searle, 1972a; Kerr and 
Searle, 1972b; Kerr et aL, 1972) and the work on apoptosis carried out by Wyllie 
(Wyllie, 1980) and Duke (Duke et aL, 1983) in the 1980s, our ability, over the last two 
decades, to understand the remarkable and genetically complex processes involved in 
apoptosis is attributed to the use o f  powerful molecular biology techniques.
We now have a good, albeit incomplete, understanding o f the wide variety o f  genes 
involved in the regulation o f  apoptosis. Such genes have been subjected to fairly 
thorough analysis to determine the complex interactive pathways o f  apoptosis. As new 
apoptosis genes continue to be identified, and new apoptosis-related functions are 
assigned to familiar proteins, our understanding o f this rapidly growing subject will 
remain in a state o f flux for some time to come (Afford and Randhawa, 2000).
As outlined in Figure 1, it is generally accepted that apoptosis occurs by one o f two 
pathways: (1) Receptor (or death receptor) pathway, and (2) Mitochondrial pathway 
(Green, 1998).
1.1.4 The role of cell surface receptors in apoptosis
Apoptosis can be triggered by specific cell surface death receptors engaging specific 
ligands. It is well established that a number o f  ligand/receptor interactions cause 
apoptosis and these include:
1. The TNF receptor superfamily (also called death receptors) which includes Fas 
receptors (also called Fas, FasR, or CD95/Apol), TNF receptors TNF-Rl and TNF-R2, 
and TRAIL (TNF-related apoptosis-inducing ligand) receptors.
2. Transforming growth factor p receptor (TGF-pR) family which mediate the action o f  
TGF-pi (Patel e/fl/., 1998).
The TNF superfamily receptors are type 1 membrane spanning glycoproteins. The N- 
terminus o f which faces to the outside o f the cell and contains 1-6 ligand binding 
domains. The C-terminus faces towards the interior o f the cell and contains a region o f  
about 60-70 residues. The receptors oligomerize upon activation with a trimeric ligand 
(or membrane-bound ligand) to form a cluster, which then interacts with cytosolic 
proteins to form the DISC (death inducing signalling complex) with its active “death 
domain”.
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Figure 1. The two main pathways of apoptosis: Relationship between the death receptor 
pathway (left) and the mitochondrial pathway (right) and their interaction with members o f  
the Bcl-2 family. Details o f the much-disputed pathways initiated by the TGF-ft family have 
been omitted.
1.1.4.1 Fas (CD95/Apo-l)
While expression o f some TNF receptors appears to be restricted to certain cell types, Fas 
(CD95/Apol) receptors are fairly well distributed across a wide range o f  cell types and 
are thought to have a central role in triggering apoptosis (Desbarats et aL, 1998; Loweth 
et aL, 1998; Luo et aL, 1997).
Transduction o f the Fas signal has been mainly studied in lymphoid cells (Nagata, 1997). 
The expression o f  Fas ligand (FasL) is essentially restricted to CD8^ cytotoxic T 
lymphocytes (CTL) and natural killer (NK) cells. The normally membrane-bound FasL 
acts as a major effector o f  their cytotoxic effects (Hanabuchi et aL, 1994; Montel et aL, 
1995).
In rat liver, Kupffer cells and sinusoidal endothelial cells (SECs) slightly express FasL- 
mRNA in the basal state, and this expression can be enhanced in culture when EPS is 
added to the medium (Muschen et aL, 1998). In contrast, FasL is not normally expressed 
in hepatocytes, although FasL-mRNA may be expressed in culture after exposure to 
dexamethasone and during several conditions causing oxidative stress (Galle et aL, 1995; 
R u getaL , 1997; Muller c /a /., 1997; Strand c /a /., 1998).
The intraperitoneal administration o f the monoclonal anti-Fas antibody/Jo2 
(lOOpg/animal) rapidly killed wild type mice but not Ipr (lymphoproliferation) mice, 
which have a Fas gene defect (Ogasawara et aL, 1993).
Despite the fact that Fas receptor is expressed in many organs, the administration o f  the 
anti-Fas antibody mainly damages the liver, possibly because hepatocytes do not express 
(or poorly express) Bcl-2. In Bcl-2 transgenic mice (mice expressing human Bcl-2 gene
_
product in their hepatocytes), hepatic apoptosis induced by the administration o f  anti-Fas 
antibody (lOpg/animal) was delayed and reduced and most o f the animals survived, 
whereas the nontransgenic mice suffered from hepatic apoptosis and death (Lacronique et 
a/., 1996).
As shown in Figure 2, FasL forms the Fas-associated death domains (FADD) which 
binds to procaspase-8 and causes its activation and the initiation o f the caspase cascade 
(Boldin «/., 1996).
It is however believed that Fas signalling involves two major pathways termed type I and 
type II (Scaffidi et aL, 1998). In type I pathway, sufficient amounts o f caspase-8 are 
recruited (at the level o f the DISC) to directly activate caspase-3, thereby bypassing the 
need for mitochondrial cytochrome c (see below). Type II pathway results in the indirect 
activation o f caspase-3. It occurs when caspase-8, present in insufficient levels at the 
DISC, cleaves the BH3 interacting domain death agonist (Bid) which induces the release 
o f mitochondrial cytochrome c to form the apoptosome complex that activates caspase-3 
(Luo et aL, 1998; Thomberry and Lazebnik, 1998; W olf and Green, 1999). This could 
explain why Bcl-2 is only capable o f preventing Fas-mediated apoptosis in type II 
(Scaffidi era/., 1998).
Tissue specificity is presumed to be the main factor determining which o f  these two 
pathways to use. Hepatocytes are presumed to use the type II pathway as hepatocytes 
from Bid-deficient (Bid-/-) mice were shown to be relatively resistant to Fas-induced 
apoptosis, whereas thymocytes from the same (Bid-/-) mice were shown to be sensitive to 
Fas-mediated apoptosis (Yin et aL, 1999).
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Figure 2. Apoptosis signalling by CD95. The oligomerization, most probably, trimerization, o f 
CD95 is required for the transduction o f the apoptotic signal. The death-inducing signalling complex 
(DISC) forms within seconds o f receptor engagement. First the adaptor FADD (Fas-associated death 
domain protein, also known as Mortl) binds via its own death domain (DD) to the clustered death 
domains o f CD95. FADD also carries a so-called death-effector domain (DED), and, again, by 
homologous interaction, recruits the DED-containing procaspase-8 (also known as FLICE) into the 
DISC. Upon recruitment by FADD, caspase-8 oligomerization drives its proteolytic activation 
through self-cleavage based on “induced-proximity” model (Figure 6: panel A). This releases active 
caspase-8 from the DISC into the cytoplasm in the form o f a heterotetramer o f two small subunits 
(plO) and two large subunits (p20). Active caspase-8 cleaves various proteins in the cell including 
procaspase-3, which results in its activation and the completion o f  the apoptotic process.
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1.1.4.2 Tumour Necrosis Factor
Tumour necrosis factors (TNFs) are a family o f ligands that exists as soluble or cell- 
bound forms. TNFs play a significant role in the modulation o f survival/apoptosis in 
cells o f a variety o f lineages, and they act via a TNF receptor superfamily comprising a 
minimum o f 19 members, with a wide range o f biological effects, not solely limited to 
the regulation o f apoptosis. Whereas at least four o f them can trigger apoptosis directly, 
it seems that some family member which are incapable o f  signalling because they lack a 
cytoplasmic tail, can function as “decoy receptors”. At present, the exact bio-function of  
this receptor family has not been clearly defined yet (Nagata and Golstein, 1995; Orlinick 
and Chao, 1998; Smith et aL, 1994).
TNF-a is mainly produced by activated lymphocytes, monocytes, and macrophages, 
including Kupffer cells (Tracey and Cerami, 1993). In humans, the TNF-a gene is 
located on chromosome 6 in the human leukocyte antigen (HLA) region (Beutler and 
Cerami, 1988). The TNF-a promoter region contain both NF-kB and activator protein-1 
(AP-1) binding sites (Zwacka et aL, 1998).
TNF-a is initially synthesized as a 26-kDa membrane-bound form o f 233 amino acids, 
which is then proteolytically cleaved between Ala and Val to the 17-kDa secreted form 
consisting o f 137 amino acids (Tracey and Cerami, 1993). Secreted TNF-a is an 
unglycosylated polypeptide that is active in its trimeric form (Jones et aL, 1989; Smith 
and Baglioni, 1987). The cell surface membrane-bound form o f TNF-a is also active 
(Tracey and Cerami, 1993). In the latter case, TNF-a bearing cells kill target cells
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through cell-to-cell contact (Decoster et aL, 1995; Kriegler et aL, 1988; Perez et aL, 
1990).
LPS can enhance TNF-a production in macrophages and Kupffer cells, thus increasing 
DNA binding o f  both NF-kB and AP-1 (Tran-Thi et aL, 1995). TNF-a induces cell death 
in cultured rat and mouse hepatocytes and in mouse liver in vivo. The effects o f TNF are 
mediated by two receptors, the 55 kDa TNF-Rl and the 75 kDa TNF-R2. As outlined in 
Figure 3, both TNF-a and TNF-(3 can bind to TNF-Rl and induce apoptosis by an 
intracellular cascade identical to the Fas receptor except that it first incorporates TRADD 
(TNF-receptor-associated death domain) which then recruits FADD (Heller and Kronke, 
1994; Leist et aL, 1995b).
Signalling through TNF-Rl is, however, more complex than CD95. Indeed, in addition 
to recruiting adaptor molecules that bind and activate caspases, TNF-Rl recruits proteins 
that engage various signal transduction pathways, some o f which abrogate the apoptotic 
response. For example, in addition to recruiting FADD, TRADD also binds the serine- 
threonine kinase RIP (receptor-interacting protein) thereby coupling stimulation o f TNF- 
R l to the activation o f NF-kB and offering protection against TNF-induced apoptosis 
(MacFarlane, 2003).
The role o f TNF-R2 in apoptosis is not well established. It has been shown that under 
conditions o f transcriptional arrest, TNF-Rl alone was shown to be responsible for the 
apoptotic signal transduction upon TNF binding (Leist et aL, 1995b; Leist et aL, 1998).
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Figure 3. Pro-apoptotie signalling by TNF-Rl. Upon binding, TNF trimerises TNF-Rl and induces 
the receptors’ death domains (DD). Subsequently, an adaptor termed TRADD (TNF receptor 
associated death domain) binds through its own death domain to the clustered receptor death domains. 
TRADD functions as a platform adaptor that recruits several signalling molecules to the activated 
receptor. The association o f TRADD with FADD mediates the activation o f apoptosis.
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The fact that pretreatment with the transcription inhibitor D-galactosamine (GalN) 
sensitises hepatocytes to TNF-a (and LPS) and leads to apoptosis, suggests the presence 
o f  TNF-induced genes which are anti-apoptotic (Lawson et aL, 1998; Leist et aL, 1994). 
Such anti-apoptotic effects o f TNF-a were confirmed to be mediated by the 
transcriptional activator NF-kB which, upon translocation to the nucleus, promotes 
transcription o f  survival genes (Beg and Baltimore, 1996; Van Antwerp et al., 1996; 
Wang et al., 1996a). As demonstrated in Figure 4, the activation o f NF-kB by TNF-a is 
attributed to the capability o f  TRADD to bind other proteins such as RIP and TRAF-2 
(TNF receptor associated factor-2) which cause phosphorylation and degradation o f  IkB 
(inhibitor o f NF-kB) that normally maintains NF-kB in an inactive cytosolic complex 
(Hsu et aL, 1996; Hsu et aL, 1995; Regnier et aL, 1997).
RIP possesses a functional N-terminal kinase domain and can autophosphorylate itself, 
but its kinase activity is not required for activation o f  NF-kB. TRAF-2 has likewise been 
implicated in the activation o f  NF-kB-inducing kinase (NIK). However, studies using 
RIP and TRAF2-deficient cells indicate that RIP is most likely responsible for NF-kB 
activation, whereas TRAF2 preferentially activates c-JUN N-terminal kinase (JNK) (Yeh 
et aL, 1999). Other studies have shown that RIP could be cleaved by caspase-8 to 
produce a dominant negative fragment which inhibits TNF-induced NF-kB activation, 
and therefore promotes apoptosis (Lin et aL, 1999; Martinon et aL, 2000).
The anti-apoptotic effect o f NF-kB at least partly is accounted for by upregulation o f  
lAPs (Inhibitors o f apoptosis) which inhibit executioner caspases (e.g. caspases-3 and 
capases-7) (Chu et aL, 1997; Wang et aL, 1998).
16
TNF
TN FR 1
T R A D D
RIP RIP
T R A F 2
NIK
IKK
i
M E K K 1 ?
I -kB / N F - kB J N K K
: iN F- kB J N K
c-JUN
Figure 4. Anti-apoptotic signalling by TNF-Rl. Stimulation o f TNF-Rl by ligand-induced 
cross-linking initiates the recruitment o f various adaptor molecules (through homophilic death 
domain-DD-interactions) and results in activation o f the NF-kB and JNK signalling pathways 
through RIP and TRAF-2, respectively.
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Thus, in addition to its pro-apoptotic effect, TNF-a can also promote growth o f  
hepatocytes (Diehl et ah, 1994) and may be required to initiate liver regeneration as 
observed in mice after partial hepatectomy (Yamada et aL, 1997). However, the role o f  
TNF-a in human liver diseases is not as well established as it is for TGF-(31 (Patel et aL, 
1998).
A model o f TNF/TNF-Rl-dependent liver injury is the Concavalin A (Con A)-model. 
Con A is a T-lymphocyte mitogenic plant lectin that leads to the in vivo production o f  
pro-inflammatory cytokines (TNF-a, IFN-y, IL-1, IL-2, IL-6, IL-10) and polyclonal T- 
cell proliferation. Due to its preferential binding to the liver, Con-A leads to a liver- 
selective injury with no other organs being affected. Mice, when injected with Con A, 
tend to develop an acute, partly apoptotic, hepatic injury that is subsequently overlaid by 
massive necrosis (Gantner et aL, 1995; Tiegs et aL, 1992) and, eight hours after 
intravenous injection, a picture o f fulminant hepatitis is observed (Louis et aL, 1997).
TNF-a is produced early in the course o f Con A-induced hepatitis, and blockade o f  its 
action is protective against liver injury (Gantner et aL, 1995; Mizuhara et aL, 1994). 
CD"^  ^ T lymphocytes have been identified as being the effector cells in Con A-induced 
hepatitis (Tiegs et aL, 1992).
Intravenously administered Con-A predominantly binds to sinusoidal endothelial cells 
(SEC), and not to Kupffer cells. Loss o f SEC barrier function may expose the underlying 
hepatocytes for further attacks by activated T-lymphocytes (Knolle et aL, 1996). 
Intravenous Con A, when given alone, induced TNF-mediated hepatotoxicity that is 
dependent on both TNF-Rl and TNF-R2. Under this model, the broad spectrum caspase 
inhibitor Z-VAD-fmk, failed to protect animals from Con A-mediated liver injury. On
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the other hand and, under transcriptional arrest (with GalN), Con A induces TNF-Rl- 
dependent, but not TNF-R2-dependent, activation o f casapase-3-like proteases and 
zVAD-fmk was shown to protect animals from Con A-mediated liver injury under these 
conditions. Therefore, it may be concluded that Con A initiates liver destruction without 
activation o f  caspase-3-like proteases, and that TNF-induced caspase-3-like proteases 
activity is triggered and required for apoptosis only under conditions o f  transcriptional 
arrest (Kunstle et aL, 1999).
1.1.4.3 TRAIL
In 1995, TRAIL (TNF-related apoptosis-inducing ligand), also called Apo-2L, a new 
member o f the TNF cytokine family, was identified purely on the basis o f  sequence 
homology to other members o f  the TNF family (Wiley et aL, 1995). Five receptors for 
this cytotoxic ligand were characterised. As outlined in Figure 5, two o f these receptors, 
TRAIL-Rl (DR4) and TRAIL-R2 (killer, DR5, TRICK2), contain classical cytoplasmic 
death domains and are able to transduce an apoptotic signal. The signal transduction 
pathways for the two pro-apoptotic TRAIL receptors (DR4 and DR5) also seems to use 
both FADD and caspase-8 which then activates downstream caspases or cleaves RIP 
directly, in keeping with their molecular brothers (Bodmer et aL, 2000; Kischkel et aL, 
2000; Sprick et aL, 2000).
Analysis o f the TRAIL DISC revealed that FADD was present together with caspase-8 
and that in a cell line lacking either FADD or caspase-8, TRAIL-induced apoptosis was 
completely abrogated (Bodmer et aL, 2000; Kischkel et aL, 2000; Sprick et aL, 2000).
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An obligatory role for FADD in TRAIL signalling was further corroborated by studies in 
FADD'^ fibroblasts expressing individual TRAIL receptors, where TRAIL-induced 
apoptosis was abolished (Kuang et ah, 2000). However, other studies have shown that 
TRADD too may be recruited by both DR4 and DR5 (Chaudhary et ah, 1997; Schneider 
et aL, 1997) and this raises the possibility that TRAIL, similar to TNF, may signal for 
NF-kB and/or JNK (MacFarlane, 2003). Indeed, it was demonstrated that DR4 or DR5 
can activate the NF-kB (Figure 5) or JNK signalling pathways, most likely through RIP 
and TRAF-2, respectively, analogous to that shown for TNF-Rl (Figure 4) (Hu et aL, 
1999; MacFarlane, 2003). More recently, it has been shown that TRAIL-induced 
apoptosis results in a caspase-dependent activation o f JNK, but significantly, JNK 
activation does not appear to be required for the induction o f apoptosis (MacFarlane et 
aL, 2000).
As with the TNF pathway (Lin et aL, 1999; Martinon et aL, 2000), caspase-8 mediated 
cleavage o f RIP could significantly inhibit the capacity o f TRAIL-sensitive cells to 
activate NF-kB (Harper et aL, 2001). Instead, in cells that are relatively resistant to 
TRAIL-induced apoptosis, the predominant TRAIL signalling event seems to be NF-kB 
activation (MacFarlane, 2003).
The other three TRAIL receptors lack fimctional death domains and are not able to 
promote cell death. These include two additional cell bound receptors (called 
“decoyDcR” receptors), TRAIL-R3 (LIT, D cR l) and TRAIL-R4 (TRUNDD, DcR2), 
and, last a soluble receptor called osteoprotegerin (OPG). So far the activities o f  OPG 
have been shown to be inhibition o f osteoclastogenesis and increased bone density in 
vivo. The existence o f multiple receptors for TRAIL suggests an unexpected complexity
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to TRAIL-mediated biological functions. (Degli Esposti, 1999; Emery et ah, 1998; Pan 
et aL, 1997; Pan et aL, 1998; Sheridan et aL, 1997).
Pre-clinical studies in mice and non-human primates have previously shown that 
administration o f recombinant human TRAIL (rh-TRAIL) can induce apoptosis in human 
tumours but yet does not induce apoptosis in normal cells. This would make TRAIL o f  
great potential to use in the treatment o f  human cancers (Ashkenazi et aL, 1999; Pitti et 
aL, 1996; Walczak et aL, 1999).
However, in contrast with previous reports, recent results have shown that rh-TRAIL 
does induce extensive apoptosis in normal human hepatocytes in culture but still confirms 
the pre-clinical data which showed that hepatocytes from other species (mouse, rat, and 
monkey) are not killed by exposure to rh-TRAIL. This suggests species differences in 
sensitivity to TRAIL, and that substantial liver toxicity might result if  TRAIL were used 
in human cancer therapy. Caspases involved in apoptosis induced by rh-TRAIL were 
similar to those involved in apoptosis induced by TNF and Fas systems, and included 
both the initiator caspases 8, 9, and 10, as well as the effector caspases 3 and 7 (Jo et aL, 
2000).
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Figure 5. Apoptotic signalling by TRAIL-Rl (DR4) and TRAIL-R2 (DR5) and its modulation 
by decoy receptors. This “extrinsic” cell death pathway is launched by death-receptor ligands 
(TRAIL/Apo2L) that trigger caspase-8 oligomerization and proximity-induced autoproteolytic 
activaion via the adaptor molecule FADD/Mortl. Activation is regulated by decoy receptors (DcRl 
and DcR2) which preclude the binding o f TRAIL to the functional receptor. DR4 or DR5 can also 
activate NF-kB or JNK signalising pathways, most likely through RIP and TRAF-2, respectively. 
JNK activation pathway (not shown) appears not to be required for induction o f apoptosis.
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1.1.4.4 TGF-p
Transforming growth factor p (TGF-P) is a member o f a large superfamily, including the 
activins, inhibins, bone morphogenic proteins, and several other growth and 
differentiation factors (Grande, 1997).
Like TNF-a, TGF-P has two reeeptors: TGF-p receptor type 1 (TGF-p R-1) and TGF-p 
receptor type 2 (TGF-p R-11). These receptors are transmembrane proteins with 
serine/threonine kinase activity in their intracellular domains (Heldin et aL, 1997). The 
dimeric TGF-p protein first binds to a dimer o f TGF-p R-11, which then associates with a 
TGF-p R-1 dimer, and phosphorylates the cytoplasmic domains o f the TGF-p R-I dimer 
(Heldin et aL, 1997).
Thus TGF-P, TGF-p R-Il, and TGF-p R-1 form a ligand-bound, phosphorylated 
tetrameric receptor complex responsible for signal transduction (Heldin et aL, 1997). 
Cytosolic Smad (zinc-finger transcription factor Schnurri mothers against 
decapentaplegic) proteins seem to play an essential role in transducing the TGF-p signal 
into the nucleus (Heldin et aL, 1997; Massague et aL, 1997).
The most abundant isoform is TGF-pl; this particular form has a wide range o f  effects, 
including the triggering o f apoptosis in a large variety o f normal and tumour cells 
(Grande, 1997; Rizzino, 1988). TGF-pl is also a potent inhibitor o f  DNA synthesis in rat 
and human hepatocytes as well as in regenerating rat livers in vivo; (Carr et aL, 1986; 
RussqW et aL, 1988).
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TGF-pl is synthesized in several cells and tissues (Grande, 1997), In the liver, TGF-pl 
is expressed in Kupffer cells, sinusoidal endothelial cells, and fat-storing perisinusoidal 
Stellate (Ito) cells (Bedossa and Paradis, 1995; Date et aL, 1998).
Active mature TGF-pl is a 25 kDa disulphide linked homodimer which gets activated 
after dissociation from the N-terminal TGF-pl latency associated peptide (LAP) 
(Massague, 1990).
The first evidence that TGF-pl can cause cell death in primary cultures o f  normal rat 
hepatocytes was reported by Oberhammer et al (Oberhammer et aL, 1991; Oberhammer 
et aL, 1993; Oberhammer et aL, 1992b). The ability o f  TGF-pl to cause hepatocyte 
apoptosis in vivo was demonstrated in transgenic mice overexpressing hepatic TGF-pl 
(Sanderson et aL, 1995).
The initial mechanisms that trigger TGF-pl-induced hepatocyte apoptosis are not 
completely understood (Neuman, 2001). Although Smad molecules are involved in the 
transduction o f  the TGF-pl signal (Massague et aL, 1997; Shi and Massague, 2003), their 
possible implication in the TGF-P 1-induced apoptosis has not been studied. However, 
more is known about later events whereby TGF-pl-induced apoptosis is associated with 
the activation o f  caspase-1, caspase-2, and caspase-3 (Cain et aL, 1996; Choi et aL, 1998; 
Inayat-Hussain etaL , 1997).
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1.1.5 The role of perforin/granzyme B system in apoptosis
In addition to the Fas/FasL and TRAIL/DR&DR5 systems, activated CTL can kill target 
cells through the perforin/granzyme B system (Kagi et al., 1994). Perforin makes holes 
in the cell membrane and, possibly, in postendosomal intracellular vesicles, which may, 
respectively, allow the entry o f extracellular and endocytosed granzyme B into the 
cytosol (Pinkoski et aL, 1998). Although granzyme B is a serine protease, it also cleaves 
proteins after aspartate (as do caspases) and thus can activate the caspase cascade 
(Darmon et aL, 1995). Thus, the executioners o f apoptosis are similar in Fas/FasL 
system and the perforin/granzyme B system (Nagata, 1997).
1.1.6 The role of mitochondria in apoptosis
1.1.6.1 General
Mitochondria are the cell’s powerhouse involved in fatty acid p-oxidation, the 
tricarboxylic acid cycle, and oxidative phosphorylation, which provide most o f  the cell 
energy. Mitochondria are also the main endogenous source o f reactive oxygen species 
(ROS) in the normal cell (Fromenty and Pessayre, 1995).
Mitochondria have two membranes: a circular outer membrane limiting the 
intermembranous space, and an inner membrane with inner folds (or cristae), which 
encircle the mitochondrial matrix and helps to maintain the mitochondrial inner 
transmembrane potential (Av|/m). Recent studies suggested that the induction o f  
mitochondrial permeability transition (MPT) results in loss o f  Ai|/m and the opening o f  the
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mitochondrial permeability transition pore (MPTP) and that this effect is prevented by the 
MPT inhibitor cyclosporin A (Loeffler and Kroemer, 2000; Yang and Cortopassi, 1998).
The MPTP is a large channel consisting o f both inner and outer mitochondrial membrane 
proteins, such as adenine nucleotide translocator (ANT) and voltage-dependent anion 
channel (VDAC), respectively, and is formed at the contact sites o f  the two membranes 
(Crompton, 1999).
Cytochrome c is one o f the components o f  the mitochondrial electron-transport chain. It 
is involved in the production o f ATP by shuttling electrons between respiratory chain 
complexes III (cytochrome reductase) and IV (cytochrome c oxidase). It is synthesized 
from two inactive precursor molecules: r^o-cytochrome c and heme, ^^o-cytochrome c 
is encoded by a nuclear gene and synthesized in the cytosol. It is imported into the 
mitochondrial intermembrane space in an unfolded configuration and, when covalently 
linked to the heme moiety, it undergoes conformational changes to yield holo- 
cytochrome c (better known as cytochrome c). Cytochrome c is a 13-kDa protein 
normally confined to the mitochondrial intermembrane space. It is only the holo- 
cytochrome c, albeit in a reduced or oxidised form, that is capable o f activating pro- 
caspase-9 (Hampton et aL, 1998; Kroemer, 1999).
1.1.6.2 Mitochondria and apoptosis
Insofar as apoptosis is concerned, mitochondria were originally believed not to be 
involved in apoptotic cell signalling as cells lacking mitochondrial DNA (mtDNA) were 
still capable o f undergoing apoptosis (Jacobson et aL, 1993). However, subsequent
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reports supported a role o f  mitochondrial participation because membrane fraction 
containing mitochondria was required for nuclear apoptosis (Green and Reed, 1998; Liu 
etaL , 1996;Newmeyer^/nr/., 1994).
Mitochondria, which normally tend to spread over the whole cell, manifest “perinuclear 
clustering” in apoptotic cells (De Vos et aL, 1998). Moreover, from a morphological 
point o f view, mitochondria are reduced in size and the matrix becomes hyperdense in 
apoptosis. This is referred to as “mitochondrial pyknosis” (Hackenbrock, 1968; Mancini 
et aL, 1997; Martinou et aL, 1999; Zhuang et aL, 1998).
Unlike nuclear DNA, mitochondrial DNA remains intact during the apoptotic process. 
This further supports the notion that DNA fragmentation during apoptosis is a specific 
nuclear event (Murgia et aL, 1992).
Mitochondria are central targets for oxidative stress. When stressed, mitochondria 
release a set o f molecules, namely cytochrome c and Apaf-1 (apoptotic protease 
activating facor-1) which are vital to the activation of caspase-9 (Kroemer and Reed, 
2000; Li etaL , 1997b).
Cytochrome c release from mitochondria has been confirmed to be an event o f paramount 
importance in the execution o f  apoptosis both in in vitro and in vivo (Kluck et aL, 1997; 
Yang et aL, 1997). Although the mechanism o f how exactly cytochrome c (and other 
mitochondrial inter-membranous proteins) manage to cross the mitochondrial outer 
membrane is not yet known, it is clear that the Bcl-2 family members are intimately 
involved in the regulation o f this process. The fact that cytochrome c release can precede
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(Zhuang and Cohen, 1998) or even occur in the absence (Gross et al., 1999a) o f  any 
change in AYm suggest that MPT can not be the sole mechanism o f cytochrome c release 
and, at the same time, indicate that MPT? can not be the sole target o f the Bcl-2 family 
protein.
As outlined in Figure 1, once in the cytosol, cytochrome c associates with the adaptor 
protein Apaf-1, in the presence o f dATP (or ATP), and then with procaspase-9 which 
results in the proteolytic activation o f the caspase-9 zymogen. Activated caspase-9 then 
converts procaspase-3 to caspase-3 (Li et al., 1997b; Liu et al., 1996; Zou et al., 1997). It 
is now thought that the cytochrome c/Apaf-1 /caspase-9 complex, otherwise known as the 
“apoptosome”, to actually represent the true form o f active capase-9 (Rodriguez and 
Lazebnik, 1999).
The fact that apoptosis could be switched to necrosis when ATP levels are reduced (Leist 
et ah, 1997b; Nicotera et al., 1998) might be related to reduced caspase activity and/or 
the formation o f the apoptosome complex (Leist et al., 1997b; Li et al., 1997b)
In the presence o f d-ATP and cytochrome c, the monomeric Apaf-1 is transformed into 
an oligomeric complex made o f at least eight subunits (Hu et al., 1998; Saleh et al., 1999; 
Zou et al., 1999). The importance o f Apaf-1-induced activation o f  caspase-9 has been 
highlighted by reports that demonstrate that Apaf-1 or caspase-9 deficiency results in 
embryonic lethality due to defective neuronal apoptosis (Cecconi et ah, 1998; Hakem et 
al., 1998; Kuida et al., 1998; Yoshida et al., 1998). On the other hand, Apaf-1 
overexpression was shown to trigger mitochondrial Av|/m, cytochrome c release into the 
cytosol, and apoptosis through a mechanism that involves the cleavage and activation o f
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caspase-9 and caspase-3 but not caspase-8 and Bid (Perkins et al., 1998; Perkins et al., 
2000).
Several pro-apoptotic (like Bax and Bak) and anti-apoptotic (such as Bcl-x^) members o f  
Bcl-2 family can directly bind to VDAC and, respectively, accelerate and close its 
channel activity and, consequently, regulate cytochrome c release (Shimizu et al., 1999).
Apoptosis induced by death receptors often bypasses the mitochondrial pathway, which 
renders such deaths insensitive to the protective effect o f  Bcl-2, and in this case, 
cytochrome c release is likely to be the result o f caspase activation rather than its cause 
(Scaffidi e ta l ,  1998).
As shown in Figure 1, many other molecules are released from the mitochondria in the 
presence o f pro-apoptotic stimuli. These include several procaspases (mainly 
procaspase-2, -3, and -9) (Loeffler and Kroemer, 2000), Smac/DIABLO (Du et al., 2000; 
Verhagen et al., 2000), apoptosis-inducing factor (AIF) (Susin et al., 1999a; Susin et ah, 
1997a; Susin et ah, 1996), and adenylate kinase isozyme 2 (AK2) (Kohler et ah, 1999; 
Single et ah, 1998).
Smac (second mitochondria-derived activator o f caspases) or DIABLO is a novel 
mitochondrial protein (with a monomeric Mr o f 21k) released into the cytosol when cells 
undergo apoptosis. In the cytosol, it physically binds to inhibitor o f apoptosis proteins 
(lAPs) and neutralizes their inhibitory activity (Figure 1). Smac promotes apoptosis 
through at least two mechanisms; (1) Inducing the proteolytic activation o f procaspase-3 
by promoting caspase-9 activity in the apoptosome complex and (2) Promoting the
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enzymatic/catalytic activity o f  the active caspase-3. Both o f  these fonctions depend on 
the ability o f Smac to bind lAPs (Chai et al., 2000; Du et al., 2000).
AIF is a flavoprotein (Mr~57k) normally confined to the mitochondrial intermembrane 
space. When apoptosis is induced, it translocates to the nucleus causing chromatin 
condensation and large-sized DNA fragmentation (to fragments o f  ~50kbp) in a caspase- 
independent pattern (Figure 1). AIF is also capable o f inducing phosphatidylserine 
extemalization, dissipation o f  the mitochondrial Ai}/m, and inducing the mitochondria to 
release cytochrome c, activate caspase-9 and, consequently, activate caspase-3 (Lorenzo 
e ta l., 1999; Susm etal., 1999b; S u s i n a / . ,  1997b).
1.1.7 Apoptotic cell death depends on the action of caspases
Caspases (cysteine aspartate proteases) are interleukin 1-(3-converting enzymes (ICE)- 
like cysteine proteinases that form a central part o f the apoptotic cascade and are believed 
to be the central executioners o f apoptosis. They can be found from humans all the way 
down to insects, nematodes, and hydra. (Budihardjo et al., 1999; Cikala et al., 1999).
Caspases cleave their substrates after aspartic acid residues (at Asp-Xxxx bonds). The 
four amino acids (Xxxx) distal to the cleavage site determine the individual caspase's 
distinct substrate specificity. Activation o f  caspases leads to the selective cleavage o f a 
certain set o f target proteins, usually at one, or at most a few aspartate residues in the 
primary sequence. Caspase substrates range from single polypeptide chain enzymes (like 
PolyADP-ribose polymerase) to more complex macromolecules (such as actin, (3-catenin,
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and the nuclear lamin network). It is the cutting o f these structural macromolecules that 
leads to the disassembly o f cell structures that characterise apoptosis (Eamshaw et al., 
1999; Nicholson, 1999; Thomberry and Lazebnik, 1998).
As cleavage o f lamins leads to the collapse o f nuclear lamina and chromatin condensation 
(Buendia et al., 1999; Rao et al., 1996), cleavage o f cytoskeletal proteins (like fodrin and 
gelsolin) contributes to the morphological changes seen in apoptosis (Kothakota et al.,
1997). It is also believed that cleavage o f  PAK2 (a member o f the p21-activated kinase 
family) mediates the cell blebbing observed in apoptotic cells (Rudel and Bokoch, 1997).
Caspases are commonly divided into two groups based on the primary structure o f their 
NH2-terminal prodomain: long prodomain “initiator” caspases (caspase-2, -8, -9, and - 
10), and short prodomain “effector” caspases (caspases-3, -6, and -7) (Nicholson, 1999). 
However, caspases may also be divided on the basis o f their substrate specificities (Rano 
et al., 1997; Thomberry et al., 1997) into three subgroups: (1) Group I caspases (1, 4, 5, 
and 13) which are mainly involved in cytokine processing and inflammation, but do not 
have a substantial role in apoptosis. (2) Group II caspases (2, 3, and 7) which are the 
major effectors o f cell death. (3) Group III caspases (6, 8, 9, and 10) constitute the 
upstream activators o f the group II effector caspases.
This molecular ordering o f group III and group II caspases has been upheld in several 
cases. Thus, for instance, caspase-8 mediates the activation o f  caspase-3 and -7 in the 
CD95 (Fas, A pol) system (Boldin et al., 1996; Muzio et al., 1996). Similarly, caspase-9 
mediates the activation o f caspase-3 in the Apaf-1/cytochrome c pathway (Li et al., 
1997b). Both o f these examples have been substantiated in caspase-8 or -9 knockout 
mice (Hakem et al., 1998; Juo et al., 1998; Kuida et al., 1998; Varfolomeev et al., 1998).
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However, there are exceptions to this molecular ordering. One such exception is whether 
caspase-6 (a group III caspase) has an effector role (e.g. lamin proteolysis) instead o f its 
putative activation role, or in addition to it (Lazebnik et ah, 1995). Another exception 
may be caspase-2 which appears to be self-activating (Ahmad et aL, 1997; Duan and 
Dixit, 1997; Thomberry e/ <7/., 1997).
As previously described, the activation o f caspases occurs via receptor-ligand binding 
and the formation o f the receptor-ligand complex, which according to Boldin (Boldin et 
aL, 1996) becomes the recognition molecule for the precursor enzyme procaspase-8. But 
the formation o f such ligand-receptor complex is by no means the sole trigger for caspase 
activation as a number o f  agents were shown to directly activate the caspase cascade, 
bypassing the receptor pathway (Buckley et aL, 1999). Other agents can penetrate the 
cell directly and modulate the apoptotic process in the absence o f specific cell surface 
receptors. Example o f such agents include heat shock/stress factors (Thompson, 1995), 
free radicals (Buttke and Sandstrom, 1994), ultraviolet radiation (Yamada and Ohyama, 
1988), numerous dmgs and synthetic peptides (Schwall et aL, 1993), toxins (Sachs and 
Lotem, 1993), and the potent lymphocyte enzymes (granzymes) (Hayes et aL, 1989).
All caspases are present constitutively and synthesized in enzymatically inert precursor 
forms (procaspases/zymogens) o f  -30-55 kDa that must be proteolytically cleaved in 
order to be activated. Each procaspase consists o f an NH2-terminal prodomain, a large 
(p20: -2 0  kDa), and a small (plO: -1 0  kDa) subunit (Whyte and Evan, 1995). The 
mature enzyme is a heterotetramer containing two p20/pl0 heterodimers and two active 
sites (Eamshaw et aL, 1999).
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As demonstrated in Figure 6, three general mechanisms o f caspase activation have been 
described so far and they include induced proximity, proteolytic cleavage by an upstream 
caspase, and the holoenzyme (apoptosome) formation (Hengartner, 2000).
The “induced proximity” model (Figure 6: panel A) is evident when, upon the binding o f  
FasL to Fas receptor, several molecules o f the initiator procaspase-8, with the help o f  
adaptor molecules (such as FADD/MORTl), are brought into a crowded proximity o f  
protein-protein interactions to form the death inducing signalling complex (DISC). This 
permits autoprocessing (autocatalytic activation) o f the initiator procaspases-8 (Muzio et 
ah, 1998). This mechanism may also mediate the activation o f caspase-2 (Yang et ah, 
1998).
The “proteolytic cleavage” (Figure 6: panel B) model is seen when the above-mentioned 
active form o f the initiator/upstream caspase-8 goes to proteolytically cleave and activate 
the downstream effector procaspases (procaspases-3, -6, and -7). The initiator caspase-8 
cleaves (at Asp-X sites) between p20 and plO domains, and usually also between the 
prodomain and the p20 domain (Thomberry et aL, 1997). Therefore a “caspase cascade” 
which acts as an amplification loop is generated and culminates in the activation o f  the 
downstream effector caspases. Activated effector caspases lead to most o f the 
morphological and biochemical features o f apoptosis (Cryns and Yuan, 1998).
The apoptosome (holoenzyme) formation model (Figure 6: panel C) applies to the 
activation o f procaspase-9 in association with cytochrome c and Apaf-1 in the presence 
o f d-ATP (Cecconi, 1999). This will further activate other caspases, including 
procaspase-3, in a positive amplification loop (Green and Reed, 1998; Kroemer and 
Reed, 2000).
33
A+
pro p20 plO n + 1
B UpstreamCaspases
pro p20 plO
A
d-ATP
+
am Apaf-1 # Cytochrome c
Active caspase
Figure 6. General mechanisms of caspase activation. Caspases are activated by 
proteolytic cleavage at Aspartate-X sites. This takes place through three main 
mechanisms: induced proximity (panel A), protelytic cleavage by upstream caspase 
(panel B), and holoenzyme formation (panel C)
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1.1.8 BcI-2 family proteins and apoptosis
Members o f  the Bcl-2 (B-cell lymphoma/leukaemia-2) family o f proteins play a major 
role in regulating apoptosis. At least 15 Bcl-2 family members have been identified in 
mammalian cells and others in viruses. Many members o f this family are anti-apoptotic 
but others are pro-apoptotic (Table 1) but how exactly these proteins modulate apoptosis 
is still unclear. All members o f  Bcl-2 family contain at least one o f four domains denoted 
Bcl-2 homology (BH) domains (BH1-BH4). As shown in Figure 7, Bcl-2 family 
members are classified into three functional groups based on these BH domains (Adams 
and Cory, 1998; Antonsson and Martinou, 2000; Gross et aL, 1999a).
The activity o f these proteins appears to be regulated, at least partly, by formation of 
homo- and hetero-complexes. Heterodimerization between pro-apoptotic (like the Bcl-2 
associated x protein, better known as Bax) and anti-apoptotic Bcl-2 family members 
(such as Bcl-2 and B c1 -X l) is a common feature (Borner et aL, 1994; Knudson and 
Korsmeyer, 1997; Yin et aL, 1994). In the pro-apoptotic proteins Bax and Bak, the BH3 
domain is o f  central importance in mediating such protein-protein interactions and 
modulating cell death (Chittenden et aL, 1995; Hunter and Parslow, 1996; Kelekar and 
Thompson, 1998; Wang et aL, 1996b; Zha et aL, 1997).
Heterodimerization may titrate one another’s function depending on their relative 
concentration (Boise et aL, 1993; Oltvai et aL, 1993; Sedlak et aL, 1995). 
Heterodimerization is achieved when the BH3 domain o f one molecule binds into a 
hydrophobic pocket formed by the B H l, BH2, and BH3 domains o f  another family 
members (Sattler et aL, 1997).
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Table 2. Regulation of apoptosis by the Bcl-2 family proteins.
Bcl-2 family members Effects
1. Bcl-2 subfamily:
Bcl-2 Anti-apoptotic (promotes survival)
Bcl-XL Anti-apoptotic (promotes survival)
Bcl-xs Pro-apoptotic (promotes death)
Bcl-w Anti-apoptotic (promotes survival)
2. Bax family:
Bax Pro-apoptotic (promotes death)
Bak Pro-apoptotic (promotes death)
Bok Pro-apoptotic (promotes death)
3. BH3 subfamily:
Bid Pro-apoptotic (promotes death)
Bad Pro-apoptotic (promotes death)
Bik Pro-apoptotic (promotes death)
Blk Pro-apoptotic (promotes death)
Bcl-2 family members may directly regulate caspases via adaptor molecules or they may 
do so indirectly by modulating mitochondrial ftinction (Chau et aL, 2000; Ng et aL, 1997; 
Zhang et aL, 2000b).
Mounting evidence points to Bax and other pro-apoptotic family members as the central 
regulators o f  the release o f  cytochrome c from mitochondrial intermembranous space. 
Although overexpression o f  Bax in cells or the addition o f  purified recombinant Bax 
directly to mitochondria triggers the release o f  cytochrome c, the exact mechanism 
through which Bax triggers the permeability o f  the outer mitochondrial membrane is 
unclear (Jurgensmeier et aL, 1998; Rosse et aL, 1998).
The latter may be achieved through the interaction between pro-apoptotic Bcl-2 family 
proteins (including Bax and Bak) with other mitochondrial membrane proteins (like
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VDAC and ANT o f the MPTP). Although evidence for this occurring in vivo is still 
lacking, whatever the mechanism is, the outcome is to generate a pore in the outer 
mitochondrial membrane for cytochrome c release (Eskes et ah, 1998), a process 
inhibited by Bcl-xL (Finucane et aL, 1999). Alternatively, Bax could stimulate 
cytochrome c release indirectly by altering mitochondrial homeostasis (for example, ion 
exchange or oxidative phosphorylation), or even to form a weakly selective ion channels 
(Jurgensmeier et aL, 1998; Narita et aL, 1998; Reed, 1997; Reed et aL, 1998; Shimizu et 
a/., 1999).
As outlined in Figure 1, the BH3-domain-only proapoptotic protein Bid exists in the 
cytosolic fraction o f living cells as an inactive precursor that becomes activated upon 
cleavage by caspase-8. Such cleavage occurs at internal Asp-sites and generates the 
active 15-kDa COOH-fragment o f  Bid, termed “truncated” Bid (t-Bid), which still 
contains the BH3 domain (Wang et aL, 1996b). After cleavage, t-Bid translocates onto 
the mitochondria where it also induces the release o f cytochrome c and leading to the 
activation o f caspase-9 followed by caspase-3 (Li et aL, 1998; Luo et aL, 1998; 
McDonnell et aL, 1999). This process also seems to be regulated by BcL-xL (Gross et 
aL, 1999b).
Bid initiates the release o f cytochrome c apparently without evoking gross mitochondrial 
swelling or permeability transition. This suggests that the loss o f  mitochondrial 
membrane potential is not the cause for Bid-mediated cytochrome c release (Luo et aL,
1998).
Bid may induce a conformational change in Bax favouring the translocation o f  cytosolic 
Bax to the mitochondria (Desagher et aL, 1999). As shown in Figure 1, it has recently
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been reported that following binding to Bid, Bax oligomerizes and then integrates in the 
outer mitochondrial membrane where it forms a pore o f sufficient size to enable the 
release o f  cytochrome c (Eskes et aL, 2000).
While oligomers o f  Bax (-140-160 kDa) formed channels in liposomes and triggered 
cytochrome c release from mitochondria, monomeric Bax (-22-24 kDa) was inactive in 
both respects. This suggests that it is only oligomeric Bax that possesses such channel- 
forming activity whereas monomeric Bax has no such activity (Antonsson et aL, 2000).
Recent studies showing the capability o f  Bax to trigger the release o f cytochrome c from 
liposomes estimated the quaternary structure o f  the cytochrome c-conducting Bax- 
channels to be a tetramer (Saito et aL, 2000). Oligomers o f  Bax, which possibly form 
complexes with yet unidentified mitochondrial proteins, were found inserted in the outer 
mitochondrial membrane. Also, it was demonstrated that in the presence o f BcL-2, Bax 
oligomer formation and insertion into the mitochondrial membrane was inhibited 
(Antonsson et aL, 2001).
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Group III Bid
Figure 7. The Bcl-2 family members. Three subfamilies (groups I-III) are indicated. BH l to 
BH4 are conserved sequence motifs. Members o f group I (like Bcl-2 and B c1-xl)  possess the four 
domains (BH1-BH4) as well as the C-terminal hydrophobic tail (TM) which localises the proteins 
to the outer surface o f  the mitochondria with the bulk o f  the proteins facing the cytosol. Proteins in 
this group are anti-apoptotic. Members o f  group II and III are pro-apoptotic. Members o f  group II 
which includes Bax and Bak are structurally similar to group I but lack the N-terminal BH4 
domain. Members o f  group III (such as Bid and Bik) share the presence o f  the (-12-16 amino 
acid) BH3 domain.
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1.1.9 Other inhibitors and regulators of apoptosis
As described in previous section, members o f the Bcl-2 family play a major regulatory 
role in apoptosis through modulating cytochrome c release from the mitochondria. This, 
however, is by no means the only way to control apoptosis as other proteins have been 
shown to regulate the apoptotic process by targeting the caspases (Nicholson, 2000).
Caspase modulation is indeed highly sophisticated, and little is known about the 
regulation o f  the interaction between procaspases and their cofactors. Consider, for 
instance, the discovery o f  cellular FADD-like ICE inhibitory proteins (c-FLIP) (Irmler et 
ah, 1997; Shu et aL, 1997). These proteins are similar in sequence to procaspase-8, 
except that they lack essential catalytic residues. As shown in Figure 1, these proteins 
probably compete with procaspase-8 for binding to its cofactor, F ADD, thus preventing 
caspase activation (Koseki et aL, 1998).
Inhibitors and regulators o f apoptosis may also target the complex proteolytic caspases. 
Identification o f caspase inhibitors has come out o f work on viruses that attenuate 
apoptosis to circumvent the normal host immune response to infection. Three distinct 
classes o f viral inhibitors have been described: the cowpox virus CrmA (Ray et aL, 
1992a), the baculovirus protein p35 (Bump et aL, 1995; Xue and Horvitz, 1995), and a 
family o f endogenous cellular inhibitors o f  apoptosis (LAPs) (Uren et aL, 1998).
Currently, five members (c-IAP-1, c-IAP-2, XIAP, survivin, and NAIP) o f  the lAPs 
family o f proteins have been identified in humans and at least three o f these have been
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shown to directly inhibit specific caspases. Members o f the lAPs family o f  proteins are 
the only endogenous inhibitors o f caspases known in mammals (Deveraux et aL, 1999).
The precise caspase targets o f  the lAPs remain elusive. Potent selective inhibition o f  
caspase-3 and -7 was observed in vitro with XIAP (Deveraux et aL, 1997) suggesting that 
lAPs inhibit apoptosis through inhibition o f  effector caspases (Figure 1). The story is not 
so simple, however, because lAPs also prevent the activation o f  these enzymes upon 
overexpression, suggesting that effector caspase proenzymes or other proteins in the 
activation complex are the real targets in cells (Deveraux et aL, 1998; Seshagiri and 
Miller, 1997).
Although the lAPs do not inhibit caspase-1, -6, -8, or -10 (Deveraux et aL, 1997), they 
are however capable o f  binding to inactive procaspase-9 and interfering with its 
processing (Deveraux et aL, 1998; Takahashi et aL, 1998).
As shown in Figure 1, both death receptor and mitochondrial pathways converge at the 
level o f caspase-3 activation, and activity o f  the latter is antagonised by lAP proteins 
(Deveraux et aL, 1997) which are in turn antagonised by the Smac/DIABLO protein 
released from the mitochondria (Du et aL, 2000; Verhagen et aL, 2000). This adds an 
extra dimension to the already complex role o f  mitochondria in apoptosis and suggests 
that mitochondria may even be as important in regulating the apoptotic process as they 
are in activating it.
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1.1.10 Physiological role of apoptosis
In biology, it might seem illogical to think o f cell death as a component o f normal growth 
and morphogenesis, although it is recognised that loss o f  a tadpole’s tail, which is 
mediated by genetically programmed cell death, is part o f the metamorphosis o f  a frog 
(Steller, 1995; Tata, 1966). The self-destructive process o f apoptosis is considered by 
biologists to play four main physiological roles (Wang and Wang, 1999):
(1) Sculpting the body: Embryologists view the massive loss o f  cells through PCD or 
apoptosis, or both as the chisel used to sculpt the body during embryogenesis, 
metamorphosis, and adult life across species (Wang and Wang, 1999). Examples 
include the elimination o f surplus cells to allow for the formation o f the digits o f  the 
limbs (Garcia Martinez et aL, 1993), the hollowing o f  solid structures to create 
lumina (Jacobson et aL, 1997), the disappearance o f the human tail (Fallon and 
Simandl, 1978), and the elimination o f  endometrial cells at the end o f  each menstrual 
cycle (Otsuki et aL, 1994).
(2) Developmental plasticity and selection o f the fittest cells as seen in brain 
development (Oppenheim, 1991) and immune system development (Healy and 
Goodnow, 1998).
(3) Homeostasis: Examples include the ovarian follicle development from the foetal 
period through reproductive ages (Kaipia and Hsueh, 1997), the renewal o f  
endometrium during each menstrual cycle (Tabibzadeh, 1996), and the 
haemotopoietic system and its default apoptotic death in the absence o f  survival
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cytokines (McKenna and Cotter, 1997). The latter constitutes the “social control 
hypothesis” proposed by Raff (Raff, 1992).
(4) Protection o f  organisms from threats created by their own deleterious cells: As in the 
“better dead than wrong” maxim pointed out by Cohen et al (Cohen et aL, 1992b), the 
purpose o f  negative selection is to eliminate autoreactive cells that bear self-reactive 
T-cell receptors to avoid autoimmune response (Healy and Goodnow, 1998). In 
addition, genomic damage resulting from insults such as ultraviolet (UV) or ionising 
radiation can trigger apoptosis (mainly through p53-dependent pathways) in genome- 
damaged cells, thereby safeguarding against potential tumorogenesis (Wang and 
Wang, 1996). Also, organisms use apoptosis to delete unwanted, injured or virus- 
infected cells (Peter et aL, 1997).
1.1.11 Apoptosis and pathology
As homeostasis o f  cell numbers depends on the careful balance between proliferation and 
apoptosis, dysregulation o f  cell death by either deficiency or excess o f apoptosis may 
result in a wide range o f pathological conditions including cancer, neurodegenerative 
disorders, viral infections (including acquired immunodeficiency syndrome AIDS), 
autoimmune diseases (McKenna and Cotter, 1997; Thompson, 1995), and liver diseases 
(Neuman, 2001).
There is substantial evidence that failure to activate apoptosis after DNA injury may be 
one route to carcinogenesis (Griffiths et aL, 1997; Lowe et aL, 1994; Lyons and Clarke,
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1997; Wyllie, 1997a), which may provide a credible explanation for the frequency with 
which pro-apoptotic regulatory genes such as p53 are deleted in the majority o f human 
cancers (Wang and Wang, 1996; Wyllie, 1997b). Also there is accumulating evidence 
that some tumour cells can escape immune detection by expressing Fas ligand on their 
surface and so activating apoptosis o f Fas-bearing cytotoxic T cells (Strand et aL, 1996a).
Excessive apoptosis is also observed in many chronic neurodegenerative disorders 
(Bredesen, 1995) such as Alzheimer’s disease (Kim et aL, 1997), Parkinson’s disease 
(Jenner and Olanow, 1996), Huntington’s disease (Yuan and Yankner, 2000); and 
amyotrophic lateral sclerosis (Friedlander et aL, 1997; Kostic et aL, 1997).
Viruses, for their own proliferative advantage, may inhibit apoptosis o f  host cells 
(Roulston et aL, 1999; Young et aL, 1997) through viral anti-apoptotic proteins which 
include EIB-19k from adenoviruses (Debbas and White, 1993), BHRFl from Epstein 
Barr Virus (Henderson et aL, 1993), CrmA from cowpox virus (Tewari et aL, 1995) and 
the FLICE-inhibitory proteins (FLIPs) from kaposis’s sarcoma-associated human herepes 
virus-8 (Thome et aL, 1997) and human molluscum contagiosum virus (Berlin et aL,
1997).
On the other hand, CD4-T cell depletion seen in AIDS patients probably relates to the 
upregulation o f FasL in these cells and therefore indicates that Fas (CD95/Apol) 
signalling pathway plays a vital role in the pathogenesis o f  AIDS (Aupeix et aL, 1997; 
Thompson, 1995).
As mentioned previously, apoptosis is essential for removal o f  autoreactive lymphocytes 
(autoimmune cells) both during development and after completion o f an immune
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response (Thompson, 1995). Failure o f this very delicate process can result in a variety 
o f autoimmune diseases (Benoist and Mathis, 1997; Cohen et aL, 1992b; Drappa et aL, 
1996).
Evidence is also accumulating that apoptosis is a significant part o f  many pathological 
processes that have long been considered to be necrosis-dependent, such as stroke 
(Uyama et aL, 1992) and myocardial infarction (Olivetti et aL, 1997; Olivetti et aL,
1996).
From a toxicological point o f view, exposure to a wide range o f  chemicals, biological 
agents, and various environmental contaminants can result in cell damage and apoptosis 
(Robertson and Orrenius, 2000).
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1.2 Apoptosis and the liver
1.2.1 Structure of the liver
The liver is a large organ making up about 3.5% o f the body weight o f an adult rat or 2% 
o f  the body weight o f  an adult human. Approximately 80% o f  the blood supply o f  the 
liver is derived from the portal vein, and the remaining 20% comes from the hepatic 
artery. The bulk o f  the liver is composed o f a single cell type, the hepatocyte (Hinton and 
Grasso, 2000).
Hepatocytes form approximately 90%of the volume o f the liver parenchyma but only 
constitute 60% o f  the total cell number. Hepatocytes are assembled into sheets, each a 
single cell thick, which bifurcate and fuse to give a very complex network. Through this 
network run the liver capillaries, termed sinusoids (Figure 8A). Sinusoids are lined by 
sinusoidal endothelial cells (SECs). Unlike the endothelia o f normal capillaries, SECs do 
not form a continuous barrier but are penetrated by fenestrations about 100 nm in 
diameter which act like a sieve preventing blood cells from direct contact with the 
hepatocytes. However, these fenestrations will allow a free exchange o f  proteins between 
the blood within the sinusoids and the “Space o f  Disse” which lies between the SECs and 
the adjacent hepatocytes (Figure 8A). The extracellular matrix o f  the space o f  Disse is 
maintained by the modified fibroblasts and fat storing Stellate (Ito) cells (Hinton and 
Grasso, 2000).
Within the sinusoids lie Kupffer cells which are fixed macrophages which form 
attachments both to the walls o f  SECs and, by means o f  processes pushed through the 
fenestrations, to the hepatocytes (Hinton and Grasso, 2000).
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Figure 8A. Architecture of the liver. Diagram showing the structural relationship 
between Hepatocytes (Hep), Space o f Disse (SOD), Sinusoidal endothelial cells (SEC), 
Sinusoids (S), Hepatic arteries (HA), Portal veins (PV), Bile ducts (BD), and Bile 
canaliculi (BC). Bile duct lining cells contact hepatocytes directly, the junction zone 
being termed the canal o f Hering (H). Adopted (with permission) from Hinton and 
Grasso (Hinton and Grasso, 2000).
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1.2.2 Apoptosis and liver disease
Even before the term apoptosis was described by Kerr et al in 1972 (Kerr et ah, 1972), 
the morphological appearance o f  this mode o f cell death in the liver had long been 
referred to as acidophilic or councilman bodies (Biava and Mukhlova, 1965; Klion and 
Schaffiier, 1966).
Often, liver disease is either associated with enhanced hepatocyte apoptosis (as seen in 
cholestatic disease, viral and autoimmune hepatitis, and metabolic disorders) or 
disruption o f apoptosis such as in hepatocellular carcinoma (Neuman, 2001).
Use and abuse o f certain drugs, especially alcohol and paracetamol, have also been 
associated with increased apoptosis and liver damage (Rust and Gores, 2000).
1.2.2.1 Cholestatic liver diseases (CLD)
1.2.2.1.1 General
Cholestasis, defined as impairment o f  bile flow, is observed in a variety o f human liver 
diseases, occurring in primary biliary cirrhosis (PBC), Primary sclerosing cholangitis 
(PSC), biliary atresia, allograft rejection, graft versus host disease (GVHD), and drug 
related liver diseases. CLD, which results from destruction o f bile duct epithelial cells 
(chlangiocytes), is better termed “cholangiopathies”. In cholagiopathies, the initial insult 
results in cholagiocyte apoptosis, which is likely to be CTL-mediated. Cholangiocyte
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apoptosis results in retention and accumulation o f hydrophobic, toxic bile salts within the 
hepatocytes, which leads to bile salt-mediated apoptosis o f hepatocytes. Thus, apoptosis 
o f both cell types (cholangiocytes and hepatocytes) contributes to liver dysfiinction in 
cholangiopathies. Toxic bile salts induce hepatocyte apoptosis by direct activation o f the 
Fas death receptor pathway (Faubion et aL, 1999; Miyoshi et aL, 1999).
Glycochenodeoxycholate (GCDC), a toxic bile salt, induces hepatocyte apoptosis in a 
ligand-independent activation o f  Fas by GCDC, which subsequently incorporates 
caspase-8 and eventually activating effector proteases, including downstream caspases 
and cathepsin B (Faubion et aL, 1999; Patel et aL, 1994b; Roberts et aL, 1997; Spivey et 
aL, 1993). GCDC-induced hepatocyte apoptosis also appears to incorporate protein 
kinase C (PKC) which mediates the increase in intracellular magnesium concentration 
and activation o f Ca^^/Mg^^-dependent endonucleases (Patel et aL, 1994a).
Ursodeoxycholate (UDCA), a hydrophilic bile salt o f confirmed value in the treatment o f  
cholangiopathies, has an anti-apoptotic cytoprotective properties (Beuers et aL, 1998; 
Guicciardi and Gores, 1998; Rodrigues et aL, 1998).
Both in intact hepatocytes and cholangiocytes, UDCA has been shown to have a direct 
cytoprotective effect. Such an effect is mediated by preventing mitochondrial membrane 
permeability transition (MPT), inhibiting the production o f ROS, and interrupting the 
release o f  cytochrome c during pro-apoptotic stimuli induced by GCDC (Botla et aL, 
1995; Que et aL, 1999; Rodrigues et aL, 1998; Rodrigues et aL, 1999) and 
chenodeoxycholate (CDC) (Neuman et aL, 1999b).
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1.2.2.1.2 Primary biliary cirrhosis and primary sclerosing cholangitis
Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by 
progressive destruction o f  intrahepatic small bile ducts. Primary sclerosing cholangitis 
(PSC) is a chronic inflammatory process associated with fibrosis o f  intrahepatic and 
extrahepatic bile ducts (Neuman, 2001).
In PBC, cholangiocytes exhibit both necrosis and apoptosis (Bemuau et aL, 1981). 
Infiltrating lymphocytes (CTL) may cause apoptotic death o f  cholangiocytes through 
Fas/FasL and Perforin/granzyme B-dependent mechanisms (Harada et aL, 1997).
In humans, the administration o f UDCA slows disease progression in PBC and improves 
liver function in both PBC and PSC (Poupon et aL, 1987; Rubin et aL, 1994). In addition 
to its direct cytoprotective effect (as discussed above) in cholangiopathies, UDCA may as 
well act indirectly through reducing the terminal ileal absorption o f toxic/hydrophobic 
bile acids (Beuers et aL, 1998).
It has been shown that UDCA, when given to patients with PBC, significantly decreases 
DNA fragmentation (Koga et aL, 1997) and modulates the expression o f Fas /FasL 
(Neuman et aL, 1999a).
In both PBC and PSC, endotoxin (like LPS) accumulates abnormally in cholangiocytes 
and leads to apoptosis. Therefore, UDCA treatment in PBC may provide a beneficial 
effect on the intrahepatic metabolism o f endotoxins (Hamada et aL, 1999; Sasatomi et aL, 
1998).
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1.2.2.1.3 Obstructive jaundice
Bile duct ligation has long been used as an animal model for obstructive jaundice. 
Although Bcl-2 is not expressed in hepatocytes under physiological conditions, it was 
expressed in hepatocytes during chronic cholestasis in bile duct-ligated rat. This may 
represent an adaptive mechanism to inhibit apoptosis by toxic bile salts (Kurosawa et ah,
1997). In contrast, cholangiocytes, which are in direct contact with bile, do express Bcl- 
2. It was demonstrated that apoptosis o f cholangiocytes in bile duct-ligated rats may be 
regulated by the interaction o f Bcl-2 (anti-apoptotic) and Bax (pro-apoptotic) (Stahelin et 
a l ,  1999).
1.2.2.2 Apoptosis and viral hepatitis
A variety o f  acute and chronic viral diseases, including hepatitis A, hepatitis B, and 
hepatitis C affect the liver. Even though the involvement o f  apoptosis in acute viral 
hepatitis is not well defined, the identification o f  apoptotic (councilman) bodies is a 
characteristic feature o f acute viral hepatitis. Fas protein expression was found to be 
enhanced in some patients with fulminant hepatitis B virus infection, suggesting the 
involvement o f  Fas-mediated apoptosis in acute hepatitis (Rivero et aL, 1998).
On the other hand, apoptosis plays an important role in chronic viral hepatitis (hepatitis B 
and C) and is believed to be mediated by the host cytotoxic T-lymphocytes (CTL). Both 
the Fas-Fas ligand as well as the perforin/granzyme B systems have been implicated in 
this CTL-mediated apoptosis o f virus-infected hepatocytes (Kagi et aL, 1994; Lowin et 
aL, 1994;Nakamoto e ta l ,  1997; Shrestac/a/., 1998).
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Hepatitis C infection induces apoptosis via the TNF-a signaling pathway (Zhu et ah,
1998). Plasma TNF-a levels are raised in chronic hepatitis B and C-infected patients 
(Lim et aL, 1994; Sheron et aL, 1991). Despite the fact that the expression o f  TNF-a and 
TNF-a receptors is increased in patients with chronic hepatitis B infection (Fang et aL, 
1996), only minimal apoptosis was observed when TNF-a was used to treat chronic 
hepatitis B virus infection (Sheron et aL, 1990). In rat hepatocytes cell lines, TN F-a-
induced extensive apoptosis only in those hepatocytes expressing high levels o f hepatitis 
B virus (Guilhot et aL, 1996). This suggests that viral components, like hepatitis B virus 
X (HBx) antigen and hepatitis c virus core protein, may play a role in sensitizing 
hepatocytes to the TNF-a and promoting apoptosis (Kim et aL, 1998; Zhu et aL, 1998). 
Sometimes, and acting in a selfish manner, viruses attempt to prevent removal o f  virally 
infected hepatocytes in order to complete their replication, and therefore may develop a 
mechanism to block apoptosis (Fujita et aL, 1996).
The expression o f TGF-(31 appears to be upregulated by HBx antigen in chronic hepatitis 
B infection (Castilla et aL, 1991; Yoo er aL, 1996) and its serum levels are also increased 
in chronic hepatitis C infection (Nelson et aL, 1997). Depending on the physiological 
status o f the cells, HBx antigen can be pro- or anti- apoptotic after interacting with the 
tumour suppressor and pro-apoptotic gene the P53, and occasionally HBx can directly 
induce apoptosis in a p53-independent pattern (Chirillo et aL, 1997; Puisieux et aL, 1995; 
Terradillos et aL, 1998; Wang et aL, 1995).
52
1.2.2.3 Apoptosis and tumours of the liver
Currently it is believed that “carcinogenesis” involves sequential changes in the 
phenotype from normal to malignant cells and occurs as a multi-step process that 
includes initiation, promotion, and metastasis. Many o f these steps can be viewed as a 
failure o f apoptosis (Que and Gores, 1997).
The available evidence indeed demonstrates disruption o f apoptosis at several steps in the 
development o f hepatocellular carcinoma (HCC). Analysis o f  22 HCC patients revealed 
a partial or complete loss o f Fas receptor (Fas) which is normally expressed constitutively 
in hepatocytes. It is presumed that loss o f Fas expression is one means through which 
malignant cells escape the Fas-mediated killing by cytotoxic T-lymphocytes (Higaki et 
ah, 1996).
Another theory (called “Fas counterattack”) through which cells o f HCC can evade 
immune destruction has been proposed. According to this theory, HCC cells express Fas 
ligand (FasL) and induce apoptosis o f activated Fas"^ ^^  T lymphocytes (Strand et ah, 
1996b).
As TGF-pi plays a major role in induction o f apoptosis and in regulating liver size, 
disruption o f TGF-pi signal may contribute to the development o f HCC by preventing 
apoptosis in target cells (Thorgeirsson et al., 1998). Cells o f HCC are usually resistant to 
apoptosis by TGF-pl, but often secrete TGF-pl to induce apoptosis o f neighbouring 
hepatocytes in a paracrine mechanism (called tumour directed apoptosis o f  adjacent 
benign tissue) aimed to achieve non-policed tumour expansion and spread within the 
liver. Those results also suggest that TGF-pl plays an important role in the altered
53
metabolism o f collagen in HCC (Murawaki et ah, 1996; Shirai et ah, 1994). 
Occasionally, this paracrine mechanism o f  producing TGF-(31-mediated apoptosis o f  
neighbouring hepatocytes may as well be adopted by activated Stellate (Ito) cells in 
alcoholic liver disease (Bissell et ah, 1995; Gressner et ah, 1996).
On the other hand, all human hepatoblastomas (like many other tumour cells) co-express 
both Fas and its ligand (FasL) on their surface. It has always remained a mystery why 
such cells do not simply kill themselves. This was attributed to the existence o f “Fas- 
resistance pathways” which may include the expression o f Bcl-2 and Fas-associated 
phosphatase-1 (FAP-1), and the expression o f soluble Fas (sFas). Hepatoblastomas even 
express some o f these Fas-mediated apoptosis inhibitors (like FAP-1) in their tumour 
cells. These results suggest that it is probably due to the action o f inhibitory molecules o f  
the Fas pathway that the tumour cells o f hepatoblastomas do not kill themselves in an 
autocrine-driven cycle and that in this manner hepatoblastomas avoid apoptosis and thus 
proliferate (Lee et ah, 1999)
1.2.2.4 Apoptosis and Wilson’s disease
Wilson’s disease (WD) is a congenital (autosomal recessive) disorder o f  copper 
metabolism that is due to a defect in the gene coding for a copper transporting P-type 
ATPase (Bull et ah, 1993; Tanzi et ah, 1993). Disturbed export o f  copper from 
hepatocytes to bile and decreased incorporation o f  copper into ceruloplasmin results in 
accumulation o f copper in a number o f  organs and particularly the liver and brain 
(Stremmel et ah, 1991).
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Copper accumulation results in the generation o f ROS and oxidative stress o f  the liver. 
Therefore, ROS may be a major contributor to apoptosis seen in WD (Jacobson, 1996; 
Mansouri et ah, 1997).
The demonstration o f high Fas protein expression on hepatocytes o f patients with 
fulminant hepatic failure due to WD, combined with the appearance o f Fas ligand mRNA 
in the cytoplasm o f  other adjacent hepatocytes suggest that, in WD, hepatocytes kill each 
other in a paracrine (or autocrine) pattern termed “fratricidal killing” (Strand et ah, 1998).
1.2.2.5 Apoptosis and drug-induced liver disease
Several hepatotoxins such as alcohol (Benedetti et ah, 1988; Goldin et ah, 1993; 
Kawahara et ah, 1994; Patel and Gores, 1995), carbon tetrachloride (LeSage et ah, 
1999a; LeSage et ah, 1999b), paracetamol (Ray et ah, 1993), cocaine (Cascales et ah, 
1994), or dimethylnitrosamine (Ray et ah, 1992b) have been shown to induce DNA 
fragmentation in vitro and the formation o f apoptotic bodies has been observed after 
treatment o f  animals with cocaine, dimethylnitrosamine, D-galactosamine, lead, or 
thioacetamide (Feldmann, 1997).
1.2.2.5.1 Alcoholic liver disease (ALD)
Although chronic alcohol consumption has been shown to cause hepatocyte apoptosis, 
the exact pathophysiology o f  apoptosis in ALD is still unclear (Slomiany et ah, 1999). 
However, several mechanisms seem to be involved in the alcohol-induced apoptosis o f
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hepatocytes. Experimental evidence has linked alcohol-induced liver injury to oxidative 
stress caused by the CYP2E1-dependent production o f reactive oxygen species (ROS) 
and lipid peroxides (Higuchi et al., 1996; Kurose et al., 1997). The associated increase in 
the anti-apoptotic Bcl-2 protein concentration in rats with experimental ALD may reflect 
an adaptive defensive mechanism against ALD (Yacoub et al., 1995).
Oxidation of alcohol by alcohol dehydrogenase generates acetaldehyde, which is capable 
o f  inducing apoptosis (Zimmerman et ah, 1995). Oxidation o f alcohol also results in 
alteration o f the cell redox potential and the generation o f  free radicals (Rust and Gores, 
2000). Prolonged glutathione (y-glutamyl-cysteinyl-glycine, better known as GSH) 
consumption chronically decreases mitochondrial GSH and sensitizes mitochondria to 
MPT and apoptosis (Colell et al., 1998; Pastorino et al., 1999).
Glutathione depletion, however, may have dual effect on apoptosis. While prolonged 
depletion o f glutathione results in increased death receptor-mediated hepatocyte 
apoptosis (Chiba et al., 1996; Colell et al., 1998; Xu et al., 1998), its acute depletion is 
associated with decreased apoptosis (Hentze et al., 2000; Hentze et al., 1999; Lawson et 
a/., 1999).
The combination o f  chronic depletion o f  hepatocyte glutathione reserves (both cytosolic 
and mitochondrial) and hepatic iron overload catalyse the formation o f free radicals and 
enhance oxidative stress on the liver (Garcia-Ruiz et ah, 1994; Sadrzadeh et al., 1994).
The demonstration o f increased TNF-a activity in patients with ALD (and in ethanol-fed 
rats), and the increase in the number o f TNF-a receptors 1 (TNF-Rl) on hepatocytes after 
chronic ethanol administration, may suggest the direct involvement o f  TNF-a in
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mediating apoptosis in ALD (Deaciuc et ah, 1995; Leist et ah, 1997a; McClain et ah, 
1993; Nanji et ah, 1994; Spengler et al., 1996). Pastorino and Hoek have reported that 
TNF-a-induced cytotoxicity is potentiated by ethanol exposure in HepG2, and in rat 
primary hepatocytes (Pastorino and Hoek, 2000). The rapid rise in intracellular levels o f  
ROS seen after stimulation o f  TNT receptors may indicate another, but indirect, role o f  
TNF-a in apoptosis in ALD (Larrick and Wright, 1990).
In normal human primary hepatocytes, ethanol signaling for apoptosis is initiated by Fas 
ligand (Neuman et al., 1999c). Exposure o f hepatocytes to ethanol generates ROS that 
induce the expression o f  Fas ligand, and because hepatocytes also express the Fas 
receptor, this suggests that hepatocytes might mediate their own death in a fratricidal 
pattern (Galle et al., 1995; Hug et al., 1997; Nanji, 1998).
TGF-pl, produced by Kupffer and hepatic Stellate (Ito) cells in ALD, may have a double 
impact on the progression o f  hepatic injury: promoting fibrogenesis and killing 
hepatocytes by apoptosis (Gressner et al., 1996; Oberhammer et al., 1993; Oberhammer 
et al., 1992a).
The capability o f UDCA (ursodeoxycholic acid) and TUDCA (tauroursodeoxycholic 
acid) to protect Hep G2 cells from ethanol-induced apoptosis has been attributed to their 
capability to decrease (or abolish) the glutathione depletion seen in ALD (Neuman et al.,
1998).
57
1.2.2.5.2 Paracetamol and hepatotoxicity
Since its introduction in the mid-1950s, paracetamol (acetaminophen, Y-acetyl-p- 
aminophenol, AAP) has been used as an over-the-counter analgesic and antipyretic. 
However, when taken in an overdose it is hepatotoxic. Hepatic necrosis resulting from 
massive overdosage with paracetamol was first reported in rats by Boyd and Bereczky in 
1966 (Boyd and Bereczky, 1966), and a report o f this complication in man soon followed 
(Davidson and Eastham, 1966; Prescott et al., 1971).
In the UK alone, paracetamol overdoses cause 200 death per year. Paracetamol-induced 
hepatic damage is the most common form o f toxic liver damage experienced in clinical 
practice in the UK and USA (Meredith and Vale, 1984).
It is well documented that under light microscopy, AAP-induced hepatotoxicity in mice 
is characterised by hepatomegaly and massive centrilobular congestion which precede the 
appearance o f  necrosis. The initial increase in liver size is attributed to result from 
plasma accumulation due to endocytic vacuolation o f hepatocytes and Disse space 
enlargement in centrilobular regions. These events occur without any increase in 
intrahepatic or portal venous pressure. There are two major consequences o f  
acetaminophen-induced hepatotoxic congestion. First, blood and plasma volumes fall 
significantly, and it was suggested that hypovolaemic shock contributes to early mortality 
after acetaminophen. Second, impaired circulation within the congested liver probably 
aggravates the initial injury. Early lesions are almost always evenly distributed around 
central veins. However, the pattern o f  damage after 24 hours o f toxicity could be 
variable. Occasionally, large confluent areas o f congestion and necrosis were observed.
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which is consistent with the concept that secondary ischaemic damage can develop in 
AAP-induced hapatotoxicity (Walker et al., 1985).
In 1975, Dixon, et al, carried out an in-depth examination (by light and electron 
microscopy) o f livers from rats killed at various time-intervals (up to 48 hr) after a single 
large dose o f AAP (3g/kg). His results revealed glycogen depletion, loss o f  ribosomes, 
and cytoplasmic matrix swelling commencing 3-6 hr after AAP administration which, in 
centrilobular hepatocytes, progressed to frank coagulative necrosis at 12-24 hr. Midzonal 
cells showed more prominent aqueous swelling with vésiculation o f  the endoplasmic 
reticulum, and, in some cells, gross hydropic vacuolation (Dixon et ah, 1975).
The exact mechanism o f paracetamol-induced liver cell death is still controversial but, 
until recently, it has been considered to be entirely the consequence o f  its metabolism by 
the cytochrome p-450 (CYP-450) system within the hepatocytes (Nelson, 1990).
Paracetamol, in therapeutic doses, is safely metabolized (and eliminated) by hepatocytes 
to non-toxic conjugates o f sulphate and glucuronic acid. However, when the enzyme 
systems involved in these processes become saturated, metabolism via CYP-450 systems 
becomes increasingly important (Mitchell et al., 1973a).
As shown in Figure 8, CYP-450 converts AAP to the highly reactive electrophillic 
metabolite A-acetyl-/7-benzoquinone-imine (NAPQI) by a pathway utilizing oxygen and 
NADPH. NAPQI is o f  interest as a proposed ultimate toxic metabolite in AAP overdose 
(Hinson et al., 1981; follow et al., 1974).
The potentially toxic effect o f NAPQI is initially largely prevented via the conjugation 
with intracellular reduced glutathione (GSH) before its renal excretion (Coles et al..
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1988; Mitchell et oL, 1973b). However, excess NAPQI depletes the stores o f GSH 
(Dahlin et al., 1984; Nelson, 1995) and the free NAPQI binds to cysteine-rich liver 
proteins and key enzymes, particularly those controlling calcium homeostasis (Boobis et 
ah, 1986). NAPQI also binds to the DNA (Moore et al., 1985) and, in addition, may 
induce peroxidation o f  plasma membrane lipid in the liver (Muriel et al., 1992; 
Ozdemirler c/fl/., 1994).
Despite the fact that there are marked interspecies variations in susceptibility to 
paracetamol (AAP), acute liver damage is relatively reproducible across a wide range o f  
laboratory animals. Mice and hamsters are known to be more sensitive to AAP than rats, 
guinea pigs, or rabbits (Davis et al., 1974; Liu et al., 1991).
As outlined in Figure 8, rapidly biotransformed AAP is predominantly excreted as 
glucuronide and sulphate conjugates (Kane et al., 1995; Kim et al., 1995). However 
marked interspecies differences were observed in the ratio o f  the two conjugation 
pathways. Rats were found to excrete 40-65% o f the AAP dose as sulphate conjugate 
(Thomas et al., 1974), whereas other species, including mice, only excreted 4-14% o f  the 
dose as conjugate o f  sulphate (Gregus et al., 1988; Whitehouse et al., 1977).
When HepG2 cells are exposed to 5mM acetaminophen plus 40 mM ethanol, there is a 
synergistic induction o f CYP2EI and therefore o f  apoptosis (Shear et al., 1995). In 
chronic alcoholics, taking paracetamol in therapeutic doses can also cause liver damage 
because ethanol induces the CYP-450 system and thereby leads to increased production 
NAPQI (S eeffe/« /., 1986).
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Centrilobular hepatic necrosis is a characteristic feature seen in paracetamol overdose 
(Dixon et al., 1975). Recently, it has been hypothesized that a significant number o f  
hepatocytes also die by apoptosis. Ray et al has even concluded that, in paracetamol- 
induced liver cell injury, the majority o f hepatocytes predominantly choose to die via 
programmed apoptotic pathway rather than facing the unprogrammed consequences o f  
necrosis (Ray et al., 1996).
The irreversible inhibition o f  mitochondrial respiration by NAPQI, and the reversible 
inhibition by paracetamol results in massive drop in intracellular energy status which 
negatively affects the cellular protective capacity (Burcham and Harman, 1991; Esterline 
et ah, 1989; Ramsay et ah, 1989). Depletion o f  glycogen and ATP, featured in 
paracetamol-induced liver damage, are energy-linked processes dependent on 
mitochondrial function. Therefore, it would not be surprising in the future to realize that 
opening o f the MPT, disruption o f mitochondrial membrane potential, and the release o f  
cytochrome c are all integral parts o f paracetamol-induced hepatotoxicity (Ray et ah,
1999).
As paracetamol is a notorious producer o f ROS, the production o f ROS and the induction 
o f  oxidative stress (or vice versa) have been proposed as a possible mechanism o f  
paracetamol-induced hepatotoxicity (Wendel, 1983; Wendel, 1984; Wendel et ah, 1979; 
Wendel and Hallbach, 1986; Wendel and Jaeschke, 1982; Wendel et ah, 1982).
In addition to being a mitochondrial poison, paracetamol can also target several other 
intracellular organelles, e.g. nucleus and endoplasmic reticulum. The disruption o f  
cellular Ca^  ^ homeostasis after hepatotoxic paracetamol overdose in mice leads to 
sustained elevation in intracellular and nuclear Ca^  ^ levels and, consequently, the
61
activation o f Ca^^-dependent endonucleases leading to DNA fragmentation (Boobis et ah, 
1990; Ray et ah, 1990; Ray et ah, 1991). The latter effect was abolished when mice were 
pretreated with calcium antagonists like verapamil and chlorpromazine (Ray et ah, 1993).
In mouse liver the following Bcl-2 family are constitutively expressed: B C L -x l , B C L -x s , 
Bak, Bad, and Bax. In contrast, Bcl-2 is not expressed in mouse whole liver 
homogenates (Patel et ah, 1998). However, western blot analysis done 6 and 18 hours 
after the intraperitoneal administration o f  paracetamol (500mg/kg) to male ICR mice 
showed a shift to a higher molecular weight band o f the B C L -x l  protein. Such a band 
may represent a phosphorylated form o f  B C L -x l  (called B C L -x l -p ) .  The appearance o f  
B C L -x l -p  was associated with massive apoptotic cell death. In the same time period, the 
level o f expression o f B C L -x l  and BCL-xs remained unaltered and BCL-2 remained 
unexpressed (Ray and Jena, 2000).
Since B C L -xl  is localised to the mitochondria (Gonzalez-Garcia et ah, 1994), it was 
hypothesized that paracetamol-induced modification o f  B C L -xl  protein (possibly by 
phosphorylation) points to the mitochondria as being one o f  the main targets in 
paracetamol-induced liver toxicity. Phosphorylation o f  B C L -xl  is presumed to result in 
the inactivation o f B C L -xl  protein, and thus the potentiation o f apoptotic cell death (Ray 
and Jena, 2000).
The fact that human macrophages, when cultured with AAP, secrete increased quantities 
o f the inflammatory mediator-TNF suggests that macrophages play a potentially 
important direct role in paracetamol-induced liver damage (Goldin et ah, 1996).
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In vivo studies in rats reported that modifying macrophage functional status using 
macrophage inhibitors such as gadolinium chloride (GdClg) could alter the degree o f  
hepatic injury induced by AAP; and these protective effects o f GdClg were attributed to 
neither the alterations in AAP metabolism nor the suppression o f NAPQI formation 
(Laskin et al., 1995). However these findings do not appear to be specific for AAP 
because a number o f different studies have described similar results o f  inhibiting 
macrophage activity on hepatic injury induced by toxicants such as galactosamine, LPS, 
carbon tetrachloride, allyl alcohol, and 1,2 dichlorobenzene (Arthur et al., 1985; Edwards 
et al., 1993; elSisi et al., 1993; Gunawardhana et al., 1993; Przybocki et ah, 1992; 
Shiratori et ah, 1988; Shiratori et ah, 1986).
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Chapter 2
Materials and Methods
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2.1 Materials
Reagents used in this study are listed according to the name o f the suppliers 
Amersham International pic, Buckinghampshire, UK
Hybond C nitro-cellulose membrane (cat # RPN 203W) and polyoxyethelenesorbitan 
(Tween-20).
Bachem, Bubendorf, Switzerland
Benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK; cat # N-1510), 
Benzyloxycarbonyl-Asp-Glu-Val-Asp-chloromethylketone (Z-DEVD-CMK; cat # N- 
1580), N-acetyl-Asp-Glu-Val-Asp-7-amido-4-trifluoromethylcoumarin (Ac-DEVD-AFC; 
cat # 1-1725) and Ac-Leu-Glu-His-Asp-7-amido-4-trifluoromethylcoumarin (Ac-LEHD- 
AFC; cat #1-1820).
Bio-Rad Laboratories Ltd, UK
Kaleidoscope prestained protein molecular weight standards (cat # 161-0324), Whatmann 
3MM filter paper, Bio-Rad protein assay dye reagent concentrate (cat # 500-0002), and 
Bio-Rad bovine y-globulin standards for protein assay (cat # 500-0005).
Boehringer Mannheim Ltd, Mannheim, Germany
Bovine serum albumin fraction V (BSA), nonidet p40 (10%^^Q, aprotinin, pepstatin, 
pefabloc, leupeptin, HEPES, and Tris base.
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British Drug House (BDH)/AnalaR Ltd, UK
Glycine, methanol, ethanol, industrial methylated spirit (IMS), sodium chloride, disodium 
hydrogen orthophosphate (Na2HP0 4 ), sodium dihydrogen orthophosphate 
( N a 2 H 2 P 0 4 .2 H 2 0 ) ,  potassium dihydrogen orthophosphate (K H 2 P O 4 ), magnesium 
chloride (MgCh), potassium chloride (KCl), trichloroacetic acid (TCA), boric acid, 
sodium malonate, sodium succinate, and [ethylene glycol-bis(P-aminoethyl ether) 
N,N,N ,N ]-tetraacetic acid (EGTA).
Calhiochem-Novabiochem Ltd, Nottingham, UK 
Rabbit anti-Caspase-3 polyclonal antibody (cat # 235412).
Camlab Ltd, Cambridge, UK 
Biophenol/chloroform mixture (1:1 ratio) (stabilised).
DAKO Ltd, Cambridge, UK
Horseradish Peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin (cat # 
P0447), HRP-conjugated rabbit anti goat immunoglobulin (cat # P0449), and HRP- 
conjugated goat anti-rabbit immunoglobulin (cat # P0448).
Enzyme Systems Products, California, USA
The negative control Benzyloxycarbonyl-Phe-Ala-fluoromethylketone (Z-FA-FMK, cat # 
Fk-029386).
67
Gibco-BRL, Paisley, Scotland, UK 
Ultra-pure agarose.
Molecular Probes, Netherlands
Mouse monoclonal anti cytochrome oxidase subunit IV.
Oncor, Gaithersburg, MD, USA 
ApopTag Direct kit.
Phone Merieux Limited, UK 
Pentobarbitone sodium (60 mg/ml).
Pierce chemical company, Roclrford, USA
Supersignal enhanced chemiluminescent (ECL)-substrate (cat # 34080T).
Pharmacia Biotech, UK 
Commassie brilliant blue (R250).
Pharmingen, San Diego, California, USA
Hamster anti-CD95 antibody (Jo2: cat # 1541 CD) and purified mouse anti cytochrome c 
monoclonal antibody (lgG2b: cat # 65981A).
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Premiere Brands, UK
Dried skimmed marvel milk (99% fat-free)
Promega corporation, UK
Lambda DNA/EcoRI Hindlll DNA markers (cat # G 1731) and Blue/Orange 6 x DNA 
loading dye (cat #G1881).
R & D  Systems, UK
Goat anti-human/mouse Bid polyclonal antibody (cat # AF860).
Roche, UK
Kits used for the estimation o f  lactate dehydrogenase (LDH), alanine aminotransferase 
(ALT), and aspartate aminotransferase (AST) were from Roche.
Santa Cruz Biotechnology, USA
Bax mouse monoclonal antibody (lgG2b: cat # Sc-7480).
Sigma-Aldrich Chemical Co. Ltd, UK
Acetaminophen (99% pure), gadolinium chloride, lipoplysaccharide, galactosamine, p- 
iodonitrotetrazolium violet (INT), ethyl acetate, 40% acrylamide/bis-acrylamide (37:1 
ratio), ethidium bromide, proteinase-K, RNase A, ^-glycerophosphate, ponceau S, 
pyronin Y, D-mannitol, amino-4-trifluoromethylcoumarin (AFC), 2-{3-mercaptoethanol,
69
bromophenol blue, lauryl sarcosine, minimum essential medium (MEM), glycerol, lauryl 
sulfate (SDS), magnesium chloride-hydrous (MgCE.bHiO), dexamethasone, and 
ethylenediaminetetraacetic acid (EDTA), sulfosalicylicic acid, and N,N,N,N- 
tetramethylethylenediamine (TEMED).
StressGen Biotechnologies Corp, Victoria, BC Canada 
Rabbit anti-caspase-9 polyclonal antibody (cat # AAP-149).
TAAB Laboratories, UK 
TAAB resin.
University o f Leicester, Leicester, UK
Cytochrome c was a gift from Dr SC Chow. Rabbit anti-caspase-7 polyclonal antibody 
was a gift from Professor GM Cohen.
Zymed Company, UK
Mouse lgG2a monoclonal B C - X l  primary antibody (cat # 33-6300)
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2.2 Solutions and Buffers
2.2.1 General
Phosphate buffered saline (PBS):
137 mMNaCl, 2.7 mM KCl, 4.3 mM Na2HP0 4 , 1.4 mM KH2PO4, pH 7.4.
2.2.2 Caspase activity assay buffers
Hypotonic extraction buffer {HEB)\
25mM Hepes, 5mM MgCb, ImM EGTA, ImM pefabloc, Ipg/ml pepstatin, Ipg/ml 
leupeptin and Ipg/ml aprotinin, pH adjusted to 7.5 (with NaOH).
Cell lysis buffer (CLB):
40mM (3-glycerophosphate, 50mM NaCl, 2mM MgCl2-6 H2 0 , 5mM EGTA, lOmM 
Hepes, pH adjusted to 7.0 (with NaOH). The buffer was stored at 4°C and used within 
one month o f  preparing.
Caspase assay buffer (CAB):
lOOmM Hepes, 10% (w/v) sucrose, 0.1% (v/v) nonidet P-40, lOmM dithiothreitol, pH 
adjusted to pH to 7.25 (with NaOH). The buffer was stored at 4°C and used within one 
month o f  preparing.
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2.2.3 Agarose Gel Electrophoresis
Lysis buffer:
Û.1M Tris, lOmM EDTA, 0.5% (w/v) sodium N-lauroylsarcosine, adjust pH to 7.8 using 
HCi.
Tris-EDTA, p H  8 {TE-8):
lOmM Tris base, ImM EDTA, pH 8.0.
lOx TBE (per litre):
890mM Tris base (108.0g), 890mM Boric acid (55.0g), 25mM EDTA (9.3g), pH 8.0.
Autoclave and store at +4°C.
Ix TBE (per litre):
Add 900mls o f  Milli-Q water to lOOmls o f  10 x TBE.
Proteinase K  (25 mg/ml):
125 mg was dissolved in 6  mis o f  Milli-Q water and stored at -20°C in 300 pi aliquots.
RNase ^  (50 mg/ml):
50 mg was dissolved in 1 ml o f 10 mM Tris (pH 7.5) containing 15 mMNaCl. This was 
then boiled for 15 minutes and stored at -20°C in lOOpl aliquots.
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Ethidium Bromide (Carcinogenic 0): 
lOmg/ml in Milli-Q water.
2.2.4 Succinate dehydrogenase (SDH) assay
MSH-EDTA buffer: 2 1 0 mM mannitol, 70mM sucrose, 3mM Hepes, and ImM EDTA, 
pH 7.4 (with KOH). Buffer was stored at 2-8°C and was not used after four weeks o f  
preparing.
Substrate: 0.3M sodium succinate, pH 7.4 
Inhibitor: 0.3M sodium malonate, pH 7.4
Chromogen: 1.5 mg/ml o f  p-iodonitrotetrazolium violet (INT) freshly dissolved in 
0.3M o f sodium dihydrogen orthophosphate (Na2H2? 0 4 .2 H2 0 ) buffer, pH 7.4
Stopping Reagent: 6 % (w/v) o f Trichloroacetic Acid (TCA)
2.2.5 SDS-PAGE and Western Blotting
Homogenisation buffer {HB)\
210mM mannitol, 70mM sucrose, 3mM Hepes, and ImM EDTA, ImM pefabloc, Ipg/ml 
pepstatin, Ipg/ml leupeptin and Ipg/ml aprotinin, pH adjusted to 7.1 (with KOH). Buffer 
was stored at 2-8°C and was not used after four weeks o f preparing.
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2x Resolving Gel buffer (AX2) (per litre):
750mM Tris (90.6g) were dissolved in 800ml o f  Milli-Q water. Then the pH was 
adjusted to 8 .8  with concentrated HCI and then made up to a final volume o f  IL and 
stored at 2-8°C.
2x Stacking Gel buffer (BX2) (per litre):
250mM Tris (30.24g) were dissolved in 800ml o f  Milli-Q water. Then the pH was 
adjusted to 6 .8  with concentrated HCI and then made up to a final volume o f IL and 
stored at 2-8°C.
10% Ammonium persulphate {w/v):
Made up by dissolving lOOmg o f Ammonium persulphate in 1ml o f Milli-Q water. Fresh 
solution was always prepared prior to every experiment.
Resolving and Stacking gels:
These were prepared as in the following table:
Resolving gel (15%) 
(Enough for two gels)
Stacking gel (4%) 
(Enough for two gels)
Milli-Q Water 2  ml 3.75 ml
2x Resolving gel buffer (AX2) 1 0  ml
2x Stacking gel buffer (BX2) 5 ml
Acryl :bis-acrylamide (40% w/v) 7.6 ml 1 ml
20% SDS 2 0 0  pi 1 0 0  pi
10% Ammonium persulphate 300 pi 1 0 0  pi
Temed 6  pi 30 pi
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Both resolving and stacking gels set at room temperature after 30 and 15 minutes, 
respectively.
2x Loading buffer:
Mix 5mls BX2 with 2mls 20% SDS, 4.0g glycerol, 0.5ml p-mercaptoethanol, and 0.1ml 
o f  1% bromophenol blue. Then take the final volume to 10ml using Milli-Q water. 
Buffer was stored at room temperature and was used within two weeks o f preparing.
Running Buffer (per litre):
Weigh 3.02g Tris base and 14.44g glycine and add 5ml o f  20% SDS. Then take the final 
volume to IL using Milli-Q water. The pH should be to 8.12 (do not adjust). Fresh 
solution was always prepared prior to every experiment.
Transfer buffer (per litre):
Weigh 3.02g Tris base and 14.44g glycine and add 600ml o f  Milli-Q water and 200ml o f  
methanol. Then take the final volume to IL using Milli-Q water. Fresh solution was 
always prepared (and left to cool for two hours at 4°C) prior to every experiment.
lOx Tris buffered saline-Tween buffer (lOx TBS-T):
Make two litres by adding 48.4g Tris base, 160g NaCl, and take volume up to 1.8L using 
Mill-Q water. Adjust pH with HCI to 7.6. Then add 20 ml Tween-20 and take the final 
volume to 2 L using Milli-Q water. Keep stored at 4°C.
75
Ix Tris buffered saline-Tween buffer (TBS-T): 
Add 900ml o f  Milli-Q water to 100ml o f lOx TBS-T.
Membrane blocking solution:
5% (w/v) non-fat powdered milk (Marvel) in TBS-T.
Commassie brilliant blue stain (gel-staining dye):
To prepare 100ml, weigh 0.25g o f commassie brilliant blue. Add 45 ml o f Milli-Q water 
and 45ml o f methanol. Finally add 10ml o f acetic acid.
Gel de-staining solution (per litre):
Made by mixing 300ml methanol and 100ml acetic acid and taking the final volume to 
IL using Milli-Q water.
lOx Ponceau S stain (stock):
Mix 2g Ponceau S, 30g o f trichloroacetic acid, and 30g o f sulfosalicylicic acid. Using 
Milli-Q water, take to a final volume o f 100ml.
Ix Ponceau S stain:
Add 90ml o f  Milli-Q water to 10ml o f  lOx Ponceau S.
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2.3 Methods
2.3.1 Animals and in vivo experiments
Male BALB/c mice were purchased from Bantin & Kingman (B&K / UK) at a weight o f  
25 g (6 - 8  weeks old). They had ad  libitum access to standard powdered chow and water. 
The animals were kept in our experimental biology unit (EBU) to acclimatise in a 
controlled environment (21-24 °C, 30-40% humidity and an alternating 12-hour cycle o f  
light and dark) for at least one week prior to all experiments.
Paracetamol, dissolved in phosphate-buffered saline (PBS), was injected intraperitoneally 
at a dose o f  500mg/kg. Anti-CD95 antibody; dissolved in PBS; was also injected 
intraperitoneally at a dose o f 40pg/animal. Where indicated, animals received an 
intravenous injection (through a caudal vein) o f  Z-VAD-fmk (10 mg/kg, dissolved in 
2.5% dimethylsulfoxide in PBS) 15 minutes prior to paracetamol or Anti-CD95 antibody 
administration. Control animals always received an equivalent volume o f the 
corresponding solvent via the corresponding route.
Mice were sacrificed at the indicated time points by an intraperitoneal injection o f  a lethal 
dose o f sodium pentobarbital ( 6  mg/animal). Where indicated, blood, obtained by 
intracardiac puncture, was immediately collected into heparinised tubes (for plasma) or 
into plain tubes (for serum) and then centrifuged at 2500g for 10 minutes to get plasma or 
serum respectively.
Pieces o f liver tissue to be processed for light and transmission electron microscopy were 
instantly fixed in 10% neutral buffered formalin. On the other hand, pieces o f  liver tissue
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to be processed for biochemical analyses, caspase assays, agarose gel electrophoresis, and 
western blotting were snap frozen by immersion into a bath o f  hexane cooled by a 
mixture o f industrial methylated spirit (IMS) and dry ice and then stored in glass tubes at 
-80°C.
2.3.2 Serum Biochemistry
Plasma activities o f ALT, AST and LDH were measured using commercial kits (Roche) 
using a Cobas Bios auto-analyser according to the manufacturer’s instructions. Quality 
controls were run with every assay.
2.3.3 Histology
For light microscopic examination, hepatic tissue specimens were fixed in 10% neutral 
buffered formalin, embedded in paraffin and cut at 5-pm thickness sections using a rotary 
microtome. The sections were stained with hematoxylin and eosin (H&E) for routine 
examination.
The in situ labeling o f apoptotic cells was performed using the ApopTag Direct TdT- 
catalysed dUTP-fluorescein nick end labeling (TUNEL) method as specified by the 
supplier (Oncor) (Gavrieli et aL, 1992). The TUNEL-stained sections were 
counterstained with propidium iodide and mounted with antifade (Oncor) and examined 
by fluorescence or confocal laser scanning microscopy (Leica).
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For transmission electron microscopy (TEM), liver tissue specimens o f  approximately 
Imm^ were fixed in 4% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight, 
followed by several 10-min washes o f  the tissues with 0.1 M cacodylate buffer (pH 7.4). 
Following counterfixing with 2% osmium tetroxide in cacodylate buffer, the specimens 
were dehydrated in ethanol and finally embedded in TAAB resin. Ultrathin sections were 
cut, stained with uranyl acetate and analysed by TEM.
2.3.4 Determination of DNA fragmentation
2.3.4.1 DNA isolation and purification
Phenol/chloroform extraction o f DNA was carried out (with minor modifications) as 
previously described (Ray et al., 1993; Ray et al., 1992).
1 0 % (w/v) liver homogenates o f frozen liver sections were homogenised in ice-cold lysis 
buffer using a glass-tefion homogeniser. The 10% homogenates were digested with 
proteinase K (0.2 mg/ml) for 6  hours at 50°C on a shaking water bath. Triple 
phenol/chloroform extraction was carried out by adding phenol/chloroform to the 
homogenate in a 3:l(v/v) ratio, respectively. Mixing was carried out by gently shaking 
the tubes for 5 minutes. The solution was then centrifuged at 3,000 rpm for 5 minutes at 
room temperature. The upper, clear aqueous layer (where the DNA is found) was 
collected. Phenol/chloroform extraction was repeated three times.
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To the aqueous layer, cold absolute ethanol (kept overnight at -20°C) was added to make 
up to a volume o f 18mls. Finally, 2mls o f 2.5M sodium acetate were added to the 
mixture which was kept overnight at -20°C.
Next day, the mixture was centrifuged at 3,000rpm/4°C/20min. The supernatant 
(ethanol) was discarded, and the DNA pellet resuspended in cold 6 6 % ethanol (kept 
overnight at -20°C) to make up to a volume o f 18mls. Again, 2mls o f 2.5M sodium 
acetate were added to the mixture, which was kept at -20°C for one hour, and then 
centrifuged at 3,000rpm/4°C/20min. The washing in 6 6 % ethanol was repeated three 
times.
The DNA sample was resuspended in 100-200 pi o f  TE-8  buffer and digested with 
RNase A (Ipg/ml) for 30 minutes at 37°C in a non-shaking water bath.
2.3.4.2 Agarose gel electrophoresis:
After preparing 1.6% (w/v) ultrapure agarose gel in IxTBE, the required volume o f  
ethidium bromide was added to make a final concentration o f 0.4pg/ml. After the 
mixture was heated in the microwave (at full power) for 3-4 minutes, the agarose was 
allowed to cool (at room temperature) to around 60°C. It was then poured into the gel 
cast and the comb was placed into the gel, which was allowed to set for one hour. After 
the cast was placed into a IL-submarine tank which was filled with IxTBE, the comb 
was carefully removed, taking care not to split the gel.
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A volume o f 30pl (15pl o f  DNA sample and 15pl o f DNA loading buffer) was loaded 
into each well. The gel was run at 10 volts overnight (at room temperature). At the end 
o f the run, the gel was removed from the tank and placed in a plastic tray and given a 
quick rinse in distilled water. Then it was put on a shaker and washed three times (x3) in 
TE- 8  buffer. Each wash was for 15-30 minutes.
Finally the ethidium bromide-stained bands were visualised under an ultra-violet 
transilluminator and photographed on a gel documentation system (UVP imagestore).
2.3.5 Succinate dehydrogenase (SDH) assay
2.3.5.1 Isolation of mitochondria for SDH assay
Mitochondriae were isolated from mice pre-frozen liver tissues which were homogenised 
in ice-cold MSH-EDTA buffer using a glass-teflon homogeniser to make a 25% (w/v) 
homogenate. The homogenate was centrifuged at 500g for 10 minutes at 4°C and the 
supernatant at 12,000g for 10 minutes. The 12,000g supernatant was used as the 
cytosolic fraction and the 12,000g pellet was used as the mitochondria. Mitochondrial 
pellet was washed by resuspending in the MSH-EDTA buffer and gently homogenised by 
hand in a glass-teflon homogeniser and centrifuged again at 1 2 ,0 0 0 g for 1 0  minutes at 
4°C. Mitochondrial pellets were resuspended in MSH-EDTA and protein concentrations 
were determined using Bio-Rad protein assay.
Mitochondrial samples to be used for the SDH assay were diluted in MSH-EDTA buffer 
to give a final protein concentration o f 2mg/ml. The final mitochondrial fractions were
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divided into aliquots and used immediately for the assay, or otherwise kept in -80°C 
freezer.
2.3.S.2 Assaying for SDH
Measurement o f SDH activity was based (with slight modification) on the Pennington 
assay (Pennington, 1961).
In LP3 tubes, duplicates o f the following mixtures (as shown in the table) were prepared 
and pre-incubated in a 37°C-preheated water bath for at least four minutes.
Standard blank Tissue blank Test sample
Mitochondrial samples (pi) # # # 150 150
Substrate (pi) # # # # # # 75
Inhibitor (pi) 75 75 # # #
MSH-EDTA buffer (pi) 150 # # # # # #
Then, taken tube by tube and at specified times, 75pi o f pre-warmed (to 37°C) 
chromogen was added to each tube, whirlmixed, and immediately placed back into the 
bath. Timing for the incubation period started the moment the tube is replaced back into 
the bath.
Each tube was incubated for a precisely timed 20 minutes, then the reaction was stopped 
by adding 1 .2 ml stopping reagent (must be kept at room temperature) to make a final
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volume o f 1.5ml. Immediately after adding the stopping reagent, the tube was lifted out 
o f the waterbath, whirlmixed, and then placed in a rack at room temperature. Strict 
timing is critical.
The red fromazan formed in the reaction was extracted into 4ml o f  ethyl acetate and 
gently centrifuged (at 500g for 3-5 minutes at room temperature) to get rid o f  
occasionally encountered turbidities. Finally, the absorbance o f  each tube was measured 
at 490nm using the spectrophotometer Kontron Uvikon 932.
2.3.6 Adenylate kinase (AK) assay
The enzyme assay was performed by a modification o f  the procedure o f  (Passarella et ah, 
1988) and (Barile et al., 1994). 0.5ml o f reaction buffer A (70mM triethanolamine and 
1.4mM EDTA in Milli-Q water, pH adjusted to 7.4 with concentrated HCl) was aliquoted 
into a quartz glass cuvette. Then, 5pi o f reaction buffer B (2.8mM glucose (Sigma) and 
7mM MgCl2 (BDH) in Milli-Q water) was also added, both buffers were prewarmed at 
37°C. An aliquot o f the isolated mitochondria, containing 35pg o f protein per sample, 
5 pi o f  carboxyatractyloside (CAT) (mitochondrial inhibitor. Sigma), 2pl oligomycin 
(mitochondrial inhibitor. Sigma), 2pi hexokinase (Roche), Ipl glucose-6 -phosphate 
dehydrogenase (G6 PD) (Roche), 5pi NADP^ (Roche), and 5pi ADP (Sigma) were then 
added. The cuvette was rapidly mixed and NADP^ reduction was measured at 340nm in 
a time-drive o f 2 minutes with 150 absorbance readings per minute using a Kontron 932 
spectrophotometer. The rate o f  NADP^ reduction is directly related to the AK activity. 
The temperature o f reaction was set at 2>TC.
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2.3.7 Cytochrome c oxidase (COX) assay
COX is an enzyme found attached to the inner mitochondrial membrane. COX activity is 
proportional to the amount o f  mitochondria present in the samples and thus COX activity 
was used as a marker for data normalisation. The enzyme assay was performed by a 
modified procedure from (Balaban et al., 1996; Miro et al., 1998; Williams et al., 1998). 
Mitochondria, 70pg o f protein/sample were incubated with digitonin (0.106mg 
digitonin/mg o f  protein as mentioned in (Boyer et ah, 1993)) (Sigma) and lOOpl enzyme 
reaction buffer (0.3M sucrose and lOmM KH2PO4) in an eppendorf and kept in ice for 15 
minutes. Meanwhile, lOpl o f 30mM cytochrome c (Sigma) solution prepared in enzyme 
reaction buffer was aliquoted into an Eppendorf and 30pl o f lOmM dithionite (Sigma) 
solution , also prepared in assay buffer, was added. The contents were carefully mixed to 
allow reduction o f cytochrome c. Cytochrome c reduction was checked 
spectrophotometrically by a quick wavelength scan between 450-600nm. Reduction o f  
cytochrome c showed a distinct peak at 550nm.
After the 15 minutes incubation period, the assay was performed by the addition o f  780pl 
reaction buffer, prewarmed at 37®C, into a 1.5ml plastic cuvette. Followed the addition 
o f  lOOpl o f incubated mitochondria and 40pl reduced cytochrome c. The cuvette was 
rapidly mixed and the reaction was followed at 550nm in a time-drive o f 2 minutes with 
150 absorbance readings per minute using a Kontron 932 spectrophotometer. The 
temperature o f reaction was set at 37®C.
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2.3.8 Determination of caspase activation
2.3.8.1 Isolation of thymocytes (positive controls):
This was carried out (with slight modification) as previously described (Chow et aL, 
1995). A three-week old male Wistar rat was sacrificed by an intraperitoneal injection o f  
9mg o f  sodium pentobarbital. The thymus was dissected out, removing the parathymie 
nodes and connective tissue, and was kept in ice-cold minimum essential medium 
(MEM). The thymus was chopped and squeezed between the frosted ends o f  two glass 
slides and filtered using 10ml o f ice-cold MEM through a bolton cloth (to remove the 
debris) into a sterile universal tube. Thymocytes were washed once by centrifuging at 
l,250rpm for 5 minutes at 4°C. The thymocytes-pellet was resuspended in 10ml o f  ice- 
cold MEM in a clean universal tube and poured into a 20ml-culture flask and were 
incubated at 37°C in an atmosphere o f 95% O2: 5% CO2 in a humidified incubator in the 
presence o f IpM dexamethasone for 6  hours. After the incubation period, thymocytes 
were washed by centrifuging at l,250rpm for 5 minutes at 4°C and the supernatant was 
carefully removed using a tap water-powered suction system. Thymocytes-pellet was 
resuspended in 1ml o f  ice-cold cell lysis buffer (CLB), poured into an eppedorf tube, 
bench-centrifuged at l,250rpm for 5 minutes at 4°C, and then resuspended again in 50pl 
o f CLB and kept overnight at -80°C. Next day, x2 cycles o f thawing and re-freezing (in a 
mixture o f IMS and dry ice) were carried out. Finally, thawed thymocytes were bench- 
centrifuged at 16,000rpm for 30 minutes at 4°C. The supernatant was collected and 
divided into eppendorfs o f  lOpl aliquots that were immediately stored at -80°C.
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Protein concentration in the thymocytes solution was determined using the Bio-Rad 
protein assay.
2.3.5.2 Preparation of total liver homogenates:
33% (w/v) total liver homogenates (Test samples) were prepared in ice-cold HEB by 
homogenising frozen liver sections using a glass-teflon homogeniser.
Protein concentration in the homogenates was determined using the biuret method 
(Gomall et ah, 1949).
2.3.5.3 M easurement o f caspase activation:
Caspase activity was assayed at room temperature using a fluorescence microtitre plate 
reader and a fluorimeter (WellFluor, Denley) in a reaction mixture containing 40pM o f  
the fluorogenic substrate peptides Ac-DEVD-AFC or Ac-LEHD-AFC as previously 
reported (Jones et ah, 1998), with the exception that each well contained Img protein. 
Amino-4-trifluoromethylcoumarin (AFC) in a ranging concentration (0-20nmoles) was 
used for plotting a standard curve each time the assay was performed. Appropriate 
blanks were also carried out.
2.3.9 SDS-PAGE and Western Blotting
2.3.9.1 Isolation of mitochondria
Frozen liver sections were homogenised in ice-cold homogenisation buffer (HB) using a 
glass-teflon homogeniser to make a 25% (w/v) homogenate. The homogenate was 
centrifuged at 500g for 10 minutes at 4°C and the supernatant at 12,000g for 10 minutes.
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The 12,000g supernatant was used as the cytosolic fraction and the 12,000g pellet was 
used as the mitochondria. The mitochondrial pellet was washed by resuspending in HB 
and gently homogenised by hand in a glass-teflon homogeniser and centrifuged again at 
12,000g for 10 minutes at 4°C. The final mitochondrial pellet was resuspended in the HB 
buffer. Both cytosolic and mitochondrial fractions were divided into aliquots and kept 
frozen at -80°C. Protein concentrations were determined using Bio-Rad protein assay.
2.3.9.2 Polyacrylamide Gel Electrophoresis
Cytosolic and mitochondrial fractions underwent SDS-15% polyacrylamide gel 
electrophoresis. A 4% stacking gel was always used. The gels were cast in a Bio-Rad 
mini gel system using the previously described recipes. Cytosolic or mitochondrial 
samples were diluted one fold in 2x loading buffer, boiled for 3-5 minutes and loaded in a 
final volume o f lOpl onto the wells o f the stacker. The total amount o f  protein loaded in 
each well ranged from lOpg to 50pg. Electrophoresis was carried out at room 
temperature for 80-90 minutes at lOOV until the tracking dye o f the loading buffer was 
within a few millimetres o f  the lower edge o f the gel.
2.3.9.3 Western Transfer of Proteins
Whatmann 3MM filter papers, Hybond C nitrocellulose membrane, and scotchbrite pads 
were soaked in pre-cooled transfer buffer for 10 minutes. Transfer o f proteins was 
carried out by layering two pieces o f  filter paper, followed by the gel, and then the 
nitrocellulose membrane. This was then layered by two more pieces o f filter paper, 
sandwiched within the scotchbrite pads and then placed in the Bio-Rad transfer system. 
The transfer tank was filled with the pre-cooled transfer buffer. The transfer was usually
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done overnight at 34V at room temperature. Occasionally, cool transfer (with the cooling 
element in place) at lOOV for 2-3 hours was carried out. Following transfer, the protein 
profile was checked on the membrane by staining with Ponceau S stain for 2-3 minutes, 
followed by de-staining in Milli-Q water. The efficiency o f  the transfer process was 
determined by staining the gel in Commassie brilliant blue stain for 1-2 hours (on a 
shaker), and de-staining for several hours (or overnight) using gel de-staining solution.
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2.3.9.4 Immunoblotting
The membrane was then blocked either overnight (at 4°C) or for one hour (on a shaker) 
in 5% (w/v) membrane blocking solution. The membrane was then probed with a 
suitable dilution o f primary antibody (or a mixture o f two primary antibodies) made in 
5% (w/v) membrane blocking solution. Used dilutions o f  primary antibodies against 
cytochrome c (Ipg/ml or 1:500 dilution), cytochrome oxidase subunit IV (0.25pg/ml or 
1:1,000 dilution), Bax (Ipg/ml or 1:200 dilution). Bid (Ipg/ml or 1:1,000 dilution), BCl- 
x l  (2pg/ml or 1:500 dilution), caspase-3 (1:2,500 dilution), caspase-7 (1:2000 dilution), 
caspase-9 (1:500 dilution), and caspase- 8  (1:1,000 dilution) were all in accordance with 
the recommendations o f the corresponding manufacturers.
Incubation in the primary antibody was always carried out at room temperature and for a 
one hour duration except in the case o f antibodies against Bid and the caspases (caspase- 
3, caspase-9, and caspase-8 ) when incubation was carried out overnight and at cold room 
temperature (4-8°C). The membrane was washed 3x 10 minutes in TBS-T on a shaker. 
After washing, incubation for one hour with a 1:2,000 dilution (in 5% (w/v) membrane 
blocking solution) o f  the appropriate HRP-conjugated secondary antibody was carried
88
out. Finally the membrane was washed again for 3x 10 minutes in TBS-T on a shaker 
before being visualised with the chemiluminescent detection system as described by the 
manufacturer (Pierce chemical company). Premixed detection reagent was added and 
incubated for 5 minutes. Excess reagent was drained o ff and the blot was wrapped in 
Saran wrap. Exposure to the x-ray film was for a variable period ranging from 5 seconds 
to 20 minutes. Band densitometry was carried out using MCID 4 (Gels-Lane Analysis).
2.3.10 Bio-Rad protein assay
Protein concentration was assessed using Bio-Rad protein assay. The test is a dye- 
binding assay based on the differential colour change o f  a dye in response to various 
concentrations o f protein.
As the dye reagent is provided as a five-fold concentrate, one volume o f  the dye reagent 
concentrate was diluted with four volumes o f Milli-Q water and then filtered through a 
Whatmann No. 1 paper. This dilute dye reagent was always discarded after two weeks.
Several dilutions o f protein standard 1 (containing from 0.2 to 1.4 mg/ml o f  bovine y 
globulin) were prepared and used in generating a standard curve each time the assay is 
performed.
Aliquots o f  lOOpl o f  standards and appropriately diluted samples were placed in clean, 
dry test tubes. Corresponding “Blank” test tubes were prepared using aliquots o f lOOpI 
o f  the sample buffer on its own. To each test tube, 5.Omis o f  diluted dye reagent were 
added, and the mixture was vortexed (avoid excessive foaming). After a period ranging
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from 5 to 60 minutes, measurement o f  OD595 (versus reagent blank) was carried out and 
plotted against concentration o f standards and read unknowns using the standard curve.
2.3.11 Statistical analysis of the data
All data are given as means + SE o f the number o f animals (SEM) indicated in the text. 
Comparison o f treatments against controls was made using Dunnett’s t-test. Where 
appropriate, Bonferroni’s multiple comparisons test was performed to determine the 
significance between different treatments. The significance level chosen for all statistical 
analyses was p < 0.05. The statistical analyses were carried out with the SPSS statistical 
package.
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Chapter 3
Paracetamol Hepatotoxicity
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3.1 Histopathology and Biochemistry in AAP overdosing
Earlier experiments (data not shown) carried out in our laboratory confirmed that the 
minimal toxic dose o f AAP in BALB/c mice was 500mg/kg (Anwar, 2001). After six 
hours o f overdosing BALB/c mice with a single intraperitoneal injection o f AAP 
(500mg/kg), haematoxylin and eosin (H&E) staining revealed histopathological evidence 
o f  acute liver injury (Figure 9). This was paralleled by a rise in the serum liver enzymes 
ALT (Figure 10), AST (Figure 11), and LDH (Figure 12). Similar results were obtained 
with higher doses o f  AAP (Figure 13).
TUNEL staining o f  liver sections from AAP-overdosed mice also confirmed the loss o f  
genomic DNA through fragmentation (Figure 14).
Adoption o f  the “six-hour” figure throughout most o f  our project was based on 
histopathological and biochemical results on earlier studies (data not shown) carried out 
on the time-course o f AAP-induced hepatic damage (Anwar, 2001). In summary, these 
studies revealed that one hour post-AAP (500mg/kg) overdosing, small vacuolations 
were observed in centrilobular (zone 3) hepatocytes. By two hours, vacuolations were 
more prominent and extended to involve zone 2 as well. By the third hour, scattered 
necrotic cells (with some RBCs) were observed in zone 3. By four to five hours, large 
numbers o f RBCs were widely spread throughout zones 1-3 with very few necrotic cells 
remaining. By the sixth hour, only a very small number o f  necrotic cells were visualised 
(mainly in zone 3). Serum liver transaminases (and LDH) were rapidly rising after the 
fourth hour post-AAP overdosing. Therefore it was felt that in order to identify the early 
events leading to the development o f liver toxicity, subsequent studies should mainly 
concentrate on the changes found in the liver six hours after AAP overdosing.
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Figure 9. Histopathological documentation of paracetamol-induced acute liver injury 
and failure of GdClg-pretreatment to prevent such injury. BALB/c mice were pretreated 
with intravenous GdCL (lOmg/kg in 20% Tween-80 in normal saline) or vehicle control 
(20% Tween-80 in normal saline) 24 hours prior to receiving intraperitoneal AAP 
(500mg/kg in PBS). All animals were sacrificed after six hours. Hepatic tissues were fixed 
in 1 0 % neutral buffered formalin, embedded in paraffin, cut into 5-pm thick sections, and 
stained with H&E as outlined in Methods earlier. Section A: “Control”; Section B: “AAP- 
treated”; and Section C: “AAP-treatment following GdCL”. Magnification lOOX. 
This work was carried out in collaboration with my colleague Dr K Anwar (Anwar, 2001).
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Figure 10. Z-VAD-fmk and Z-DEVD-cmk prevent the rise in serum alanine transaminase 
(ALT) after paracetamol intoxication.
“Control” mice received ip-PBS (0.5ml). “AAP” group received ip-AAP (500mg/kg). 
“AAP+Z-VAD” group received iv Z-VAD-fmk (lOmg/kg in 2.5% DMSO in PBS) 15 minutes 
prior to dosing with AAP. “AAP+Z-DEVD” group received iv Z-DEVD-cmk (lOmg/kg in 2.5% 
DMSO in PBS) 15 minutes prior to dosing with AAP. “Z-VAD” group received iv Z-VAD-fmk 
(lOmg/kg in 2.5% DMSO in PBS) and ip-PBS (0.5 ml) 15 minutes later. All animals were 
sacrificed after 6 hours. ALT activity in serum was measured using commercial kits (Roche) on 
a Cobas Bios auto-analyser according to the manufacturer’s instructions. Data given represents
Mean ± SEM. Each group consisted o f  five animals. *: Significantly different from control
(p<0.05). f  : Significantly different from AAP-treated group (p<0.05).
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Figure 11. ZL-VAD-fmk and Z-DEVD-cmk prevent the rise in serum aspartate 
transaminase (AST) after paracetamol intoxication.
“Control” mice received ip-PBS (0.5ml). “AAP” group received ip-AAP (500mg/kg). 
“AAP+Z-VAD” group received iv Z-VAD-fmk (lOmg/kg in 2.5% DMSO in PBS) 15 minutes 
prior to dosing with AAP. “AAP+Z-DEVD” group received iv Z-DEVD-cmk (lOmg/kg in 2.5% 
DMSO in PBS) 15 minutes prior to dosing with AAP. “Z-VAD” group received iv Z-VAD-fmk 
(lOmg/kg in 2.5% DMSO in PBS) and ip-PBS (0.5 ml) 15 minutes later. All animals were 
sacrificed after 6 hours. AST activity in serum was measured using commercial kits (Roche) on 
a Cobas Bios auto-analyser according to the manufacturer’s instructions. Data given represents
Mean ± SEM. Each group consisted o f  five animals. *: Significantly different from control
(p<0.05). f  : Significantly different from AAP-treated group (p<0.05).
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Figure 12. Z-VAD-fmk and Z-DEVD-cmk prevent the rise in serum lactate dehydrogenase 
(LDH) after paracetamol intoxication.
“Control” mice received ip-PBS (0.5ml). “AAP” group received ip-AAP (500mg/kg). 
“AAP+Z-VAD” group received iv Z-VAD-fmk (lOmg/kg in 2.5% DMSO in PBS) 15 minutes 
prior to dosing with AAP. “AAP+Z-DEVD” group received iv Z-DEVD-cmk (lOmg/kg in 2.5% 
DMSO in PBS) 15 minutes prior to dosing with AAP. “Z-VAD” group received iv Z-VAD-fmk 
(lOmg/kg in 2.5% DMSO in PBS) and ip-PBS (0.5 ml) 15 minutes later. All animals were 
sacrificed after 6 hours. LDH activity in serum was measured using commercial kits (Roche) on 
a Cobas Bios auto-analyser according to the manufacturer’s instructions. Data given represents
Mean ± SEM. Each group consisted o f  five animals. *: Significantly different from control
(p<0.05). f  : Significantly different from AAP-treated group (p<0.05).
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Figure 13. Z-VAD-fmk does not abolish hepatic injury (reflected by serum ALT) after 
intoxication by higher doses of paracetamol.
“Control” mice received ip-PBS (0.5ml). “AAP” group received ip-AAP (600mg/kg, ip). 
“AAP+Z-VAD” group received iv Z-VAD-fmk (lOmg/kg in 2.5% DMSO in PBS) 15 minutes 
prior to overdosing with AAP (600mg/kg, ip). All animals were sacrificed after 6 hours. 
ALT activity in serum was measured using commercial kits (Roche) on a Cobas Bios auto­
analyser according to the manufacturer’s instructions. Data given represents Mean + SEM.
Each group consisted o f five animals. *: Significantly different from control (p<0.05).
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3.2 Role of phagocytes in paracetamol overdosage
In earlier studies, phagocytes (consisting mainly o f in situ activated Kupffer cells and 
chemotactically attracted blood monocytes to the site o f  injury and inflammation) have 
been hypothesised, through the release o f cytotoxic and proinflammatory mediators, to 
play a major role in the hepatotoxicity o f  AAP (Ferluga and Allison, 1978; Laskin and 
Pilaro, 1986; Laskin a/., 1986).
Pretreatment o f  animals with gadolinium chloride (GdCls), a recognised inhibitor o f  
hepatic macrophage function, is a well known model in biological sciences (Husztik et 
aL, 1980; Laskin e /o /., 1995).
Laskin (Laskin et aL, 1995) reported that pretreatment o f  rats with intravenous 
gadolinium chloride (GdClg, 7mg/kg) for 24 hours, prior to overdosing with 
intraperitoneal AAP (800mg/kg), completely blocked hepatic necrosis and prevented the 
rise in serum transaminase levels induced by AAP. Laskin also concluded that the effects 
o f GdCls were not due to suppression o f  NAPQI formation
In our project, we found that intraperitoneal AAP overdosing (500mg/kg) o f  BALB/c 
mice was associated with marked rise in all o f the serum liver enzymes (Table 3). On the 
other hand pretreatment with GdCb (lOmg/kg, iv) for 24 hours prior to overdosing with 
AAP did not prevent AAP-related liver injury as evidenced by the continuing rise in 
serum liver enzymes (Table 3) and the persistence o f  damaged hepatic tissue (Figure 9). 
However, when examining histological sections for DNA damage as assessed by TUNEL 
staining, it was found that pretreatment with GdClg has prevented the formation of  
apoptotic cells in AAP-overdosed animals (Figure 14). Thus, we concluded that although
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pretreatment with GdCb was very successful in preventing apoptosis, it could not stop 
liver damage from taking place. This suggests that cytokines released from Kupffer cells 
are not the major effectors o f  AAP-induced hepatic damage in BALB/c mice model.
Table 3. Effects o f  Gadolinium chloride treatment on paracetamol-induced alterations in 
serum liver enzyme levels.
Treatment n ALT (lU/L) AST (lU/L) LDH (lU/L)
Control 61 ±14 286 ± 126 3300 ±1056
Control + GdCls 69 ±19 119 ±44 1878 ±476
Paracetamol 9 1835 ±621" 546 ± 175 6137 ± 1039'
Paracetamol + GdClg 10 1979 ± 609" 1030 ± 221" 10400 ± 1872'
NOTE: BALB/c mice were pretreated with Gadolinium chloride (GdClg) (10 mg/kg, iv) or 
vehicle control (20% Tween 80 in normal saline) for 24 hours prior to dosing with 
paracetamol (500 mg/kg, ip). After six hours, the animals were sacrificed and serum 
prepared for the measurement o f the liver-derived enzymes ALT, AST and LDH as 
described under Methods.
All data are given as Mean ±  SEM.  ^Significantly different from control (p<0.05).
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Figure 14. Detection of DNA fragmentation in the liver following paracetamol 
intoxication using the TUNEL assay: Gadolinium chloride (GdCL) and Z-VAD-fmk 
prevent DNA fragmentation. Mice were pretreated with gadolinium chloride (GdCb; 10 
mg/kg, in 20% Tween 80 in normal saline, iv) 24h before or with Z-VAD-fmk (10 mg/kg; in 
2.5% DMSO in PBS, iv) 15 min prior to dosing with AAP (500 mg/kg, ip). After six hours, 
all animals were sacrificed and hepatic tissue specimens were collected and fixed in 10% 
neutral buffered formalin, embedded in paraffin and cut at 5-pm thickness sections. The 
sections were processed for TUNEL staining as described under Methods and visualized by 
confocal laser scanning microscopy. The left panel shows the TUNEL stained cells (green), 
the middle the propidium iodide (PI) counterstained nuclei (red) and the right panel the 
merged images. Note that nearly all TUNEL stained cells are parenchymal liver cells with 
condensed nuclei, suggesting that the TUNEL assay identifies apoptotic cells under the 
present conditions. The merged images from the section prepared from AAP-treated and 
AAP- and GdClg-pretreated animal also show the presence o f congested areas with large 
numbers o f erythrocytes (dark green fluorescence). This work was carried out in 
collaboration with my colleague Dr K Anwar (Anwar, 2001).
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3.3 Role of caspase inhibitors in paracetamol hepatotoxicity
Z-VAD-fmk is widely used as a “broad specificity” irreversible inhibitor o f caspases. As 
previously reported by Kunstle et al (Kunstle et al., 1997), pretreatment o f mice with Z- 
VAD-fmk (lOmg/kg) was protective from CD95- and TNF-alpha-induced liver injuriy 
(as determined by plasma ALT) and also from hepatocyte apoptosis (assessed by DNA  
fragmentation). Similar results were found when apoptosis was initiated via TNF-alpha 
or via CD95 in primary murine hepatocytes or in various human cell lines. These findings 
indicate that, in mammals, both the CD95 and the TNF-a receptors share a signaling 
pathway that involves caspases (Kunstle et ah, 1997).
In our project, pretreatment o f BALB/c mice with Z-VAD-fmk (lOmg/kg in 2.5% DMSO 
in PBS, iv) proved to be significantly protective against AAP-induced liver injury, when 
the latter was given at a dose o f 500mg/kg. This also was evidenced biochemically by 
the marked decrease in serum liver enzyme levels [ALT (Figure 10), AST (Figure 11), 
and LDH (Figure 12)].
Z-VAD-fmk pretreatment also managed to abolish the pathological changes (Figure 15) 
and prevented the appearance o f  TUNEL positive parenchymal cells (Figure 14) due to 
AAP overdosing. However, this hepatoprotective effect o f Z-VAD was lost with doses 
o f AAP higher than 500mg/kg (Figure 13)
After the sixth hour o f  AAP-overdosing, livers from AAP-treated mice were grossly 
different from the control animals, they looked dark, haemorrhagic, and were massively 
swollen and congested. On the other hand, livers from mice pretreated with Z-VAD-fmk 
before receiving AAP looked very healthy and were generally indistinguishable from
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those in the untreated group in both gross appearance and under the microscope (Figure 
15).
Protection from paracetamol-induced toxicity with Z-VAD-fmk may suggest that 
caspase-3 is o f pivotal importance in paracetamol-induced apoptosis as Z-VAD-fmk 
specifically inhibits the processing o f  caspase 3 (CPP32) to its active form (Slee et aL,
1996).
In addition to the protective effect o f Z-VAD-fmk, we also observed that the caspase-3 
like inhibitor Z-DEVD-cmk also alleviated, albeit to a lesser extent, the damage induced 
by AAP (Figures 10-12). However, one notable difference between the two was that, on 
histopathology, Z-VAD-fmk blocked the accumulation o f neutrophils in the liver whereas 
large number o f  neutrophils was still observed in the Z-DEVD-cmk-treated mice. This 
difference may be attributed to the difference in caspase specificity between the two 
peptide inhibitors, with Z-DEVD-cmk expected to show a greater degree o f  selectivity 
towards the group 2 caspases as compared to the broad spectrum acting Z-VAD-fmk 
which also block the pro-inflammatory group 1 caspases (Nicholson and Thomberry,
1997).
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3.4 Role of sinusoidal endothelial cells in paracetamol toxicity
The fact that both GdCls and Z-VAD-fmk were capable o f preventing DNA damage on 
TUNEL assay (Figure 14) may suggest that at least two different mechanisms (namely 
the inhibition o f cytokine rlease from macrophages/Kupffer cells and the prevention o f  
caspase processing, respectively) are involved in preventing apoptosis.
However, while GdCb pretreatment was unable to protect the liver against AAP-induced 
injury (Figure 9), Z-VAD-fmk was protective (Figure 15). This suggests that cytokines 
secreted by Kupffer cells play a major role in apoptosis o f  hepatocytes in AAP toxicity.
The liver is the major detoxifying organ in humans and because o f  their location 
(between blood stream and hepatic parenchyma), sinusoidal endothelial cells (SECs) are 
probably more vulnerable to toxins than any other type o f cell in the body. When 
Walker, et al investigated (using TEM) AAP-induced hepatotoxicity and its associated 
hepatic congestion, he realised that AAP (750 mg/kg, orally) causes changes in the 
relationship between hepatocytes and SECs. He then observed endocytic vacuolation at 
lateral and sinusoidal margins o f  centrilobular hepatocytes, loss o f  microvilli. Disse space 
enlargement, dilatation o f bile canaliculi, and disappearance o f the studlike projections 
from hepatocyte lateral surfaces. He concluded that RBCs enter the enlarged Disse space 
and endocytic vacuoles via enlarged pores in SECs, thereby collapsing the sinusoids. 
However he reported that lining SECs are not lost, but apparently held in position by 
preservation o f  intercellular junctions, cytoplasmic projections from hepatocytes, and 
anchorage by fat-storing cells within the Disse space. He finally observed that 
congestion can abate by 24 hours, indicating that RBCs can return to the general 
circulation from the Disse space (Walker et al., 1983; Walker et al., 1985).
—
Also it is reported that treatment o f  mice with anti-CD95 leads to damage o f SECs cells 
and hepatic microvascular perfusion failure. Intravenously administered anti-CD95 (10 
microgram/mouse) antibodies to mice leads to sinusoidal perfusion failure and loss o f  
integrity o f  SECs as early as Ihour post dosing. Histological evidence o f  hepatocellular 
apoptosis and haemorrhagic necrosis were most pronounced at 6 hours. Blocking o f  
caspase activity using Z-VAD-fmk attenuated the sinusoidal perfusion failure, fully 
protected the liver from apoptotic damage, and preserved an intact microarchitecture 
(Wanner gr a/., 1999).
In our project, results o f  histology (Figures 9 & 15) confirmed the presence o f  severe 
hemorrhagic damage/congestion after six hours o f  overdosing BALB/c mice with AAP 
(500mg/kg, ip). To investigate whether this may be due to changes in the relationship 
between hepatocytes and SECs, we used TEM to look for any abnormalities in the 
morphology o f SECs. As shown in figure 16, there was clear evidence o f  direct damage 
to SECs evidenced by marked blebbing (open arrows) and in numerous places SECs were 
found detached from the adjacent hepatocytes (closed arrows) leaving hepatocytes in 
direct contact with RBCs (asterisks) both intra-and extra-vascularly.
We therefore hypothesise that protection against AAP overdose may be dependent on an 
intact sinusoidal endothelium. This may suggest that the protective property o f Z-VAD- 
fmk against AAP-induced liver injury could primarily be due to anti-apoptotic effects on 
the SECs (and in turn the prevention o f hemorrhagic damage) rather than through its 
effects on the hepatocytes.
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Figure 15. Z-VAD-fmk prevents liver damage in response to paracetamol. BALB/c 
mice were dosed with AAP (500mg/kg in PBS, ip) or pretreated with Z-VAD-fmk 
(lOmg/kg in 2.5% DMSO in PBS, iv) 15 minutes prior to dosing with AAP (500mg/kg, ip). 
Animals were sacrificed after six hours. Hepatic tissues were fixed in 10% neutral 
buffered formalin, embedded in paraffin, cut into 5-pm thick sections, and stained with 
H&E as described in Methods section. Control (A); AAP treatment (B); AAP treatment 
following Z-VAD-fmk (C). Magnification lOOX. Each section is representative o f the 
sections obtained from 8-10 animals per treatment group. This work was carried out in 
collaboration with my colleague Dr K Anwar (Anwar, 2001).
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Figure 16. Paracetamol induces sinusoidal endothelial cell damage in the liver. Mice were 
dosed with AAP (500 mg/kg, ip) and after six hours were sacrificed. Hepatic tissue specimens 
were collected and were fixed in 4% glutaraldehyde, processed and examined by TEM as described 
under Methods. This micrograph shows that damage had occurred to sinusoidal endothelial cells- 
SECs (white asterisk) with extensive blebbing (open arrows) and detachment from adjacent
hepatocytes (closed arrows). Red blood cells (* ) are also observed, some o f which having
accumulated in the space o f Disse. Bar represents 2 pm scale. This work was done in 
collaboration with my colleague Dr K Anwar who also showed that SECs from control animals 
(receiving ip PBS on its own) were normal (not shown) (Anwar, 2001).
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3.5 Role of reactive FMK-moiety in AAP toxicity
Caspases are a family o f  cysteine proteases which play a crucial role in apoptosis and 
inflammation. The involvement o f  caspases in these processes can be demonstrated by 
their irreversible inhibition with fluoromethyl ketone (fink-) and chloromethyl ketone 
(cmk)-derivatives o f  peptides resembling the cleavage site o f  known caspase substrates. 
These inhibitors irreversibly alkylate the cysteine residue in the active site o f  caspases. 
Z-VAD-fmk also efficiently affinity-labels cathepsin B and cathepsin H, and along with 
other caspase inhibitors (like Z-DEVD-fmk and Ac-YVAD-cmk), it efficiently inhibits 
cathepsin B activity in vitro and in tissue culture cells at concentrations that are generally 
used to demonstrate the involvement o f caspases (Schotte et ah, 1999).
To rule out any non-specific effect o f the reactive FMK-moiety o f the caspase inhibtors 
towards cathepsins or the bioactivation pathway for AAP-induced liver injury, we 
investigated the effects o f  Z-FA-fmk (benzyloxycarbonyl-Phe-Ala-fluoromethylketone: 
lOmg/kg as 0.2ml in PBS, iv) on AAP-induced hapatotoxicity. Unlike the caspase 
inhibitors, Z-FA-fmk did not prevent hepatic injury (Figure 17). Also, work carried out 
by K Anwar (data not shown) clearly demonstrated that the number o f  TUNEL positive 
cells did not diminish (as compared to AAP-treatment) in the absence o f the dipeptide 
(Anwar, 2001).
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Figure 17. Effect of FMK moiety of caspase inhibitors on AAP toxicity in BALB/c mice.
“Control” mice received 0.2ml o f 0.9% normal saline (clinical, iv) 24 hours prior to receiving 
PBS (0.5ml, ip). “AAP” group received AAP (500mg/kg as 0.5ml PBS, ip). “AAP+Z-VAD” 
group received iv Z-VAD-fmk (lOmg/kg in 2.5% DMSO in PBS) 15 minutes prior to dosing 
with AAP. “AAP+Z-FA-fmk” group received FMK (lOmg/kg, in 0.2ml in PBS, iv) 15 
minutes prior to AAP (500mg/kg as 0.5ml in PBS, ip). All animals were sacrificed 6 hours 
after receiving AAP. ALT activity in serum was measured using commercial kits (Roche) on 
a Cobas Bios auto-analyser according to the manufacturer’s instructions. Data given 
represents Mean ± SEM. The numbers in parasthesis refer to the number o f animals in
individual groups. *: Significantly different from control (p<0.05). f  : Significantly different 
from AAP-treated group (p<0.05).
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Chapter 4
Caspases and paracetamol
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4.1 Role of caspases in paracetamol hepatotoxicity
Although the two main apoptosis receptors o f mammalian cells (the 55 kDa TNF-Rl and 
CD95) are activated independently o f  each other, it is esablished that they share a distal 
proteolytic signal involving caspases (Kunstle et ah, 1997; Rouquet et ah, 1996a).
We have shown earlier that pretreatment o f BALB/c mice with Z-VAD-fmk (lOmg/kg) 
15 minutes prior to AAP overdosing (500mg/kg) significantly protected against AAP- 
induced liver injury (Figures 10-12), abolished histopathological changes (Figure 15), 
and prevented the appearance o f TUNEL positive parenchymal cells (Figure 14).
As Z-VAD-fmk was developed and has been extensively used as a broad specificity 
irreversible inhibitor o f caspases, we therefore decided to look for caspase activity in 
AAP-induced liver injury. While the treatment o f BALB/c mice with anti-CD95 resulted 
in the expected increase in Ac-DEVD-afc cleavage (representative o f caspase-3-like 
activity), the cleavage o f  Ac-DEVD-afc from AAP-treated mice showed a significant 
inhibition o f such activity (Figures 18 and 19).
The cleavage o f  the caspase-9 substrate Ac-LEHD-afc was similarly inhibited by AAP 
treatment (Figure 20). Examination o f  the time course o f the inhibition revealed that the 
inhibition o f Ac-DEVD-afc (Figure 19) and Ac-LEHD-afc (Figure 20) occurred at 3hr 
post dosing, which corresponds to the time when AAP-induced liver damage became 
detectable (Figures 9 & 14).
On the other hand, measurements o f caspase-3 like activity (using Ac-DEVD-afc as a 
substrate) showed that while anti-CD95 treatment resulted in a very significant rise (x l5
110
fold) in Ac-DEVD-afc cleavage, such activity was completely lacking in liver 
homogenates from AAP-treated animals (Figure 18). The lack o f  increase in activity was 
not due to an endogenous inhibitory activity because the liver homogenates from AAP- 
treated mice failed to decrease the DEVDase activity o f  thymocyte apoptotic extract 
(Figure 21) nor was any DEVDase activity released into the serum (Figure 22).
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Figure 18. Paracetamol-induced apoptosis does not involve the increase in caspase 3- 
like activity. Mice were overdosed with AAP (500mg/kg, ip). After six hours, animals 
were sacrificed and their livers snap-frozen. Homogenates were prepared as described under 
Methods and were tested for caspase-3 like activity using Ac-DEVD-afc as a substrate. 
Where indicated, animals were pretreated with Z-VAD-fmk (lOmg/kg in 2.5% DMSO in 
PBS, iv) 15 minutes prior to dosing with AAP (500mg/kg, ip) or were injected with anti- 
CD95 antibody (40pg/animal in PBS, ip) six hours before sacrifice. All data given as mean 
± SEM. The numbers in parasthesis refer to the number o f animals in individual groups.
Significantly different from control (p<0.05).
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Figure 19. Time-Course o f o f Ac-DEVD-afc cleavage activity (representative of 
caspase-3 like activity) during paracetamol-induced liver injury. BALB/c mice 
were injected with AAP (500mg/kg, ip) and were sacrificed at the indicated time 
points. Each time point represents one animal. Hepatic tissue specimens and serum 
samples were collected and processed for analysis o f  Ac-DEVD-afc (A)  and serum 
ALT levels (A) as described in Methods.
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Figure 20. Time-Course o f inhibition o f Ac-LEHD-afc cleavage (a substrate for 
caspase-9) during paracetamol-induced liver injury. BALB/c mice were injected 
with AAP (500mg/kg, ip) and were sacrificed at the indicated time points. Each time 
point represents one animal. Hepatic tissue specimens and serum samples were 
collected and processed for analysis o f  Ac-LEHD-afc (T )  and serum ALT levels (A) 
as described in Methods.
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Figure 21. The failure of liver homogenates from AAP-treated animals to decrease 
DEVDase activity o f thymocyte apoptotic-extract indicates the absence o f an 
endogenous inhibitory activity in those homogenates. Thymocytes from male Wistar rats 
incubated in the presence o f IpM dexamethasone were prepared as described under Methods. 
BALB/c mice were overdosed with AAP (500mg/kg in PBS, ip) or with ip-PBS (Control). 
After six hours, animals were sacrificed and their livers snap-frozen. Homogenates were 
prepared as described under Methods and were tested for caspase-3 like activity using Ac- 
DEVD-afc as a substrate. Each group consisted o f  two animals.
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Figure 22. Lack of DEVDase activity in serum from paracetamol-treated 
BALB/c mice. Thymocytes from male Wistar rats incubated in the presence o f IpM  
dexamethasone were prepared as described under Methods. BALB/c mice were 
overdosed with AAP (500mg/kg in PBS, ip) or with ip-PBS (Control). Serum was 
prepared for the measurement o f caspase-3 like activity using the substrate Ac-DEVD- 
afc as described in Methods. After six hours, animals were sacrificed. Each group 
consisted o f two animals.
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4.2 Effector caspases and paracetamol toxicity
Caspases are a family o f  at least 10 human cysteine proteases that participate in cytokine 
maturation and in apoptotic signal transduction and execution mechanisms (Li et al., 
1997a). Caspases are synthesised as inactive zymogens composed o f three domains (an 
N-terminal prodomain, the p20, and the plO domains) and whose activation requires 
limited proteolysis or binding to co-factors. The mature enzyme is a heterotetramer 
containing two p20/pl0 heterodimers and two ative sites (Eamshaw et al., 1999).
Based on their presumed biological function, caspases are often divided into three major 
groups: (1) cytokine activators (like caspase-1), (2) initiators o f  apoptosis (which is 
further subdivided into intrinsic (caspase-9) and extrinsic activators (caspases -8 and -10), 
and (3) executioners o f  apoptosis (caspases -3, -6, and -7) (Cohen, 1997; Nicholson and 
Thornberry, 1997; Salvesen and Dixit, 1997). Others divide caspases into two groups 
based on the primary structure o f their NH2-terminal prodomain: long prodomain 
“initiator” caspases which include caspases-2, -8, -9, and -10, and short prodomain 
“effector” caspases which mainly include caspases-3 and -7 (Nicholson, 1999).
To transmit the apoptotic execution signal, caspase zymogens are sequentially activated 
through either an intrinsic or an extrinsic pathway. The activation o f  caspases at the apex 
o f each pathway, the initiators, occurs by recruitment to specific adapter molecules 
through homophilic interaction domains, and the activated initiators directly process the 
executioner caspases to their catalytically active forms (Stennicke and Salvesen, 1998; 
Stennicke and Salvesen, 2000).
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We investigated the role o f  caspases in AAP-mediated parenchymal cell apoptosis and 
focused on the “effector” caspases-3 and -7, given their importance in liver apoptosis 
(Jones et ah, 1998; Woo et ah, 1999; Zheng et ah, 2000; Zheng et ah, 1998).
Although no increase in Ac-DEVD-afc cleavage activity (reflecting the processing and 
activation o f caspase-3) was observed in BALB/c mice treated with AAP (Figures 18 & 
19), we further examined caspases-3 and -7 by western blot analysis to test whether the 
lack o f  activation was due to a lack o f processing or due to a post-processing inhibition.
Western blots from cytosolic (post-mitochondrial) fractions isolated from anti-CD95 
antibody treated BALB/c mice showed the partial disappearance o f a band corresponding 
to the size o f  procaspase-3 (Figure 23 top) and this was also observed after AAP dosing. 
However, this was not paralleled by the appearance o f the active fragments (pi 7 or p20) 
in either treatment group even though the antibody used was able to recognize the large 
fragments (Figure 23 top). The same observation was made using another anti-caspase-3 
antibody that our lab had previously found to recognize pl7/p20 in mouse tissues (Jones 
et ah, 1998).
In contrast, a clear loss o f the p29 form o f procaspase-7 with the appearance o f p i9 had 
occurred after CD95 activation but not in AAP-exposed mice (Figure 23 bottom).
Therefore, it is clear that the classic execution caspases-3 and -7 do not play a detectable 
role in carrying out AAP-induced damage whereas they do in the case o f  CD95 
engagement. However, caspases (the identity o f which is not known) are probably 
involved in initiating AAP-induced liver injury.
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Besides caspase-3 and caspase-7, the activation o f  other caspases, especially caspase-9 
and -8, was not determined. However, we did attempt to measure caspase-9 activation 
but failed to see any processing after AAP or anti-CD95 suggesting that the method 
lacked sufficient sensitivity. Likewise, there is a lack o f commercially available anti- 
caspase-8 antibodies that reliably detect the processing o f  the murine form o f  this 
caspase.
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Figure 23. Processing of procaspases-3 and -7 in paracetamol-induced liver injury in 
BALB/c mice. Animals were dosed with anti-CD95 (40(xg/animal, ip) or AAP (500mg/kg) 
and after six hours, the animals were sacrificed and the livers removed for homogenisation 
and isolation o f cytosolic fractions as described under Methods. Protein measurement was 
carried out using Bio-Rad assay and each lane contained 50 micrograms. The proteins were 
separated by SDS-PAGE and immunoblotted for caspases-3 (top) and caspase-7 (bottom). 
Each lane represents a separate animal. In the blot for caspase-3, a positive control for the 
detection o f pi 7 [from HeLa cells exposed to the human anti-CD95 antibody (CH-11, Kamiya 
Biomedical Company, Seattle, WA)] was included.
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Chapter 5
DNA fragmentation and paracetamol
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5.1 Paracetamol overdosage causes loss of genomic DNA through 
fragmenatation
It has previously been shown that, in male NIH swiss mice, Ca^^-dependent endonuclease 
fragmentation o f DNA into oligonucleosomal-length fragments is a characteristic feature 
o f paracetamol-induced hepatic cell death (Ray et al., 1993). Pretreatment o f  these mice 
with the Ca^^-calmodulin antagonist “chlorpromazine” or with the Ca^^-channel blocker 
“verapamil” prevented both the increase in nuclear calcium and DNA damage (Ray et al., 
1993; Ray et al., 1996; Ray et al., 1990).
In our project, the process o f identifying DNA fragmentation on agarose gel 
electrophoresis proved not to be straightforward. In early stages o f  experiments, after 
preparing 30% (w/v) liver homogenates in HB (Homogenisation Buffer: 0.25M Sucrose, 
5mM Tris, pH 7.4) with 1% (w/v) SDS, DNA was extracted twice with phenol- 
chlorophorm, preciptated once with ethanol/sodium acetate, and kept (at -20°C) 
overnight. Next day, after centrifuging (at 2000 rpm), DNA pellet was resuspended in 
TE-8 buffer (lOmM Tris-HCl, ImM EDTA, pH 8.0) and digested with DNase-free 
RNase A (Ipg/ml) for 30 minutes at 37°C. DNA aliquots were then loaded onto a 1% 
(w/v) agarose gel containing 0.2 pg/ml ethidium bromide and then separated by constant 
voltage mode electrophoresis at 80 volts for 1-2 hours at room temperature. A Hind III 
digest lambda DNA served as molecular size standards. Finally electrophoresis gels were 
illuminated with 300nm light and a photographic record was made with instant film.
With the use o f the above mentioned protocol, the yield o f  DNA was extremely low and a 
DNA “smear” was produced (Figure 24).
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Figure 24. Early experiment showing a smear of DNA fragmentation.
“Control” mice received intraperitoneal PBS, “AAP” group were dosed with 
intraperitoneal-AAP (500mg/kg), “z-VAD” group received intravenous z-VAD-fmk 
(lOmg/kg, in 2.5% DMSO), and “AAP+zVAD” group were pretreated with z-VAD- 
fmk 15 minutes prior to receiving AAP. Each lane represents a separate animal. All 
animals were sacrificed six hours later.
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Further attempts to detect DNA fragmentation were carried out (with minor modification) 
as previously reported (Ray et al., 1993; Ray et al., 1992) and as outlined in “Materials 
and Methods”.
In summary, 10% (w/v) liver homogenates o f frozen liver sections were homogenised in 
LB (Lysis Buffer: O.IM Tris, lOmM EDTA, 0.5% (w/v) sodium N-lauroylsarcosine, pH 
7.8) and were allowed to stand for 30 min at 4°C. Suspensions were digested with 
200pg/ml o f  proteinase K for 6 hours at 50°C on a shaking water bath. To remove 
proteins associated with the DNA after dissolution o f liver tissue, DNA was extracted 
three times with phenol/chloroform and precipitated with 100% ethanol and 2.5M sodium 
acetate. After the third ethanol preciptation (overnight at -20°C), DNA was washed 
(three times) with 66% ethanol and 2.5M sodium acetate, redissolved in TE-8 buffer 
(lOmM Tris-HCl, ImM EDTA, pH 8.0) and digested with DNase-free Rnase A (Ipg/ml, 
30 minutes at 37°C). DNA was redissolved in TE-8 for a final time and loaded onto a 
1.6% (w/v) agarose gel containing 0.4|Lig/ml o f ethidium bromide. A Hind III digest o f  1- 
DNA was used as a molecular size standard. Separation was achieved by constant 
voltage mode electrophoresis at 10 volts overnight. Electrophoresis gels were 
illuminated with UV light (300nm) and a photographic record was made with instant 
film.
To examine the compatibility o f this new method with our system, an experiment was 
designed to investigate the “Time-Course” o f AAP-induced effects on genomic DNA  
fragmentation (Figure 25).
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Figure 25. Time-Course of paracetamol-induced effects on the electrophoretic 
behaviour of genomic DNA from livers of BALB/c mice. “Control” mice received 
intraperitoneal PBS (0.5ml) and were sacrificed after six hours, whereas “AAP-treated 
mice” were dosed with intraperitoneal-AAP (500mg/kg) and sacrificed after the 
indicated number o f hours (1, 2, 3, 4, 5, and 6). Each lane represents a separate animal.
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Figure 25 shows that AAP overdose produced marked degradation o f DNA (with a ladder 
o f DNA fragments) between 3 and 6 hours.
Conjunct histopathological studies carried out by K Anwar (data not shown) confirmed 
that AAP-induced hepatotoxicity did not appear until 3 hours after AAP treatment 
(Anwar, 2001).
Based on the results shown in Figure 25, we concluded that this new protocol was more 
likely to detect DNA fragmentation and, therefore, was adopted for all future experiments 
with agarose gel electrophoresis.
5.2 Time-course for protection from paracetamol-induced 
hepatotoxicity by Z-VAD-fmk
In order to identify the time-window through which intravenous Z-VAD-fmk (lOmg/kg, 
dissolved in 2.5% DMSO in PBS) could still be protective to hepatocytes when 
administered at different intervals after receiving intraperitoneal AAP (500mg/kg), we 
designed a “Time-Course”experiment as illustrated in Figure 26.
Figure 26 shows that one single intravenous injection o f  Z-VAD-fmk (lOmg/kg in 2.5% 
DMSO in PBS) is protective against AAP-induced DNA damage and, consequently, 
against liver injury (evidenced by normal or slightly raised serum enzymes as shown in 
Figure 27). This protective effect is only achieved if  Z-VAD-fmk was to be administered 
simultaneously or up to 2 hours after overdosing with AAP.
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On the other hand, loss o f the protective effect o f Z-VAD-fmk (after the 2-hour window) 
was associated with severe liver injury as evidenced by DNA fragmentation (Figure 26) 
and the significant perturbation in serum biochemistry (Figure 27).
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Figure 26. Z-VAD-fmk prevents DNA fragmentation at different intervals after 
paracetamol administration.
“Control” mice received intraperitoneal PBS (0.5ml). Intravenous Z-VAD-fmk 
(lOmg/kg in 2.5% DMSO in PBS) was administered to the “AAP+Z-VAD-fmk” 
group simultaneously (0 hr) or at the indicated time points (Ihr, 2hr, and 4hr) after 
AAP. “AAP alone” group received intraperitoneal AAP (500mg/kg in PBS). Each 
lane represents a separate animal. All animals were sacrificed after 6 hours.
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Figure 27. Z-VAD-fmk prevents the rise in serum ALT after paracetamol 
intoxication.
“Control” mice received intraperitoneal PBS (0.5ml). Intravenous Z-VAD-fink (lOmg/kg 
in 2.5% DMSO in PBS) was administered simultaneously (0 hr) or at the indicated time 
points (Ihr, 2hr, 4hr, and 6hr) after AAP. All animals were sacrificed after 6 hours. ALT 
activity in serum was measured using commercial kits (Roche) on a Cobas Bios auto­
analyser according to the manufacturer’s instructions. Data given represents Mean ± SEM
o f %=5. *: Significantly different from control (p<0.05).
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Chapter 6
Mitochondria and paracetamol
130
6.1 Mitochondrial cytochrome c and paracetamol hepatotoxicity
Mitochondria play an important role in the cell death induced by many drugs, including 
hepatotoxicity from overdose o f  AAP (Adams et al., 2001). Disruption o f  mitochondrial 
function is recognised to be an integral part o f AAP toxicity (Burcham and Harman, 
1991; Esterline et al., 1989; Ramsay et al., 1989; Ray et al., 1999).
AAP toxicity has also been shown to cause ultrastructural changes in mitochondria 
(swelling and fusion) and mitochondrial dysfunction (increased resting respiration, 
decreased ADP-stimulated respiration, and decreased the respiratory control ratio; RCR) 
occur early (10-30 minutes) after AAP adminisstration (Meyers et al., 1988; Ruepp et al., 
2002).
The detrimental effect o f AAP on mitochondria results in hepatic ATP depletion and the 
formation o f ROS (Jaeschke, 1990; Tirmenstein and Nelson, 1990) and peroxynitrite 
(HOONO) (Hinson et al., 1998; Knight and Jaeschke, 2002; Knight et al., 2001).
In apoptosis, release o f cytochrome c (13 kDa) from the mitochondrial intermembranous 
space results in activation o f  procaspase-9 in association with Apaf-1, which finally leads 
to activation o f  caspase-3. It is the activation o f  the latter that is o f  paramount 
importance in the execution o f  apoptosis both in in vitro and in vivo studies (Hampton et 
ah, 1998; Kluck et al., 1997; Kroemer, 1999; Li et al., 1997b; Liu et al., 1996; Rodriguez 
and Lazebnik, 1999; Yang et al., 1997; Zou et al., 1997).
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Release o f  cytochrome c from mitochondria in AAP overdose was reported by Adams et 
al (Adams et al., 2001), Ferret et al (Ferret et al., 2001), and Knight and Jaeschki (Knight 
and Jaeschke, 2002).
In order to investigate mitochondrial cytochrome c release associated with AAP-induced 
hepatotoxicity, mitochondria were isolated as described under Methods.
We first needed to examine the possibility o f  mitochondria contaminating the cytosolic 
fraction (S-100) during preparation and to investigate if  cytochrome c could have been 
released into the cytosol o f  control BALB/c mice receiving ip PBS on its own.
In blots from control animals, cytochrome c was detected in both mitochondrial and 
cytosolic fractions, albeit to a much lesser extent in the latter (Figure 28). Co-blotting for 
the inner mitochondrial membrane protein cytochrome c oxidase (COX) revealed the 
presence o f mitochondria in the mitochondrial fractions only and therefore ruling out the 
possibility o f  any mitochondrial contamination o f  the cytosol.
The rationale for focusing on mitochondrial cytochrome c (and probing it against COX), 
rather than estimating cytosolic cytochrome c, was to avoid the risk o f  underestimating 
the release due to the rapid leak o f cytosolic proteins (e.g. as seen with ALT, AST, and 
LDH) into the general circulation under in vivo conditions.
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Figure 28. Presence of mitochondria is confined to the mitochondrial fraction. No 
mitochondrial contamination of the cytosol.
Two control BALB/c mice received PBS (0.5ml, ip) and were saerificed after six hours. 
Livers were removed for homogenisation and separation into mitoehondrial and cytosolic 
fractions were carried out as described under Methods. Proteins were separated by SDS- 
PAGE and immunoblotted for cytochrome c (Cyt c: 13 kDa) and cytochrome c oxidase 
subunit IV (COX: 17 kDa). Positive control o f cytochrome c was a gift from Dr Chow SC 
(Centre for mechanism o f Human Toxicity, University o f Leicester, UK).
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Recent reports by Nagai et al (Nagai et al., 2002) showed that in vitro hepatocytes 
(cultured from C57BL/6 mice) treated with a cytotoxic dose o f AAP failed to release 
cytochrome c from mitochondria and cell death was entirely necrotic. However, when 
AAP was given concomitantly with TNF-a (but not either one alone), the mode o f cell 
death was shifting towards apoptosis and was accompanied by cytochrome c release into 
the cytosol and by an increase in caspase-8 and-3-like activities (Nagai et al., 2002).
To investigate the in vivo effect o f  AAP toxicity on cytochrome c release from 
mitochondria, BALB/c mice were overdosed with intraperitoneal AAP (or the positive 
control; anti-CD95) as described under Methods
In our system, isolated mitochondria from AAP-treated mice contained less cytochrome c 
compared to the controls (Figure 29). Similar results were observed in the positive 
control group (treated with anti-CD95 antibody). Those results are in line with previous 
in vivo studies implicating cytochrome c release in AAP toxicity (Adams et al., 2001; 
Ferret et al., 2001; Knight and Jaeschke, 2002).
Co-blotting for the inner mitochondrial membrane protein cytochrome c oxidase (COX) 
revealed that the loss o f cytochrome c was specific to the intermembrane resident 
cytochrome c and was not caused by a general decrease in mitochondrial mass present in 
the mitochondrial fraction (Figure 29).
Figure 29 also shows that the overall yield o f  mitochondria from liver homogenates 
prepared from AAP-exposed mice did not differ from that o f control animals, therefore 
suggesting that no major change in mitochondrial density had occurred in response to the 
hepatotoxic dose o f AAP.
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Figure 29. Paracetamol induces cytochrome c release from liver mitochondria. BALB/c 
mice were closed with AAP (500mg/kg, ip) or anti-CD95 antibody (40pg/animal, ip) and after 
six hours, the animals were sacrificed and the livers removed for homogenisation and 
isolation o f mitochondria as described under Methods. The mitochondrial proteins were 
separated by SDS-PAGE and immunoblotted for cytochrome c (Cyt c) and cytochrome c 
oxidase subunit IV (COX) (arrows). The ratios between Cyt c and COX were obtained by 
density scanning o f the film using an MCID image analysis system. Each lane represents a 
separate animal.
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The pretreatment o f BALB/c mice with the broad spectrum casapse inhibitor Z-VAD- 
fmk (lOmg/kg, iv) 15 minutes prior to injection o f AAP (500mg/kg, ip) only had minimal 
effect on the extent o f  cytochrome c release (Figure 30). The same was also observed in 
anti-CD95 antibody-treated mice. Therefore we may conclude that the release o f  
cytochrome c in this in vivo model o f  AAP toxicity is essentially caspase-independent.
6.2 Release of cytochrome c from mitochondria correlates with the
release of adenylate kinase
As the release o f two mitochondrial proteins, cytochrome c and apoptosis-inducing factor 
(AIF), into the soluble cytoplasm o f cells undergoing apoptosis is well established, it has 
also been demonstrated that the intermembranous protein adenylate kinase isoenzyme 2 
(AK2) was translocated into the cytosol concomitantly with cytochrome c in apoptotic 
cells (Kohler et al., 1999; Single et al., 1998).
The next set o f experiments addressed the question whether the release o f cytochrome c 
(Cyt c) from mitochondria was restricted to this protein or whether other intermembrane 
space proteins o f higher molecular weight were also relocated into the cytosol. The 
levels o f mitochondrial adenylate kinase (AK) were measured and correlated with the 
activity o f COX as an indicator o f mitochondrial mass. As shown in Figure 31, the 
results o f this set o f  experiments support the notion that, in AAP overdose, the process o f  
Cyt c release involves a non-selective change in outer membrane permeability.
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Figure 30. Cytochrome c release from liver mitochondria after in vivo administration of 
acetaminophen or anti-CD95 activation: Role of the pan-caspases inhibitor Z-VAD-fmk.
BALB/c mice were dosed with AAP (500mg/kg, ip) or anti-CD95 antibody (40pg/animal, ip) 
and after six hours, the animals were sacrificed and the livers removed for homogenisation 
and isolation o f mitochondria as described under Methods. Where indicated, animals were 
pretreated with Z-VAD-fmk (lOmg/kg, iv) 15 minutes prior to dosing with AAP or anti-CD95 
antibody. Mitochondrial proteins were separated by SDS-PAGE and immunoblotted for 
cytochrome c (Cyt c) and cytochrome c oxidase subunit IV (COX). The ratios between Cyt c 
and COX were obtained by density scanning o f the film using an MCID image analysis 
system. Each lane represents a separate animal.
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Figure 31. Release of adenylate kinase from mitochondria by paracetamol and after 
activation o f CD95. BALB/c mice were dosed with AAP (500mg/kg, ip) or anti-CD95 
antibody (40pg/animal, ip) and after six hours, the animlas were sacrificed and the livers 
removed for homogenisation and isolation o f  mitochondria as described under Methods. 
Mitochondrial activities o f  adenylate kinase (AK) and cytochrome c oxidase (COX) were 
assayed spectrophotometrically. Each bar represents the mean ratio o f  AK/COX ± SEM
o f n=A. *: Significantly different from control (p<0.05). * * : Significantly different from 
control (p<0.01).
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6.3 Release of cytochrome c from mitochondria correlates with the loss 
of succinate dehydrogenase activity
Succinate dehydrogenase (SDH) is an intramitochondrial enzyme o f  the citrate cycle, 
located in the inner mitochondrial membrane. It is a flavoprotein containing FAD and 
plays a key role in the mechanism o f  electronic transport and energy production. In 
aerobic cells SDH catalyses the oxidation o f  succinate to fumarate transferring the 
electrons directly to ubiquinone (Munujos et al., 1993).
Although the exact contribution o f  mitochondria in AAP-induced liver injury and cell 
death is unclear, alterations to mitochondrial respiration with decrease in SDH activity 
with AAP treatments have been reported both in vivo (Katyare and Satav, 1989) and in 
vitro (Burcham and Harman, 1991).
Burcham and Harman (Burcham and Harman, 1991) showed that SDH (associated with 
respiratory complex II in the inner mitochondrial membrane) was found to be very 
sensitive to NAPQI, while NADH dehydrogenase (respiratory complex I) was inhibited 
to a lesser extent. They concluded that loss o f the ability to utilize succinate- and 
NADH-linked substrates due to attack o f the respiratory chain by NAPQI causes a 
disruption o f  energy homeostasis in AAP hepatotoxicity.
Donnelly et al (Donnelly et al., 1994) also reported that inhibition o f  mitochondrial 
respiration preceded overt hepatic necrosis (as indicated by an elevation o f  ALT activity) 
after administration o f a hepatoxic dose o f  AAP (750mg/kg) to fasted male CD-I mice.
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However, loss o f  SDH activity is not unique to AAP hepatotoxicity as it has also been 
reported during ischaemia/reperfusion injuries (Benitez Bribiesca et al., 2000).
In our project, to investigate the effect o f in vivo AAP hepatoxicity on SDH activity, 
SDH assay was determined by measuring the formation o f the red formazan due to 
tétrazolium salt reduction, as outlined in Methods. As shown in figure 32, treatment o f  
BALB/c mice with an overdose o f AAP has led to a significant drop in mitochondrial 
SDH activity. Similar results were observed in anti-CD95 treated mice. This further 
supports the direct involvement o f mitochondria in AAP hepatotoxicity.
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Figure 32. Mitochondrial succinate dehydrogenase (SDH) activity after AAP and anti- 
CD95 treatments. BALB/c mice were dosed with AAP (500mg/kg, ip) or anti-CD95 
antibody (40pg/animal, ip) and after six hours, the animlas were sacrificed. The livers were 
removed, homogenised, and mitochondria were isolated and assyed for SDH activities as 
described under Methods. Each group consisted o f  three animals. Data given represents
Mean ± SEM. Significantly different from control (p<0.01).
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6.4 Role of pro-apoptotic members of the Bel-2 family in paracetamol-
induced hepatic injury
The role o f pro-apoptotic members o f  the Bcl-2 family in the redistribution o f  
cytochrome c (Cyt c) from mitochondria was investigated. As shown in figure 33, the 
BH3-only 22 KDa protein Bid (called full-length or intact Bid) was found to undergo 
cleavage (after both AAP- and anti-CD95-treatments) to a fragment corresponding to an 
apparent molecular mass o f  15 KDa representing the COOH-terminal cleaved product 
(called truncated Bid; t-Bid). After either treatment, both intact Bid and its truncated 
form (t-Bid) were also found in the mitochondria, thus indicating translocation o f  both 
forms from the cytosol to the mitochondria.
Figure 33 also shows the density o f  the band corresponding to t-Bid in the cytosolic 
fraction was inversely related to that in the mitochondrial fraction in both treatment 
groups. This is expected as full-length Bid is normally localised in the cytosol (Wang et 
al., 1996b) and t-Bid is translocated to the mitochondria upon induction o f  apoptosis (Li 
et ah, 1998).
In western blot o f  proteins, which are proteolytically processed during activation, one 
expects to see a decrease in the proform if  there is an increase in the cleavage product. 
This is nicely shown for Bid cleavage in CD95-induced apoptosis (Figure 33 top). 
However it is difficult to explain the increase in the proform (Bid) and a dramatic 
increase in the cleaved form (t-Bid) in AAP-treated group (Figure 33 bottom).
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We simply do not know the exact reason why on a protein to protein basis, there is no 
detectable decrease in Bid levels after AAP. However, we suspect changes in Bid 
turnover during AAP-induced injury.
It is worth noting that bands o f  cytosolic t-Bid were very broad (and denser) in AAP- 
treatment compared to those treated with anti-CD95, and the opposite was observed in 
the mitochondrial fraction (wider and denser t-Bid in the anti-CD95 treatment compared 
with AAP treatment). This may be related to the formation o f  additional cleavage 
products (like pl3 and p l l )  by caspase(s) that migrate closely with p i 5 (Gross et al., 
1999b) and this will overestimate the total amount o f  Bid that was cleaved.
The pancaspase inhibitor Z-VAD-fmk was capable o f preventing the two processes 
(cleavage o f  intact Bid to t-Bid and the mitochondrial translocation o f  the two forms) 
after both (AAP- and anti-CD95-) treatments. This implied that cleavage o f  Bid in AAP 
treatment was caspase-dependent and suggested that the caspase(s) critical to the 
initiation o f AAP-induced cell death is (are) located upstream o f Bid activation.
It is also difficult to explain why full-length Bid was identified in the mitochondrial 
ft-action o f the negative control animals (without AAP or anti-CD95 treatment), and 
moreover, how t-Bid was detected in the mitochondrial fraction in the negative controls 
from the anti-CD95 treatment but not in the negative controls from the AAP experiment. 
However, this is not utterly unexpected as other studies reported the presence o f intact 
Bid in the mitochondrial fraction from control tissues (Desagher et al., 1999; Tafani et 
al., 2002b). This behaviour o f  Bid may be related to its lipid transfer activity as reported 
by Esposti, et al (Esposti et al., 2001).
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On the other hand, as shown in figure 34, overdosing BALB/c mice with AAP led to the 
translocation o f Bax to the mitochondrial fraction, where it was found inserted in 
mitochondria, primarily as a monomer although some dimer formation was also detected. 
The pattern was similar in anti-CD95 antibody-treated animals with the difference that 
after CD95 activation, the translocation o f Bax to the mitochondria and dimer formation 
had ocurred to a greater extent.
At the same time as Z-VAD-fmk prevented processing o f  Bid and its (and that o f  t-Bid) 
mitochondrial translocation, it failed to inhibit Bax translocation to the mitochondria. 
This suggested that mitochondrial translocation o f Bax was not mediated by Bid and is, 
therefore, caspase-independent and most likely involves other non-caspase factors 
(Mikhailov et ah, 2001; Pan et al., 2001; Smaili et al., 2001; Tafani et al., 2002a).
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Figure 33. Paracetamol induces Bid processing and translocation to the mitochondria in 
vivo. BALB/c mice were dosed with AAP (500mg/kg, ip) or anti-CD95 antibody (40|ig/animal, 
ip) and after six hours, the animlas were saerificed and the livers removed for homogenisation and 
isolation o f mitoehondria as deseribed under Methods. Where indicated, animals were pretreated 
with Z-VAD-fmk (lOmg/kg, iv) 15 minutes prior to dosing with AAP or anti-CD95 antibody. The 
cytosolic (post-mitochondrial fraction) and mitochondrial proteins were separated by SDS-PAGE 
and immunoblotted for Bid. Each lane represents a separate animal.
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Figure 34. Paracetamol induces Bax translocation to mitochondria in vivo. BALB/c 
mice were dosed with AAP (500mg/kg, ip) or anti-CD95 antibody (40pg/animal, ip) and 
after six hours, the animals were sacrificed and the livers removed for homogenisation and 
isolation o f mitochondria as described under Methods. Where indicated, animals were 
pretreated with Z-VAD-fmk (lOmg/kg, iv) 15 minutes prior to dosing with AAP or anti- 
CD95 antibody. Mitoehondrial proteins were separated by SDS-PAGE and immunoblotted 
for Bax and cytochrome c oxidase (COX), the latter to ensure equal loading o f  
mitoehondrial proteins. Each lane represents a separate animal.
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Chapter 7
Discussion
147
7.1 Purpose of study
This project had two major aims: (1) The identification o f apoptosis in paracetamol- 
induced liver injury and (2) the elucidation o f  the mechanism and the role o f  apoptosis in 
paraeetamol-related hepatotoxicity.
The idea o f  this project was bom after several laboratories have demonstrated that 
systemic injection o f  inhibitors o f  caspases (Z-VAD-fmk and Ac-YVAD-cmk) not only 
prevented in vivo hepatocyte apoptosis induced by injection o f  anti-Fas antibody (or 
TNF-a) but also completely protected the animals from the lethal effects o f  such 
substances (Kunstle et ah, 1997; Rodriguez et ah, 1996; Rouquet et ah, 1996b).
7.2 Background
Large amounts o f  the widely used mild analgesic and antipyretic drug AAP may cause 
acute liver failure and death in both human beings (Clark et ah, 1973; Davidson and 
Eastham, 1966; Proudfoot and Wright, 1970) and experimental animals (Boyd and 
Bereezky, 1966; Davis et ah, 1974; Dixon et ah, 1975; Mitchell et ah, 1973a).
The development o f  liver damage following ingestion o f  AAP falls into two phases 
(Read, 1979). The first phase appears to be due to generation o f  the reactive metabolite 
NAPQI (Dahlin et ah, 1984; Mitchell et ah, 1973a), and can be effectively antagonised 
by treatment with V-acetylcysteine (NAC) (Prescott et ah, 1979; Walker et ah, 1981).
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Whereas in clinieal practice, the therapeutic oral dose o f  AAP is 0 .5-lg  every 4-6 hours 
to a maximum o f 4g in a day, severe hepatic and renal damage can result from taking as 
little as 150mg/kg (about lOg or 20 tablets) in one dose, which is only 2.5 times the 
recommended maximum daily clinical dose (Laurence et al., 1997). Patients especially 
at risk are those on enzyme-indueing drugs (e.g. carbamazepine, phénobarbital, 
phenytoin, rifampicin, and alcohol) and those who are malnourished (in anorexia, in 
alcoholism, or those who are HIV positive) to the extent that their livers and kidneys are 
depleted o f glutathione by NAPQI (Moore et al., 1997).
The plasma concentration o f  AAP is o f  predictive value: if  it lies above a semilogarithmic 
graph joining points between 200mg/l (1.32 mmol/1) at 4 h after ingestion to 50mg/l (0.33 
mmol/1) at 12 h, then serious hepatic damage is likely (Laurence et ah, 1997; Timbrell, 
2000). However, plasma concentration measured earlier than 4 h is unreliable because o f  
incomplete absorption (Laurence et ah, 1997).
If plasma levels at least 4 h post ingestion is above this “normal treatment line” and the 
patient is presenting up to 24 h after ingestion, such patients should be given intravenous 
NAC (prepared in 5% dextrose and given to a total o f  around 300mg/kg over 20 hours, in 
three divided doses) (BNF, March 2003). On the other hand, malnourished patients and 
those on enzyme-inducing drugs should be treated if  AAP level is above the “high risk 
treatment line” (BNF, March 2003).
This phase o f  acute toxicity is normally followed by a period o f  apparent recovery. 
However, if  not treated early, and especially when the amount ingested is toxic, then 
patient’s condition tends to deteriorate resulting, in the worst scenario, in liver failure and 
death. The pathological mechanisms operating in this final phase o f  damage are not fully
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understood. The damage depends on the continued presence o f AAP in the blood stream, 
and this is the best predictor o f  likely clinical outcome (Insel, 1996). However treatment 
with NAC has little benefit at this stage indicating that some factor distinct from AAP 
metabolism may play a major role in the development o f liver damage.
It is generally accepted that the ultimate form o f  hepatic damage caused by AAP is 
necrosis (Adams et al., 2001; Gujral et al., 2002; Knight and Jaeschke, 2002; Pierce et 
al., 2002). However, several reports have presented evidence for the occurrence o f  
apoptosis in AAP-induced hepatic damage. For instance, AAP toxicity in rats is 
accompanied by a small increase in the number o f  isolated parenchymal cells with 
apoptotic morphology (Dixon et al., 1975; Gujral et al., 2002; Ray and Jena, 2000; Ray et 
ah, 1996), the formation o f  oligonucleosomal-length DNA fragmentation and DNA  
laddering (Ray et al., 1993; Ray et al., 1990), cleavage o f  poly(ADP-ribose)polymerase 
(PARP) (Zhang et al., 2000a), and the appearance o f TdT-catalysed dUTP-fluorescein 
nick end-labeling (TUNEL) positive cells (Lawson et al., 1999).
More recently. Ferret and co-workers have shown that caspase-3 and -9 activities were 
slightly increased in mice that were administered a hepatotoxic dose o f  AAP (Ferret et 
al., 2001), resulting in the in situ cleavage o f  the caspase substrate PARP (Zhang et al., 
2000a).
Besides the possibility o f  direct induction o f  apoptosis by the cytotoxic metabolite o f  
AAP, V-acetyl^-benzoquinone imine (NAPQI), additional factors and in particular, 
cytokines such as TNF (released from non-parenchymal cells) and CD95 ligand have 
been implicated in AAP-induced liver damage (Fiorucci et al., 2002; Gardner et al..
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2002; Laskin et al., 1995; Zhang et al., 2000a). These are also well-established inducers 
o f  parenchymal cell apoptosis (Leist et ah, 1995a; Ogasawara et al., 1993).
Apoptosis is well known to play an important role in the aetiology o f  several liver 
diseases (Neuman, 2001; Patel et al., 1998). However, it is far from clear whether 
apoptosis contributes to the induction o f acute liver failure by AAP.
7.3 Mode of cell death after paracetamol overdose in BALB/c mice:
Necrosis or Apoptosis?
It is well known that apoptosis and necrosis share common initial events and can no 
longer be considered as completely separate forms o f  cell death (Kass and Orrenius, 
1999; Lemasters, 1999; Lemasters et al., 1998; Raffray and Cohen, 1997; Tsujimoto et 
a l ,  1997).
Even though the induction o f  apoptosis in AAP-induced liver injury, as based on 
morphological criteria was described over twenty-five years ago (Dixon et ah, 1975; Ray 
et ah, 1993; Ray et ah, 1990; Zhang et ah, 2000a), the number o f  cells with a truly 
apoptotic morphology in the areas o f  damage remains very low (Dixon et ah, 1975; 
Gujral et ah, 2002). Likewise, the activation o f  the apoptosis execution caspases-3 and -7 
in response to AAP is moderate (Ferret et ah, 2001; Pierce et ah, 2002), i f  not sometimes 
absent (Lawson et ah, 1999) (This PhD). Consequently, the ultimate mechanism o f  cell 
death in AAP toxicity could be concluded as being necrotic (Gujral et ah, 2002).
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Here, we report that the pan-caspase inhibitor Z-VAD-fmk prevented AAP-induced liver 
damage. A similar protective effect was observed with Z-DEVD-cmk. As it is well 
accepted that caspase inhibition does not prevent necrosis (oncosis) (Denecker et al., 
2001; Kalai et al., 2002), we therefore concluded that caspase inhibitors used in our study 
(Z-VAD-fmk and Z-DEVD-cmk) do not prevent AAP-induced necrosis, and this has 
recently been confirmed in vitro (Nagai et al., 2002). In the latter study they found that 
AAP-induced glutathione depletion sensitises culture mouse hepatocytes to TNF-a- 
induced apoptosis.
However, typical features o f  necrosis were evident in cells surrounding central veins by 
the third hour after AAP dosing o f  BALB/c mice. Most likely, it is this un-interrupted 
necrotic damage to hepatocytes that accounts for the fourfold increase in serum ALT in 
AAP overdosed BALB/c mice, despite the presence o f caspase inhibitors.
At the dose o f  AAP used in our project (500mg/kg), those transient necrotic areas 
remained very small and were followed by the development o f  large areas o f  midzonal 
damage with extensive haemorrhagic congestion. Several recent studies have reported 
the importance o f such haemorrhagic damage in the development o f  several forms o f  
liver injury (Gao et al., 1998; Wanner et al., 1999).
From our data, it appears that preventing the development o f haemorrhagic damage in 
midzonal areas may be critical to the hepatoprotective effects o f our caspase inhibitors in 
AAP overdosing. We therefore proposed a model for AAP-induced liver injury whereby 
the initial events leading to the injury actually involve an apoptotic pathway, as revealed 
by the sensitivity to the caspase inhibitors. However apoptosis does not go to full 
completion (only DNA fragmentation and nuclear pyknosis are observed) and
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degenerates into necrosis. A likely reason for the incompletion o f  the apoptotic 
programme and the switch from apoptosis to necrosis/oncosis or necro-apoptosis is the 
loss o f cellular ATP, which is a well documented effect o f AAP intoxication in vivo 
(Jaeschke, 1990; Knight and Jaeschke, 2002; Tirmenstein and Nelson, 1990) and in vitro 
(Kamendulis and Corcoran, 1992) and results from the induction o f  mitochondrial 
dysfunction by AAP (Knight and Jaeschke, 2002; Meyers et ah, 1988; Ruepp et al., 
2002; Strubelt and Younes, 1992; Weis et al., 1992a).
Despite the fact that many reports have shown that cellular ATP is necessary for 
apoptosis and its depletion causes an apoptogenic signal to become necrotic (Eguchi et 
al., 1997; Kim et al., 2003; Leist et al., 1997b; Tsujimoto, 1997), it is not fully clear what 
role(s) ATP has in hepatocyte apoptosis. For example, others have suggested that in the 
liver, hepatocytes triggered to undergo apoptosis by TNF are actually very well capable 
o f  surviving in an ATP-depleted environment and without having to degenerate into 
necrosis (Latta et al., 2000).
7.4 TUNEL assay and DNA fragmentation as markers of apoptosis in
paracetamol hepatotoxicity
Detection o f DNA fragments in situ using the TdT-catalysed dUTP-fluorescein nick end- 
labeling (TUNEL) is increasingly applied to investigate active cell death (apoptosis). 
However, when the specificity o f the assay was studied in well-defined models o f  
apoptosis and necrosis as well as in postmortem autolysis in rat liver, it was found that a 
similar TUNEL-positive reaction appeared in necrotic hepatocytes after a cytotoxic dose
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o f  carbon tetrachloride (CCI4) or N-nitrosomorpholine (NNM). Also, in insufficiently 
fixed, autolytic livers TUNEL-positive nuclei were observed. Therefore, as DNA  
fragmentation is common to different kinds o f cell death, its detection in situ (using 
TUNEL assay) should not be considered a specific marker o f apoptosis (Grasl-Kraupp et 
a l ,  1995).
As it has been reported that the use o f laser scanning confocal microscopy is a very useful 
tool in validating apoptosis (Hahn et al., 2001), it was therefore employed in examining 
our histological sections stained with TUNEL to rule out non-specific damage.
In our study, TUNEL staining clearly confirmed the abundance o f  fragmented DNA in 
AAP-overdosed BALB/c, which is in agreement with previous studies (Ferret et al., 
2001; Gujral et al., 2002; Lawson et al., 1999). Our TUNEL analysis also showed that 
the pancaspase inhibitor Z-VAD-fmk completely prevented the appearance o f  apoptotic 
cells after AAP administration and prevented the appearance o f  liver damage. A  similar 
protective effect against AAP-induced liver damage was also observed with Z-DEVD- 
cmk (Anwar, 2001). Both o f  these results confirm that DNA fragmentation in AAP 
toxicity is caspase-dependent.
We found that most TUNEL-positive hepatocytes were found in the midzonal area and 
had nuclei that were highly condensed when examined by using the nucleic acid counter 
stain propidium iodide (PI). Moreover, the distribution o f  the TUNEL fluorescence was 
restricted to the nuclear area and was not observed in the cytoplasm. This shows that 
under our experimental conditions the TUNEL technique unambiguously identified 
apoptotic cells rather than necrotic cells. This was further corroborated by transmission 
electron microscopy (TEM) which showed that the hepatocytes in the congested zone
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generally showed well-formed stacks o f  rough endoplasmic reticulum with little evidence 
for damage to mitochondria (unpublished data) (Anwar, 2001).
These findings strongly support the occurrence o f  limited set o f  apoptotic features in 
AAP hepatotoxicity. This is in clear distinction to another study (Gujral et al., 2002) 
where the TUNEL-positive cells were localised around the centrilobular areas and were 
characterised by a generalised (but not nuclear) TUNEL staining o f  the cells and features 
typical o f  necrosis. The difference between our study and the latter is most likely due to 
differences in strain (C3HeB/FeJ versus BALB/c mice) and experimental conditions 
(300mg/kg in fasted animals versus 500mg/kg with access to food and water ad libitum), 
and this probably also explains why the latter laboratory did not see any protective effect 
o f  Z-VAD-fmk against AAP-induced hepatic injury in a previous study (Lawson et al.,
1999).
The absence o f  execution caspase activation is not in contradiction with the occurrence o f  
apoptotic nuclear condensation and DNA fragmentation [as detected by the TUNEL 
reaction or as oligonucleosomal-length fragments when resolved by agarose gel 
electrophoresis (Ray et al., 1990)].
Recently, Strasser and colleagues (Marsden et al., 2002) reported that the kinetics o f  
apoptosis in caspase-9'^' or Apaf-T^' cells is virtually indistinguishable fi*om that observed 
in wild-type cells. In these knockout cells, caspase-3 processing was completely absent 
and only barely detectable levels o f active caspase-7 were reported.
Therefore, the classic pathway o f  execution caspase activation downstream o f  
mitochondrial cytochrome c release may be redundant for the generation o f  some
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apoptotic features. The lack o f  caspase-3 activation would help explain why the PI- 
counterstained nuclei o f the TUNEL-positive parenchymal cells in the AAP-treated livers 
were highly condensed rather than typically fragmented as found after in vivo CD95 
stimulation (Ogasawara et al., 1993) and resembled the abnormal apoptotic nuclear 
morphology o f  hepatocytes following CD95-activation in caspase-3'^' mice reported by 
others (Zheng et al., 1998).
7.5 Initiation of paracetamol-induced apoptosis involves mitochondria:
Role of Bcl-2 family members
Bcl-2 family members play a key role in processes underlying programmed cell death or 
apoptosis (Jacobson, 1997; Kroemer, 1997; Reed, 1997). It is increasingly appreciated 
that proteins o f  the Bcl-2 family are crucially involved in the control o f  apoptotic 
pathways (Chao and Korsmeyer, 1998; Vander Heiden and Thompson, 1999).
This family o f  proteins is composed o f  both proapoptotic (Bax, Bak, Bok, Bik, Blk, Bcl- 
xs. Bad, Bid, Hrk, BNIP3, BimL, Bad, and EGL-1) and antiapoptotic (Bcl-2, B cI-xl, Bcl- 
w, M cl-l, A l, NR-I3, BHRFl, LMW5-HL, 0RF16, KS-Bcl-2, E1B-19K, and CED-9) 
molecules (Adams and Cory, 1998; Antonsson and Martinou, 2000). These proteins can 
form homo- and hetero-dimers that involve amino acid sequences known as Bcl-2 
homology (BH) domains. Although four BH domains (BH1-BH4) have been identified 
(Kelekar and Thompson, 1998; Kroemer, 1997; Reed, 1997), it is the BH3 domain o f  
proapoptotic members that is vitally important as it appears to be required for the 
interaction between anti- and proapoptotic molecules (Chittenden et al., 1995).
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The Bcl-2 family members Bax and Bid act as promoters o f apoptosis (Eskes et al., 1998; 
Jurgensmeier et al., 1998; Li et al., 1998; Luo et al., 1998; Narita et al., 1998; Rosse et 
al., 1998) and translocate to mitochondria to facilitate the release o f  cytochrome c (and 
other proteins resident in the intermembrane space) into the cytosol, where it binds to a 
complex o f  proteins to form the apoptosome (Bossy-Wetzel and Green, 1999; Eskes et 
al., 2000; Gross et al., 1999b; Kluck et al., 1999; Vander Heiden and Thompson, 1999; 
Zheng et ah, 2000). The apoptosome then promotes the self-cleavage o f  procaspase 
enzymes, which leads to the activation o f executioner caspases (Green, 2000). Emerging 
evidence indicates that Bid is involved in various pathways o f  apoptosis that interplay the 
activation o f caspases with mitochondrial dysfunction (Green, 2000; Gross et al., 1999b; 
Kudla et al., 2000; Luo et al., 1998; Wei et al., 2000; Yin et al., 1999; Zha et al., 2000).
Here we report that the induction o f  the initial apoptotic response by AAP involved 
mitochondria, most likely through the recruitment and activation o f  the pro-apoptotic 
Bcl-2 family members Bax and Bid and the release o f  cytochrome c. The dimerization o f  
Bax is an initial event in the integration o f  Bax into the mitochondrial outer membrane 
(Antonsson, 2001; Antonsson et al., 2001; Gross et al., 1998; Wolter et al., 1997), and 
once integrated it is thought that Bax oligomerizes to form a cytochrome c-permeable 
channel (Epand et ah, 2002; Pavlov et ah, 2001; Saito et ah, 2000).
It has also been shown that the BH3-only protein Bid facilitates Bax oligomerization and 
insertion into the mitochondrial outer membrane, a process that is executed even more 
efficiently by the C-terminal part o f  cleaved Bid (called truncated Bid or t-Bid) (Eskes et 
ah, 2000; Korsmeyer et ah, 2000; Kuwana et ah, 2002; Roucou et ah, 2002).
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In this study we found that Bid was cleaved to a pi 5 truncated form o f  similar apparent 
molecular mass as t-Bid and was translocated to the mitochondrial fraction in response to 
AAP treatment. The ability o f  the pancaspase inhibitor Z-VAD-fmk to block Bid 
proteolysis after AAP administration implicates caspase-8 and the participation o f  a death 
receptor in AAP-induced liver injury (Li et al., 1998; Luo et al., 1998), and suggests that 
the formation o f t-Bid is mediated by caspases rather than by calpains (Chen et al., 2001) 
or lysosomal proteases (Stoka et al., 2001).
Whether Bid cleavage in AAP hepatotoxicity occurred through an indirect activation o f  
caspase-8 by downstream effector caspases or was mediated by caspase-8 through the 
CD95 pathway (Fiorucci et al., 2002; Zhang et al., 2000a) or by TNF (Laskin et al., 
1995) remains to be elucidated.
Another feature observed in this study was that not only t-Bid but also full-length Bid 
relocated to mitochondria in response to AAP and anti-CD95 antibody treatment. This 
phenomenon has recently been observed in the presence o f  physiological concentrations 
o f  phospholipids (such as phosphatidic acid and phosphatidylglycerol) and proposed a 
major role for Bid in cellular lipid transfer between mitochondria and other intracellular 
membranes, thereby explaining the dynamic relocation o f  intact Bid (and t-Bid) to the 
mitochondria (Esposti et al., 2001).
This may be related to the propensity o f  t-Bid to bind to cardiolipin, which is a membrane 
lipid unique to mitochondria (Lutter et al., 2000). The presence o f  intact Bid in 
mitochondria has also been confirmed in other studies (Desagher et al., 1999; Tafani et 
a l ,  2002b).
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In our study, there were differences in the extent o f  Bax translocation between AAP and 
anti-CD95 treatments. In addition, the translocation o f Bax in response to anti-CD95 
antibody treatment was nearly completely dependent on caspases (and possibly Bid 
truncation) as evidenced by the ability o f  the pan-caspase inhibitor Z-VAD-fmk to block 
both Bid processing and Bax translocation. In the case o f  AAP, Bax translocation to the 
mitochondria was observed in agreement with a previous report (Adams et al., 2001). 
However, Z-VAD-fmk, although inhibiting Bid proteolysis, failed to prevent Bax 
translocation.
These findings suggest that CD95 death receptor mediated apoptosis in the liver proceeds 
primarily via caspase-8-mediated Bid truncation, which is in agreement with the report 
that Bid-deficient mice are nearly completely resistant to anti-CD95 antibody-induced 
hepatocyte apoptosis in vivo (Yin et al., 1999). In contrast, additional factors must be 
involved in AAP-induced Bax translocation to mitochondria. Such factors mediating Bax 
translocation could include a perturbation o f  intracellular Ca^  ^ homeostasis (Pan et al.,
2001), ATP depletion (Mikhailov et al., 2001), a loss o f  mitochondrial membrane 
potential (Smaili et al., 2001), or changes in intracellular pH (Tafani et al., 2002a), all o f  
which have previously been shown or are likely to occur and play a critical role in AAP 
injury (Jaeschke, 1990; Kamendulis and Corcoran, 1992; Kass et al., 1992; Moore et al., 
1985; Weis eta l., 1992a).
At the same time that Adams et al (Adams et al., 2001) reported the crucial role played 
by Bax as an early determinant o f  AAP-mediated hepatotoxicity in mice, they also found 
that overexpression o f the anti-apoptotic protein Bcl-2 not only failed to protect against 
AAP toxicity but, unexpectedly, exacerbated the degree o f injury. The reason for this is
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unclear, although the phenomenon appears similar to the apparently paradoxical 
aggravation o f  ischaemia/reperfusion-induced liver cell apoptosis and hepatic damage in 
Bcl-2-overexpressing mice (Oshiro et ah, 2002).
In agreement with other reports (Adams et al., 2001; Ferret et al., 2001; Knight and 
Jaeschke, 2002), AAP overdose in our project induced the release o f  cytochrome c (Cyt 
c) from mitochondria to the cytosol. The fact that Cyt c release into the cytosol occurred 
even in the presence o f  the pancaspase inhibitor Z-VAD-fmk suggests that the release in 
AAP toxicity takes place in a caspase-independent manner.
It is known that cytochrome c translocation from mitochondria is a multistep process 
involving an increase in outer membrane permeability, the diffusion o f  a small pool o f  
unbound cytochrome c and the dissociation o f the bulk o f  the mitochondrial cytochrome 
c from cardiolipin binding site followed by its release from mitochondria (Ott et al.,
2002). The peroxidation o f  cardiolipin was recently reported after AAP administration to 
mice, and this correlated with a loss o f mitochondrial cytochrome c (Ferret et al., 2001).
Interestingly, the in vitro induction o f  necrosis by AAP may not trigger the release o f  
cytochrome c from mitochondria (Nagai et al., 2002), the latter requiring an apoptotic 
costimulus. However, the relevance o f these in vitro findings to the present in vivo study 
remains to be determined.
The extent o f  cytochrome c released from mitochondria in our study was essentially 
identical after anti-CD95 antibody treatment or AAP administration, and accounted for 
more than 50% o f  the total mitochondrial cytochrome c content. Z-VAD-fmk only had a 
minor inhibitory effect in the case o f CD95 but had no detectable effect on AAP-induced
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cytochrome c release. In addition, AK, a protein o f twice the molecular weight o f  
cytochrome c, was also released to a virtually identical degree.
Also, in this study and in agreement with previous reports (Burcham and Harman, 1991; 
Katyare and Satav, 1989), we have demonstrated the loss o f succinate dehydrogenase 
(SDH) activity in AAP-treated BALB/c mice (compared to saline-treated controls). This 
further implicates NAPQI in disrupting mitochondrial respiration and compromising 
cellular energy homeostatsis in paracetamol toxicity.
Although cytochrome c and AK release could have occurred in the absence o f  inner 
membrane permeability transition (MPT) (Jurgensmeier et al., 1998; Pavlov et al., 2001; 
Waterhouse et al., 2001), several studies would support a model for the release o f  
cytochrome c from mitochondria in the liver in situ implicating MPT in addition to Bax. 
A-acetyl-^-benzoquinone imine (NAPQI), the reactive metabolite o f  AAP, has previously 
been shown to induce damage to mitochondria through its pro-oxidant activity and Ca^  ^
mobilization and is capable o f  inducing MPT in isolated mitochondria (Weis et al., 
1992a) and in isolated rat hepatocytes (Kass et al., 1992), whereas the MPT inhibitor 
cyclosporin A was found to protect from AAP hepatotoxicity in vivo (Haouzi et al., 
2002).
As other reports have demonstrated that MPT (and outer mitochondrial membrane 
damage) occurs in response to CD95 activation in hepatocytes in vitro (Hatano et ah,
2000) and in vivo (Feldmann et al., 2000) and in TNF-induced hepatocyte apoptosis in 
vivo (Angermuller et al., 1999) and, as the pretreatment with cyclosporin A (a 
permeability transition inhibitor) prevented or considerably delayed both anti-CD95 
antibody-(Feldmann et al., 2000) and TNF-(Pastorino and Hoek, 2000) induced
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mitochondrial outer membrane rupture, cytochrome c release, and apoptosis, we therefore 
concluded that our observations fit a model whereby in vivo cytochrome c release after 
AAP administration to BALB/c mice occurs in response to MPT.
7.6 Lack of execution caspase activity in paracetamol toxicity
Caspases are cysteine proteases, the active site o f which is highly conserved among all 
caspases. Caspases require a reduced cysteine for their proteolytic activity (Hentze et al., 
2000; Hentze et al., 1999).
In our study, we were unable to correlate the protection by the caspase inhibitors (Z- 
VAD-fmk and Z-DEVD-cmk) with an increase in caspase activity or the detection o f  the 
active form o f caspases-3 and -7. Using the caspase-3 and -9 peptide substrates, Ac- 
DEVD-afc and Ac-LEHD-afc, a significant decrease in activity was measured when 
serum levels o f  ALT began to rise. Examination o f  the time course o f  the inhibition 
revealed that the inhibition o f  Ac-DEVD-afc and Ac-LEHD-afc occurred at 3hr post 
dosing, which corresponds to the time when AAP-induced liver damage became 
detectable on histopathology. This lack o f  caspase activity was not due to release o f  
caspases into the serum as DEVDase activity in serum from AAP-treated BALB/c mice 
was negligible. Also, this caspase inactivity was not due to the presence o f  endogenous 
caspase inhibitors in the liver homogenates o f AAP-treated animals as homogenates from 
those animals failed to suppress the DEVDase activity o f  positive controls (thymocyte 
apoptotic extract incubated with IpM dexamethasone for 6h).
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Such lack o f caspase activation could have been due to oxidation or covalent adduct 
formation with the caspases which are known to possess thiol group(s) (Lawson et ah, 
1999). Consequently, this may inactivate the caspases (Nobel et al., 1997) or interfere 
with their activation pathway (Hentze et al., 1999).
This could also be secondary to glutathione (GSH) depletion as recent reports (Hentze et 
al., 2003; Hentze et al., 2002) have suggested that GSH depletion can block death 
receptor-induced apoptosis at basically three levels within the signaling cascade: (1) the 
conversion o f  inactive procaspase-8 to active caspase-8; (2) the caspase-9-mediated 
apoptosome pathway; and (3) the enzymatic activity o f  the executioner caspase-3.
As loss o f GSH and modification o f protein sulfhydryl groups is well documented in 
AAP toxicity (Moore et al., 1985; Tirmenstein and Nelson, 1990; Weis et al., 1992b), we 
can therefore conclude that it is the delicate balance between the physiological 
antioxidants (like GSH) and various oxidants which will determine whether caspase- 
initiated apoptosis in AAP toxicity can proceed to completion.
Another likely reason for failure to activate caspases is depletion o f cellular ATP which is 
characteristic o f AAP intoxication. As described earlier, AAP can disrupt mitochondrial 
function (Knight and Jaeschke, 2002; Meyers et al., 1988; Ruepp et al., 2002; Strubelt 
and Younes, 1992; Weis et al., 1992a) and result in cellular ATP depletion (Jaeschke, 
1990; Knight and Jaeschke, 2002; Tirmenstein and Nelson, 1990).
Cellular ATP content is an apoptosis-related metabolic parameter that may be modified 
selectively in the liver (Eguchi et al., 1997; Leist et al., 1997b). ATP depletion affects 
apoptotic pathways in three fundamentally different ways. First, biochemical evidence
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suggests that ATP, together with cytochrome c, is needed for the formation o f the 
apoptosome (Li et al., 1997b; Liu et al., 1996). Accordingly ATP depletion will prevent 
activation o f  execution caspases at a step downstream o f cytochrome c release (Leist et 
al., 1999a; Stridh et al., 1999). Such cells with damaged mitochondria are in most cases 
still destined to die, but the absence o f caspase activity switches the mode o f  cell death 
from apoptosis to necrosis (Eguchi et al., 1997; Kim et al., 2003; Leist et al., 1997b; 
Leist et ah, 1999a; Leist et al., 1999b; Stridh et al., 1999; Tsujimoto, 1997). Second, in 
some models, ATP depletion may block apoptotic steps upstream o f  cytochrome c release 
(Leist et al., 1999b; Stridh et al., 1999). In such cases, both caspase activation and 
mitochondrial damage are prevented, and cells may truly survive (Volbracht et al., 1999). 
Finally, in cases where CD95 stimulation triggers a cascade o f  proteolytic events that 
directly lead to apoptosome-independent activation o f  effector caspases, ATP depletion 
may have no effect at all on caspase activation (Eguchi et al., 1999) or cell death (Ferrari 
e ta l., 1998).
AAP is both a notorious producer o f  reactive oxygen species (ROS) and a potent inducer 
o f  oxidative stress (Wendel, 1983; Wendel, 1984; Wendel et al., 1979; Wendel and 
Hallbach, 1986; Wendel and Jaeschke, 1982; Wendel et al., 1982). Reactive nitrogen 
species (particularly nitric oxide NO) may too be important in AAP hepatotoxicity 
(Jaeschke et ah, 2003; James et ah, 2003). Thus, another reason for inability to activate 
caspases may relate to the production o f  ROS and nitrogen species, as both o f  which can 
block caspase activity.
As caspases are redox sensitive enzymes, they are regulated by ROS (Fadeel et al., 1998). 
In the oxidative-stress model, generation o f  ROS (namely hydrogen peroxide) through
164
redox cycling inhibits caspase activity, and caspase inactivation by this mechanism may 
prevent cell death by apoptosis (Samali et al., 1999). Other reports suggest that, 
depending on the degree o f  the initial oxidative stress, caspases are either activated and 
the cells die by apoptosis, or they remain inactive and therefore degenerate into necrosis 
(Hampton and Orrenius, 1997).
By regulating the activity o f  caspases, nitrogen species can also interfere with the 
execution steps o f  apoptosis. This may take place either upstream (i.e. processing o f  
caspases-3 and -7) (Dimmeler et al., 1998) or downstream o f  cytochrome c release 
(Torok et al., 2002; Zech et al., 2003) or both (Kim et ah, 2002; Leist et al., 1999b; Li et 
1999).
However, given that the execution caspases-3 and -7 were not activated under our 
experimental conditions, it is clear that the apoptotic response to AAP was not properly 
executed and most likely degenerated to give features o f  premature secondary necrosis, a 
conclusion that was supported by other reports (Adams et al., 2001; Pierce et al., 2002).
We also concluded that apoptosis has an important causal role in initiating the damage 
but because o f  the lack o f completion o f the process (possibly due to excessive loss o f  
ATP) and its degeneration, the ultimate damage to the liver presents many features o f  
necrosis, which is in clear agreement with the majority o f  publications (Adams et al., 
2001; Gujral et ah, 2002; Knight and Jaeschke, 2002; Pierce et al., 2002).
The identity o f  the caspase(s) that is (are) responsible for initiating AAP-induced liver 
cell damage and was (were) targeted by the pancaspase inhibitor Z-VAD-fmk in this 
study remains unclear.
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Although the reactive haloketone moiety o f  the peptide inhibitors has previously been 
reported to interact with other proteases such as cathepsin B (Schotte et ah, 1999), we 
found that the nonselective fmk-based peptide Z-FA-fmk failed to inhibit AAP-induced 
liver injury. This confirms that the peptide inhibitors used in this study acted by targeting 
the caspases involved in apoptosis.
Increasing the dose o f  AAP to > 600 mg/kg resulted in the loss o f  the protective effect o f  
the caspase inhibitors used. Consequently, it was concluded that the dose window for Z- 
VAD-fmk protection is relatively narrow. This suggests that the role o f apoptosis in 
initiating key events that lead to liver damage in AAP toxicity is restricted to the lower 
portion o f  the hepatotoxic dose o f  AAP, whereas at higher concentrations the primary 
mechanism initiating cell death is necrosis.
As published reports on cases o f  adult human AAP overdosage showed that the quantities 
o f  ingested AAP required to result in acute hepatic (and hepatorenal) failure ranged 
between 14-142g (equivalent to 200-2000 mg/kg) (Prescott, 1996), and as the dose o f  
AAP used in this study (500mg/kg) was well within this range, we therefore felt the 
limitation o f apoptosis to this lower portion o f  hepatotoxic dose o f AAP (as used in our 
mouse-model) is o f  great relevance to clinical cases o f  human AAP toxicity.
Taken together our results show that caspases and apoptosis play an important causal role 
in the mechanism o f  AAP-induced hepatic injury by initiating the sequence o f  events that 
ultimately lead to liver necrosis.
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7.7 Sinusoidal endothelial and Kupffer cells in paracetamol
hepatotoxicity: Role of hepatic congestion and cytokines
In our project, six hours after BALB/c mice were overdosed with AAP (500mg/kg), the 
animals were hypothermic and the livers were grossly enlarged with massive 
accumulation o f RBCs. The critical mechanism responsible for the congestion in the 
liver appears to be the damage induced by AAP to the sinusoidal endothelial cells 
(SECs). Such damage was documented (using TEM) and was in agreement with earlier 
reports both in mice (Walker et ah, 1983) and patients (Bramley et al., 1991).
Hepatic congestion secondary to damaged SECs leads to the disruption o f  hepatic 
micro vascular perfusion which may then lead to acute liver injury and subsequent liver 
failure (Gao et al., 1998; Takei et al., 1991; Thurman et al., 1988; Wanner et al., 1999). 
Congestion may also be more critical in the development o f AAP-mediated hepatic injury 
than the direct cytotoxic effects o f  NAPQI on parenchymal cells (Dahlin et al., 1984; 
Jollow et al., 1973; Mitchell et al., 1973a). The latter is typical o f the first phase o f  
injury, and in this study centrilobular parenchymal cell necrosis was evident by 2-3 hours 
post AAP administration but then regressed thereafter even though liver injury continued 
to develop.
Prevention o f  endothelial cell damage by the caspase inhibitors blocked the development 
o f  liver apoptosis, liver damage, and went on to protect from liver failure induced by 
AAP. The critical role o f  endothelial cell damage and ensuing congestion in liver failure 
is also supported by recent work on the death receptor CD95 (Nishimura et al., 1997; 
Wanner et al., 1999), on ischaemia-reperfusion-induced liver injury and concanavalin A-
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induced hepatitis (Gao et ah, 1998; Knolle et al., 1996; Samarasinghe and Farrell, 1996; 
Takei et al., 1995; Takei et al., 1991; Thurman et al., 1988).
The fact that no TUNEL-positive SECs were identified in sections obtained six hours 
after AAP-dosing o f  BALB/c mice suggests that endothelial cell apoptosis did not go to 
completion, but rather was only sufficient to cause the formation o f  large pores through 
reorganization o f  the cytoskeleton o f  the SECs. However, a more recent re-investigation 
o f  the time-course o f  AAP-induced hepatic damage has revealed the presence o f  TUNEL- 
positive SECs at four hours following AAP administration (Hinton R and Kass GEN, 
unpublished results).
It is well known that SECs are exceedingly sensitive to damage during reperfusion 
(Deaciuc et al., 1999; Gao et al., 1998; Samarasinghe and Farrell, 1996; Takei et al., 
1991; Thurman et al., 1988) and to TNF (Takei et al., 1995). Although direct activation 
o f AAP by the SECS has been documented (DeLeve et al., 1997) and a further 
contribution by parenchymal cell-produced NAPQI is also likely, it is still difficult to 
establish the exact mechanism by which AAP is cytotoxic to SECs in vivo.
To investigate the role o f  Kupffer cells in AAP-hepatotoxicity, we used gadolinium 
chloride (GdCls) as a suppressor o f  Kupffer cell function (Husztik et al., 1980; Laskin et 
al., 1995). Pretreatment o f  BALB/c mice with GdCls did not prevent the rise in serum 
transaminases or the appearance o f damaged and congested areas. However TUNEL 
staining confirmed that GdCfi-pretreatment prevents the formation o f  apoptotic cells. 
This lack o f protection (against hepatic injury) by GdClg rules out a Kupffer cell- or a 
macrophage-derived component such as TNF or nitric oxide as major effectors o f  hepatic 
damage in AAP-induced injury. Conversely, the ability o f  GdCls to prevent apoptosis o f
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parenchymal cells implicates the direct involvement o f Kupffer cell-derived cytokines in 
hepatocyte apoptosis.
Our results are in contrast with the study by Laskin and co-workers (Laskin et a l ,  1995) 
who showed that pretreatment o f  Long Evans Hooded rats with GdCfi, completely 
blocked AAP (800mg/kg)-induced hepatic necrosis, the increase in serum transaminases, 
and liver damage. It is likely that species differences account for this difference in 
response to AAP. In fact, it is known that SECs show marked strain differences in their 
susceptibility to cytotoxic damage by AAP (DeLeve et al., 1997). The latter also 
probably accounts for the lack o f  cytoprotection by Z-VAD-fmk from AAP-induced 
hepatic damage in fasted C3Heb/FeJ mice (Lawson et al., 1999) while in this study fed 
BALB/c mice were used.
In this thesis, we report that Kupffer cell-derived cytokines are responsible for 
parenchymal cell apoptosis in AAP-induced liver injury. However, inhibition o f  
parenchymal cell apoptosis does not prevent hepatic injury and liver failure. In contrast, 
damage to the sinusoidal liver endothelium appears to be the critical event that is 
responsible for liver failure through hemorrhagic damage and shut down o f  hepatic 
microvascular perfusion.
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7.8 CONCLUSION
In conclusion, our results show that the initiation o f  mitochondrial pathway o f  apoptosis 
was shared by both CD95 and AAP. Yet, whereas anti-CD95 antibody treatment 
activated the full caspase cascade as evidenced by the large increase in DEVDase 
activity, the apoptotic pathway was only incompletely activated in response to AAP 
treatment. Instead, it degenerated to induce premature secondary necrosis.
The development o f  liver injury in AAP overdose was not directly related to parenchymal 
cell apoptosis. Instead, damage to the sinusoidal endothelial cells appeared responsible 
for liver failure through haemorrhagic damage and shut down o f  hepatic microvascular 
perfusion.
The protection provided by the caspase inhibitors highlights the importance o f  caspases 
(Figure 35) and apoptosis in initiating the events that lead to AAP-induced hepatic injury 
and subsequent necrosis. However, further work is necessary to identify the caspase(s) 
that initiate AAP-induced liver injury.
Even though the execution o f  apoptosis may be carried out by other types o f  proteases 
whose identity remains to be established, the ability o f  caspase inhibitors to block the 
development o f  liver failure should encourage further work into the possibility o f  
targeting caspases as a therapeutic opportunity in AAP-induced liver injury.
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Figure 35. Schematic representation of in vivo paracetamol-mediated apopotosis and 
caspase activation. This pathway shows the working relationship between the paracetamol 
metabolite NAPQI, TNF, caspases, Bid, Bax, and their convergence on the mitochondria and the 
role played by the pancaspase inhibitor Z-VAD-fmk in modulating this response. Paracetamol 
appears to activate apoptosis through both Kupffer cell (KC)-derived cytokine (TNF) release 
causing death receptor-mediated apoptosis o f parenchymal cells (Pathway I) and a direct 
activation pathway o f the mitochondria (Pathway II). The latter may play a predominant role in 
apoptosis o f SECs and may be responsible for the hepatic congestion described in this thesis.
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